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Abstract  2 
Abstract 
 
Arboviruses (Arthropod-borne viruses) cause acute diseases that are increasingly 
affecting both human and animal health. Currently, there is a critical lack of 
understanding about the nature of arbovirus-host interactions in the lymph 
nodes (LNs), the place where the adaptive immune response is initiated and 
shaped. In this study, we used bluetongue virus (BTV) and its natural sheep host, 
to characterise the early events of an arbovirus infection with particular focus 
on the LNs. Our findings reveal a previously uncharacterized mechanism used by 
an arbovirus to manipulate host immunity. This study shows that BTV, similarly 
to other antigens delivered through the skin, is transported rapidly via the lymph 
to the peripheral lymph nodes. Here, BTV infects and disrupts the stromal 
network of marginal reticular cells and follicular dendritic cells composing the 
scaffolding of the follicular area. These cells contribute to antigen presentation 
and affinity maturation of B-cells for the production of antibodies. 
Consequently, we observed a loss of germinal centre structure, which hinders B-
cell proliferation. This process results in a delayed production of high affinity 
and virus neutralizing antibodies that is directly related to the virulence of the 
BTV strain used and the severity of disease. Moreover the humoral immune 
response to a different antigen is also hampered in BTV-infected animals.  Our 
data show that an arbovirus can evade the host antiviral responses by inducing 
an acute immunosuppression. Although transient, this immunosuppression occurs 
at the critical early stages of infection when a delayed host humoral immune 
response likely affects virus systemic dissemination and the clinical outcome of 
disease.   
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1 Introduction 
 
1.1 Bluetongue  
Bluetongue is one of the main vector-borne diseases affecting ruminants. It is 
caused by bluetongue virus (BTV) a double stranded RNA virus classified within 
the family Reoviridae, genus Orbivirus. BTV is transmitted through the bite of 
blood feeding insects of the Culicoides genus. The range of susceptible hosts to 
BTV includes both wild and domestic ruminants. In most cases BTV infection is 
asymptomatic or results in a mild clinical disease. However, in some occasions, 
bluetongue can evolve towards a severe haemorrhagic fever with poor prognosis.  
1.1.1 History of Bluetongue 
The first report of an outbreak of Bluetongue was described in South Africa in 
1905 by James Spreull (Spreull 1905) when Merino sheep were introduced for the 
first time into the region in the late 18th century. Probably the virus had been 
circulating in the indigenous ruminant population for a long time. The disease 
was originally called “epizootic catarrh” or “malarial catarrhal fever” and only 
later was named bluetongue after the Afrikaans “blaauwtong”, the term used by 
local people to describe the cyanotic tongue presented by severely affected 
sheep. Until 1920s bluetongue remained confined to the African regions, then it 
made its first appearance in Cyprus in 1924 with recurrent outbreaks until 1943 
(Gambles 1949). Soon after bluetongue was recognised as the causative agent of 
the “sore muzzle” in California in 1952 (Hardy & Price 1952). Thereafter, 
Bluetongue has been identified in in many regions of Africa, Americas, Australia 
and Europe. Currently only Antarctica is unaffected by Bluetongue.  
Many of the initial seminal discoveries about BTV have been made at the 
Onderstepoort Veterinary Institute (OVI) in Pretoria, South Africa. In 1906, Sir 
Arnold Theiler was the first to demonstrate that the disease was caused by a 
filterable agent present in the blood of affected sheep, thus indicating that a 
virus was the etiological agent of bluetongue (Coetzee et al. 2012). Only few 
years later, Theiler obtained a crude blood vaccine that was obtained by 
passaging multiple times the virus in sheep (Theiler 1907), this attenuated virus 
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vaccine was extensively used in South Africa for over 40 years and could confer 
protection against several serotypes, although with some variability and failures. 
Following the first reported infection, it was immediately clear that the disease 
was not contagious, as it could not be transmitted by close contact between 
healthy and diseased animals (Spreull 1905). However, blood, serum and spleen 
extracts from infected animals were recognised as a source of infection when 
inoculated in healthy animals, independently of the chosen routes (intravenous, 
subcutaneous, intradermal or intraperitoneal) (Spreull 1905). The observation 
that bluetongue occurred with a seasonal peak and that sheep could be 
protected by overnight stabling, led to the hypothesis that an arthropod vector 
could have been involved in the transmission cycle of the disease. In 1944 this 
suspecion was confirmed by Du Toit, which demonstrated that sheep developed 
bluetongue when inoculated with a suspension of adults Culicoides imicola 
caught in the wild. In addition, the same author also showed that the disease 
was reproduced when Culicoides were fed on infected sheep and subsequently 
allowed to fed on susceptible animals after an incubation period of 10 days (Du 
Toit 1944). 
Given the unreliable protection conferred by Theiler’s vaccine, the existence of 
a plurality of BTV serotypes was long hypothesized. However, it was 
demonstrated only many years later by Neitz, who established cross-protection 
serological test in sheep (Neitz 1948). This study confirmed that sheep, after 
recovering from BTV infection, acquired a lifelong protective immunity against 
the same serotype, but only a partial protection against different serotypes. An 
in vitro serum neutralization test was developed in the 1960s and led to the 
characterization of 12 different serotypes circulating in South Africa (Howell et 
al. 1970).  
With the advent of laboratory techniques such as virus isolation and propagation 
in fertilised chicken eggs and later in cell culture, it become possible to start 
the production of more effective multivalent-vaccines, able to confer protection 
against different serotypes (Coetzee et al. 2012). Nowadays, the availability of 
reverse genetic and molecular biology techniques allow the production of 
recombinant vaccines (Calvo-Pinilla et al. 2014). However, despite the progress 
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in this area, a vaccine able to elicit a broad protection against the many existing 
BTV serotypes (currently 27 identified) is still not available. 
1.1.2 Emergence of Bluetongue in Europe 
BTV is widespread in tropical, subtropical and temperate zones of the globe. The 
disease is endemic mainly between latitudes 35°S and 40°N (Africa, Asia and 
South America), in areas where competent insect vectors are present. Several 
factors such as globalization, increase in international travelling and trades, 
movement of livestock, deforestation and climate change have been identified 
as facilitating the ongoing geographic expansion of competent insect vectors and 
the recent occurrence of bluetongue outbreaks in Northern Europe (MacLachlan 
et al. 2009; Mintiens et al. 2008; Purse et al. 2005). Hematophagous Culicoides 
insects are responsible for BTV transmission. More than 1000 species of 
Culicoides are present worldwide but only some of them have been identified as 
competent BTV vectors. The regional distribution of Culicoides varies and 
particular associations have been noticed between certain Culicoides species 
and specific BTV serotypes. The classical African-Asian vector for BTV is 
Culicoides imicola, which was absent in Europe until 1998 and it is now widely 
distributed in Mediterranean European regions. However, different Palearctic 
species, such as Culicoides obsoletus, Culicoides pulicaris, Culicoides dewulfi, 
Culicoides scoticus, and Culicoides chiopterus, seem to be responsible for BTV 
distribution in Northern Europe. Therefore, it is likely that the spread of BTV in 
Europe is the consequence of an adaptation of the virus to different vector 
species, living at colder temperatures. Similarly, in the Americas, BTV-10, 11, 13 
and 17 are widely distributed in areas corresponding to the presence of 
Culicoides sonorensis. On the contrary, BTV-2 seems to be restricted to the 
Southern regions due to its adaptation to Culicoides insignis. 
After its first description in South Africa, more than a century ago, the 
geographical distribution of BTV has been constantly expanding. The first severe 
outbreak in Europe occurred in 1956 in the Iberian Peninsula, where BTV-10 
killed approximately 180,000 sheep (MacLachlan 2011; Sellers et al. 1978; Pérez 
de Diego et al. 2014). Following this outbreak, it became clear that BTV could 
become established in Europe. Therefore, as a precautionary measure, the 
World Organization for Animal Health (OIE) classified BT as a list "A" notifiable 
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disease, which includes veterinary diseases that have the potential for very 
serious and rapid spread, and which have serious socio-economic or public health 
consequence (OIE - World Organisation for Animal Health 2016a). This imposes 
severe limitation in trade and livestock movement in the affected country, in 
order to prevent the spread of the disease. 
Before 1998, brief recurrent BT outbreaks have been observed in the 
Mediterranean regions of Europe, due mainly to livestock trade with the North 
African countries and wind-dispersal of infected midges across the 
Mediterranean Sea (Purse et al. 2005). Indeed, infected Culicoides can be 
passively disseminated with the wind for long distances (Carpenter et al. 2009). 
However, the pattern of BTV prevalence in Europe started to change radically in 
October 1998 (Figure 1-1), when BTV-9 was detected for the first time in the 
Greek Islands of Kos, Rhodes, Leros and Samos, close to the Turkish coast. From 
there, the outbreak expanded northward reaching Albania, Serbia, Bosnia, 
Croatia and Montenegro and westward into mainland Greece and Italy (Purse et 
al. 2005). BTV-1, 4 and 16 followed the same distribution route, reaching Italy, 
Corsica and the Balkan countries (MacLachlan 2011; Purse et al. 2005). Incursion 
of BTV-2 also occurred in 2000, spreading from Tunisia and Algeria into mainland 
Italy, and the islands of Sardinia, Sicily, Corsica and the Baleares. In addition, in 
2004, BTV-4 reached the coast of Spain and Portugal from Morocco. From there 
on, BTV-1, BTV-2, BTV-4, BTV-9, and BTV-16 persisted in the southern European 
countries expanding the affected territories 800 km north from the usual 
localization (50°N) (Figure 1-1) (Saegerman et al. 2008).   
In 2006, the first cases of Bluetongue were detected in Northern Europe, with 
numerous infected herds in the Netherlands and Belgium. The serotype 
responsible was readily identified as BTV-8, and subsequent sequence analysis 
indicated the presence of similarities of this strains with field isolates from the 
sub-Saharan Africa (Maan et al. 2008). The outbreak expanded rapidly, reaching 
during the same year France, Germany and Luxembourg. The outbreak halted 
during the winter, when the cold weather reduced the activity of Culicoides. 
However, the cold temperature did not manage to extinguish completely the 
outbreak and the following spring the virus resurfaced in all the affected 
countries as well as in Denmark, Switzerland and Czech Republic (Wilson & 
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Mellor 2009). In 2007 BTV made also its first appearance in the United Kingdom 
(Wilson & Mellor 2009). 
 
Figure 1-1 Map of Culicoides and BTV distribution in Europe 
Map showing the distribution of BTV prior to 1998 (grey regions) and that of BTV since 1998 (up to 
November 2004, pink regions). Hatched lines indicate the approximate known northern and 
southern range limits of the three most important vector groups in Europe. Open circles indicate 
sites where Culicoides imicola was found to be absent before 1998. Picture adapted from:  (Purse 
et al. 2005). 
 
Inactivated vaccines against BTV-8, that were not available at the beginning of 
the European outbreak, started to be released on the market in early 2008 as a 
result of compulsory vaccination campaigns that limited significantly the 
propagation of disease. Only few cases of bluetongue were identified in 2008, 
when the virus reached Spain and Sweden (Roy et al. 2009; Wilson & Mellor 
2009). 
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It has been estimated that the cost of the 2007-2008 outbreak in France, 
amounted to 1.4 billion dollars. Besides the direct economic losses due to 
decreased livestock productivity, the emergency containment measures imposed 
by the OIE to control the outbreaks had a big economic impact on the 
agricultural sector, generating significant economic losses to the European 
Union. 
Many aspects of the 2007-2008 BTV-8 outbreak in Northern Europe were unusual. 
First, this was the first time that BTV spread and persisted for a long period of 
time at these latitudes. Secondly, the incursion route of this strain is still 
uncertain (Maan et al. 2008), since the Netherlands is located far from the BTV-8 
endemic regions, and therefore it could not originate from the classical routes of 
introduction previously described for Mediterranean Countries. The possibility of 
its introduction with trade of African flowers and plants, carrying infected 
Culicoides, or the untracked, illegal introduction of livestock are options that 
have been considered but never confirmed (Mintiens et al. 2008). 
Moreover, the BTV-8 strain responsible of the outbreak presented some 
unconventional features, displaying a highly virulent phenotype in sheep and 
inducing disease also in 10% of affected cattle, which generally are 
asymptomatic (Darpel et al. 2007; Elbers et al. 2008). Many reports highlighted 
the ability of this specific strain to cross the placental barrier between dam and 
foetus, allowing vertical transmission (Darpel et al. 2009; Santman-Berends et 
al. 2010; Dal Pozzo et al. 2009; Van Der Sluijs et al. 2013), a trait that has been 
generally associated solely with tissue culture adapted strains.  
 
1.1.3 Overwintering and unconventional transmission routes 
The transmission cycle of BTV can be maintained all year round in regions with 
mild winters like the tropics, whereas in temperate regions Bluetongue 
outbreaks generally appear in late summer to autumn, the period coinciding 
with the time of major activity of the competent vectors (White et al. 2005).  
One of the unsolved mysteries of Bluetongue is where the virus “hides” during 
the cold months, when the temperature drops below the threshold of activity of 
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the arthropod vector, and virus replication in the midge cease (White et al. 
2005; Carpenter et al. 2009). In temperate regions, transmission usually resumes 
after several months of quiescence, a period that is considered longer than the 
normal phase of infectious viraemia in the mammalian host and longer than the 
typical lifespan of the adult vector (Wilson et al. 2008). Plausible explanations 
have been proposed that includes host or vector related mechanisms.  
Adult Culicoides tend to survive no longer than 10–20 days and they are not 
tolerant to sub-zero conditions. Although unlikely, it is possible that BTV could 
persist in long-lived adult Culicoides that manage to survive the winter, 
contradicting reports describe an extended survival of this species during mild 
winter seasons if they can find an indoor shelter (Gerry & Mullens 2000; Wilson 
et al. 2008). However, most of the Culicoides species survive the winter as 
larvae; hence a logical option would be the possibility of transmission of the 
virus from adult midges to their offspring through a transovarian infection. 
Despite the detection of BTV RNA, experimental studies have failed to detect 
infectious virus in Culicoides larvae (White et al. 2005; Nunamaker et al. 1990; 
Wilson et al. 2008).  
Persistence of the virus in the mammalian host is another logical alternative. 
BTV infected animals develop long lasting viraemia. In blood, virus RNA 
detection, by means of qPCR, can give positive results in asymptomatic animals 
for a period of 7-8 months after initial infection. However, isolation of infectious 
virus from the blood is limited to the initial 2 months (Bonneau et al. 2002; 
Koumbati et al. 1999; Singer et al. 2001). After this period, the blood is not 
anymore considered as a source of infection for Culicoides (Bonneau et al. 2002; 
MacLachlan et al. 1994). These data suggest that it is unlikely that a ruminant 
host could function as a virus reservoir during the long time that elapses 
between two outbreaks. However, the presence of a chronic or latent infection 
in ruminants cannot be completely excluded (Wilson et al. 2008) for example in 
immunoprivileged sites in the host. This could give a relapse of infection and 
viraemia under certain circumstances, such as stressing conditions and 
immunosuppressive events. During an experimental BTV infection, it has been 
demonstrated that the virus could be recovered from  T cells, isolated from 
peripheral blood samples from day 3 to 13 pi, when these cells were cultured in 
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presence of IL-2 (Takamatsu et al. 2003). T-cells did not show cytopathic effect 
and survived for long time in culture with constant viral production, hence it was 
hypothesized a role of  T-lymphocytes in the relapse of infection. However, 
contrary to the in vitro data, it was not possible to isolate infected  T-
lymphocytes from sheep blood after the initial two weeks (Takamatsu et al. 
2003). Hence, the relevance of these observations in vivo would require further 
investigation. 
BTV transplacental and sexual transmission through the semen has generally 
been exclusively attributed to culture-adapted strain. A study in 1979, using 
tissue culture adapted strains, showed that sheep infected at mid-gestation with 
BTV serotype 4 and 16 produced clinically normal lambs that were viraemic for 2 
months after birth (Gibbs et al. 1979). Only recently, investigation of the BTV 
strain involved in the Northern Europe outbreak, has demonstrated 
transplacental transmission of BTV-8 and BTV-2 minimally passaged in tissue 
culture (Rasmussen et al. 2013). If confirmed, these observations indicate that 
vertical transmission could contribute to the long-term persistence in a 
asymptomatic host and the perpetuation of infection.  In addition, bulls and 
rams can occasionally shed virus with semen, although this seems to happen only 
in concomitance with viraemia, and this could potentially contribute to the 
venereal transmission of BTV (Gu et al. 2014; Kirkland et al. 2004). Currently, 
trade regulations require that breeding animals test negative for BTV before the 
export of semen. 
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Figure 1-2 Bluetongue virus transmission in summer and winter. 
In summer, there is alternative transmission between mammalian host and arthropod vector. 
During winter, various mechanisms of viral persistence have been hypothesised. Figure modified 
from (Wilson et al. 2008). 
 
There is also the possibility that BTV overwintering relies on the presence of 
unidentified animal reservoirs, such as small rodents, although currently these 
are only speculation (MacLachlan 2011). It is important to note that BTV 
neutralising antibodies have been found with high prevalence in wild African 
carnivores, such as lions, hyenas and wild dogs, and in domestic dogs and cats 
(Alexander et al. 1994). These carnivores likely contracted BTV through 
ingestion of infected ruminants carcasses, since the lack of seroconversion in 
smaller predators (jackals and mongoose) sharing the same environment rules 
out a transmission through the arthropod vector (Alexander et al. 1994). 
Similarly, in 1992 a canine vaccine accidentally contaminated with BTV serotype 
11 was administered to domestic dogs, causing severe disease and abortion in 
pregnant bitches. BTV was found in lung capillaries of the affected animals 
causing a lethal pulmonary ooedema (Brown et al. 1996) indicating that, under 
specific circumstances, this species could host the virus. However, the 
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epidemiological relevance of these observation together with an in depth 
analysis of BTV infection in carnivores is still missing.  
Circumstantial evidence are available for a wide variety of overwintering 
mechanisms, however the lack of substantial experimental and field-collected 
data do not provide enough support for any of the proposed mechanism. The 
establishment of a proper surveillance plan would certainly help in identifying 
which are the risks factors and the animal species involved in BTV epidemiology. 
 
1.2 Bluetongue virus (BTV) 
BTV is an Orbivirus of the family of Reoviridae, a widely distributed group of 
viruses infecting humans and other mammals (Rotaviruses, Orbiviruses, 
Seadornaviruses and Orthoreoviruses), fish (Aquareoviruses), birds 
(Orthoreoviruses), insects (Cypoviruses and Idnoreoviruses), plants (Oryzaviruses, 
Fijiviruses and Phytoreoviruses) and fungi (Mycoreoviruses) (Figure 1-3) (Roy et 
al. 2009).  
 
Figure 1-3 Reoviridae family, genus and host range. 
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Within the genus Orbivirus are included 22 virus species (representing 22 distinct 
virus serogroups) that have been recognized by the International Committee for 
the Taxonomy of Viruses (ICTV). Recently, phylogenetic comparisons of isolates 
from different Orbivirus species, with ‘unclassified’ isolate, have led to 
proposals to ICTV for recognition of seven additional species (Belaganahalli et al. 
2015). All orbiviruses are transmitted by hematophagous arthropod vectors, 
which include Culicoides, ticks and mosquitos (Figure 1-4). The range of 
susceptible mammalian hosts is wide and collectively includes domestic and wild 
ruminants, equines, marsupials, sloths, bats, birds and humans. 
 
Figure 1-4 Orbiviruses and their vectors.  
The genus Orbivirus includes 22 species that can be transmitted by different hematophagous 
arthropods vectors. 
 
The structure of the BTV virion has been investigated in detail in several studies 
(Verwoerd et al. 1972; Prasad et al. 1992; Grimes et al. 1998). BTV is a non-
enveloped double stranded RNA virus (dsRNA virus) with icosahedral structure, of 
about 80 nm in diameter. The capsid is composed of 3 protein layers containing 
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the genome of the virus formed by 10 linear segments of dsRNA encoding for 7 
structural proteins (VP1 to VP7) and 4 non-structural proteins: NS1, NS2, NS3, 
NS4 (Ratinier et al. 2011) with evidences of a fifth non structural protein S10 
ORF2 recently described (Figure 1-5) (Stewart et al. 2015). 
VP2 and VP5 form the outer capsid and have the greater genetic variability 
among the BTV proteins. VP2 is responsible for the virus attachment to the cell 
surface and is also the main determinant of the virus serotype. Whereas VP5 
form globular-shaped structures that facilitate cell-membrane penetration. So 
far 27 different serotypes have been identified (BTV-1 to BTV-27) (Roy et al. 
2009; Schwartz-Cornil et al. 2008; Nomikou et al. 2015). The intermediate layer 
of the virus capsid is composed by trimers of VP7, which is also the major 
immunodominant protein (Figure 1-5). The inner shell, which protects the viral 
genome, is formed mainly by VP3 and the minor enzymatic proteins VP6 (dsRNA 
helicase), VP4 (RNA capping enzyme) and VP1 (RNA-dependent RNA polymerase) 
which are involved in transcription and replication (Figure 1-5) (Schwartz-Cornil 
et al. 2008).  
Among the non-structural proteins of the virus, NS1 and NS2 are the most highly 
expressed in mammalian cells. NS1 is fundamental for virus replication; it forms 
multimers that assemble into cytoplasmic tubules within the infected cells and it 
also seems to be implicated in the cytopathic effect of BTV (Owens et al. 2004). 
NS2 is the principal constituent of the viral inclusion bodies, it binds ssRNA and 
is responsible for BTV ssRNA condensation, before its encapsidation (Kar et al. 
2007; Jones et al. 1997). NS3, and its shorter version NS3a (lacking the N-
terminal 13 amino acid residues), is expressed on the cellular membrane and is 
implicated in virus release from the cells (Beaton et al. 2002). For long time NS3 
was thought to be expressed mainly in insect cells with only a minor role in 
mammalian cells. However, recent studies have proved that NS3 acts as 
interferon-antagonist in mammalian cells (Chauveau et al. 2013) and its role has 
been re-evaluated. Finally, the recently identified NS4 protein has been shown 
to localise in the nucleoli of the infected cells (Ratinier et al. 2011), as well as 
having a role in modulating the cell type-I interferon (IFN) response (Ratinier et 
al. 2016). Bioinformatics analysis has also identified the presence of a second 
open reading frame in segment 10 of the BTV genome, overlapping the NS3 open 
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reading frame in the +1 position (Sealfon et al. 2015). By using a viral expression 
vector, the transcript of this coding region, named S10-ORF2, localises in the 
cell nucleoli and seems to have a role in inhibiting gene expression, but not RNA 
translation (Stewart et al. 2015). The expression of this putative new protein 
during BTV infection is still to be confirmed.  
 
Figure 1-5 Schematic representation of a BTV particle and its genome segments. 
BTV viron is assembled in three layers. The outermost capsid is formed by trimers of VP2 and VP5 
proteins. The intermediate layer (core) is composed of VP7 trimers. The inner capsid (subcore) is 
formed by VP3 which encloses the replication protein complex (VP1, VP4, VP6) and dsRNA. The 
10 segments of dsRNA forming the BTV genome, the proteins that it encodes and their main 
recognised role are summarised on the left. 
 
1.2.1 Bluetongue virus replication cycle 
In the mammalian host BTV interacts with the target cell membrane by means of 
the outer capsid protein VP2, which forms trimers that bind to the cell surface 
glycoproteins. In the insect cells instead, core particles (lacking the outer capsid 
layer) binds to the cells through VP7 trimers (Xu et al. 1997). Binding triggers a 
clathrin-mediated internalization of the virus particle through endocytosis 
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(Figure 1-6). Clathrin coated vescicles form early endosomes where the outer 
capsid proteins VP2 and VP5 are rapidly dissociated (Figure 1-6) (Forzan et al. 
2007). pH acidification induces VP5 interaction with the endosomal membrane 
where VP5 acts like a fusion protein and allows the release of uncoated virus 
particles in the cytoplasm (Forzan et al. 2004). BTV replicates in the cytoplasm 
of infected cells, virus RNA transcription and replication occurs within the virus 
core where VP6 facilitates the separation of the two strands of viral RNA and 
VP1 transcribe positive sense ssRNA copies (Boyce et al. 2004). These mRNA 
copies are then capped at the 5' terminus by VP4 and then extruded in the cell 
cytoplasm through the pores formed by VP3 in the core. Viral mRNA is then 
translated by the host cells machinery, starting at approximately 2 hpi (Figure 
1-6) (Schwartz-Cornil et al. 2008). At this stage, NS1 is implicated in the 
upregulation of BTV protein synthesis that by 8 hpi almost completely replace 
the host cells mRNA translation. Viral RNA is then directed to the viral inclusion 
bodies (VIB), mainly formed by NS2 (Figure 1-6) (Kar et al. 2007), where they are 
assembled together with VP3 forming the inner core, followed by the addition of 
VP7 trimers that constitutes the intermediate layer of the capsid. VP2 and VP5 
are subsequently added in the cell cytoplasm when the particle exits the VIB 
(Figure 1-6). The method of release of virions from the infected cells varies 
depending of the host and type of cell involved. In insect cells BTV is release by 
budding, without causing membrane disruption or cell lysis, while in mammalian 
cells BTV release is mediated by the viroporin activity of NS3 which destabilise 
the cell membrane (Han & Harty 2004). This generally results in cell lysis and 
death with consequent release of additional viral particles (Figure 1-6) 
(Schwartz-Cornil et al. 2008). 
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Figure 1-6 BTV replication cycle 
BTV enters the cell by endocytosis in clathrin-coated pits. Acidification of early endosomes causes 
VP5 mediated membrane fusion. The outer capsid is dissociated from the particle and the core 
enters the cell cytoplasm. Inside the active core, transcription of viral RNA takes place and the 
ssRNA
+
 (mRNA) is extruded through the pores in the VP3 layer. BTV protein translation is 
performed via host cell translational machinery and viral NS1 is involved in up-regulation of BTV 
gene expression. Subcore and core assembly takes place in viral inclusion bodies (VIB) and it is 
facilitated by interactions with NS2. NS4 is transported to the cell nucleus and localises in the 
nucleolus where it interferes with IFN synthesis. Complete particles are formed by core association 
with VP2 and VP5. NS3 is involved in trafficking and egress of mature particles either by budding 
or by cell lysis (Mohl & Roy 2014). 
 
1.3 Clinical outcomes of BTV infection 
The outcome of BTV infection is extremely variable, ranging from a completely 
unapparent infection to a lethal disease. Determinants of this variability have 
not been completely identified. It is believed that the consequences of infection 
are determined by a combination of factors, including the viral serotype and 
strain, the infected host (species, breed, immune status and genetic 
background) and the surrounding environment (Caporale et al. 2011). 
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1.3.1 Host-related factors 
The range of host species susceptible to BTV infection is very broad and includes 
both wild and domestic ruminants (see below). Upon infection, all ruminants can 
support BTV replication and tend to develop a persistent viraemia. However, a 
large variability in the clinical presentation of BTV infection has been recorded, 
with sheep and some species of wild ruminants (such as white tailed deer) being 
more prone to develop a severe form of the disease. In domestic ruminants, 
clinical bluetongue is generally characterised by a marked fever in sheep, whilst 
in goats and cows the infection is generally asymptomatic even if accompanied 
by prolonged viraemia (Caporale et al. 2014; Erasmus 1975; Richards et al. 1988; 
MacLachlan et al. 2009). In addition, the same BTV serotype has shown 
differences in virulence among various sheep breeds, and in different areas of 
the world (MacLachlan et al. 2009). Clinical disease in indigenous breeds in 
tropical and sub-tropical area is rarely observed. On the contrary, The North 
European breeds of sheep have been described to be very susceptible to BTV-
induced disease as opposed to African or South-East Asian breeds. Strikingly, 
when live attenuated BTV vaccines commonly used in South Africa were tested 
for the first time in Dorset poll sheep, they were able to induce fever and 
viraemia and proved unsafe for the European market (Veronesi et al. 2010; 
Veronesi et al. 2005). A study that compared the effects of a standardised 
infection by using different sheep breeds, revealed no major differences in the 
outcome of infection in Mediterranean (Sardinian and Italian) and Northern 
European breeds (Dorset poll, generally considered highly susceptible to clinical 
bluetongue disease) suggesting that other factors, apart from the sheep breed, 
may contribute do the insurgence of disease (Caporale et al. 2014).  It has to be 
considered that, the more severe clinical presentation of Bluetongue tend to be 
associated with viral strains appearing in new geographic areas or when 
susceptible ruminant breeds are introduced into endemic areas (Coetzee et al. 
2012) as occurred during the first recorded outbreak of Bluetongue in South 
Africa, as a consequence of the introduction of Merino sheep (Spreull 1905), and 
during the recent BTV-8 outbreak in Northern Europe (Darpel et al. 2007). These 
observations suggest that a certain degree of herd immunity must be present in 
endemic areas and that viral adaptation to the residing ruminants population 
might also develops, thus these factors might have a major role in determining 
the outcome of BTV infection. 
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1.3.2 Virus-related factors 
BTV presents a profound genetic heterogeneity. BTV exists in at least 27 
serotypes, and within the same serotype strains with different virulence have 
been described (Nomikou et al. 2015; Caporale et al. 2014). BTV genetic 
diversity is the result of antigenic shift and antigenic drift. Reassortment of viral 
genes (antigenic shift) can take place either in the vertebrate or invertebrate 
host, as a result of coinfection with multiple serotypes and strains (Shaw et al. 
2013; Nomikou et al. 2015). Moreover, BTV is an RNA virus and as such it has a 
high mutation rate (10-5 to 10-3 misincorporations per nucleotide copied) 
(Bonneau & Mullens 2001) (antigenic drift). In addition, RNA virus populations do 
not consist of a single genotype; rather, they consist of a group of related 
sequences, termed quasispecies by some authors (Vignuzzi et al. 2006; Domingo 
et al. 2012). The generation of a “cloud” of viral variants accounts for the rapid 
evolution and adaptability of the virus. This allows the virus to promptly change 
cell tropism and host range, and escape external constrains (such as immune 
response and antiviral agents). A combination of selection pressure and rapid 
viral mutations results in an accelerated form of Darwinian evolution. However, 
arboviruses often evolve more slowly than other RNA viruses, likely because of 
restrictive pressures imposed during alternating passages in arthropod and 
mammalian hosts (Holmes 2003; Coffey et al. 2008; Weaver et al. 1999). A 
decrease in population variability, and a selection of a specific minority variant 
in the VP2 protein, was observed in Culicoides sonorensis fed on BTV viremic 
sheep, indicating that host switching constitutes a bottleneck and that a founder 
effect might therefore play an important role in genetic diversification of BTV 
strains in nature (Bonneau & Mullens 2001). More recently, in vitro experiments 
demonstrated that isolation of BTV from infected blood, using a mammalian cell 
line (BHK21), in contrast with isolation using insect cells, severely impact 
population variability leading to a decrease in genetic diversity (Caporale et al. 
2014).  
Furthermore, phylogenetic analysis of the nucleotide sequence of the 10 BTV 
genes shows that cognate BTV genes may differ depending on the geographic 
origin of each virus, in a process termed topotyping. Negative selection of 
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individual BTV genes occurs over time following the incursion of novel viruses 
into new regions, creating genetically distinct region-specific clusters that might 
be related to the ecology of the area (Balasuriya et al. 2008; Gould & Pritchard 
1990; Nomikou et al. 2015). Hence, accordingly to this phenomenon, BTV strains 
can be further clusters into the two major “eastern” and “western” groups, as 
well as several additional groups and sub-groups (Nomikou et al. 2015; Maan et 
al. 2008). 
Although all the genetic factors described above are likely to play a role in 
determining disease and transmission, the genetic determinants of BTV virulence 
largely remain uncharacterized, as do those that are associated with emergence 
of the virus in new regions, and in novel vector species.  
1.3.3 Environmental factors 
In addition, to complicate an already intricate picture, environmental factors 
such as high temperature and ultraviolet radiation, seems to facilitate the onset 
of disease (Spreull 1905), however the mechanisms involved still need to be 
elucidated. It is not clear if such factors have a direct impact on the mammalian 
host and its response to the virus, or if, more likely, they influence the ecology 
of the vector. 
1.3.4 Experimental procedures 
Studies of the pathogenesis of BT are mainly based on observations made in 
experimentally infected animals. Most of these studies have been performed 
through the inoculation of virus with needle injection, which do not take into 
account additional factors related to the bite of an infected Culicoides vector. 
Various inoculation routes have been used to successfully reproduce the disease 
in ruminants, the most frequently used being intravenous, subcutaneous, 
intradermal, or a combination of these. It has been shown that the route of 
inoculation can significantly alter the outcome of infection (Umeshappa et al. 
2011), with the intravenous route often generating a milder disease in 
comparison to an intradermal infection. The reasons of this variability remain to 
be clarified.   
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Similarly, the type of inoculum used affects the variability of the data obtained. 
Early pathogenesis studies preferentially employed the inoculation of infectious 
blood collected from BTV infected animals at the peak of disease (Spreull 1905; 
Darpel et al. 2012). However, the use of infectious blood as source of infection, 
did not allow to control confounding factors such as virus titre, the presence of 
multiple serotypes, the inoculation of donor animal immune cells and antibodies 
and the concomitant inoculation of unrelated blood borne pathogens. 
Subsequently, with the advent of cell cultures, experimental infections moved to 
use viral strains obtained from field-infected animals isolated and propagated in 
immortalised cell lines. This gave the possibility to more precisely titrate the 
virus and use a “cleaner" inoculum, decreasing confounding factors. However, 
inoculation of cell culture passaged virus fail in general to reproduce the 
severity of disease that is often obtained with infectious blood (Caporale et al. 
2014). In a recent study, deep sequencing analysis revealed a marked decrease 
in the genetic diversity of the BTV population after passaging in mammalian 
cells, whereas virus passaging in a Culicoides cell line resulted in an increased of 
low-frequency variants compared to virus never passaged in cell culture. These 
observations indicate that Culicoides might be a source of new viral variants, 
and that viral population diversity can be another factor influencing BTV 
virulence (Caporale et al. 2014).  
Thus, variability on the outcome of BTV infection can also be influenced by the 
experimental settings used, which could modify the course of disease in ways 
that have still not been fully elucidated. 
 
1.4 Bluetongue  
1.4.1 Disease in sheep 
Bluetongue is mainly a disease of sheep. Despite a marked variability, all sheep 
breeds are susceptible to the disease (MacLachlan et al. 2009; Erasmus 1975). 
Contrasting results have been reported regarding the host related factors that 
determine this variability. In general terms, fine wool (such as Merino) and 
European sheep breeds are considered more susceptible than the more rustic 
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African breeds (Spreull 1905; Neitz 1948; Erasmus 1975). However, marked 
differences have also been observed within different individuals of the same 
breed. Hence, factors like immune status, age and genetic background can also 
have a role in determining the final outcome of infection (MacLachlan et al. 
2009).  
1.4.1.1 Clinical presentation 
The disease in sheep can range from a completely asymptomatic infection, to a 
fulminant lethal disease. After experimental infection, the incubation period 
varies from 2 to 15 days, although it is more frequently of 4 to 6 days. The first 
sign of Bluetongue is a marked fever (41-42°C) that can last between 2 and 7 
days (Spreull 1905; Erasmus 1975). Often the degree of the febrile response does 
not correlate with the severity of other clinical manifestations, and in most 
resistant sheep the febrile reaction is generally the only indication of infection 
(Spreull 1905). In more severe forms, a few days after the initial pyrexia, it is 
possible to observe hyperaemia of the oral and nasal mucosae, generally 
accompanied by extensive salivation and nasal discharge that can become 
mucus-purulent or haemorrhagic. Erosive and crust lesions are often visible on 
the muzzle, likely due to mechanical action of the tongue. In addition, 
lachrymation and hyperaemia of the eyelids are also present (Erasmus 1975). 
Severely affected sheep develop ooedema of the face that can sometimes 
extend to the neck. Petechial lesions are often present on lips and tongue and 
haemorrhages at the muco-cutaneous junction of the mouth. In some cases, the 
tongue can appear significantly swollen and cyanotic, and protrude from the 
mouth, hence the name “bluetongue” given to the disease. Erosion and ulcers 
can be present on the mucosa of the mouth, on the gums, cheeks, palate and 
tongue. This results in anorexia and depression of the animal. A haemorrhagic 
diarrhoea can also appear which is considered as a highly unfavourable 
prognostic sign (Spreull 1905; Erasmus 1975). 
Feet lesions can also be present; coronitis can develop and consists of 
hyperaemia of the coronary bands, sometimes accompanied by ulcerative lesions 
(Darpel et al. 2007; Erasmus 1975). The hoof can appear inflamed and, as a 
result of the pain, the animal is often recumbent or standing in antalgic position. 
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Hyperaemia can be present on the skin of various regions, on the muzzle, axilla 
and groin, and sometimes of the whole body. Wool growth can be affected and 
part of the fleece can be lost in patches. Respiratory symptoms are very 
frequent, ranging from an increase in the respiratory rate (tachypnoea) to a 
severe dyspnoea. 
The mortality rate in BT can vary markedly in natural field conditions, ranging 
from 2 to 30%. The majority of affected animals recover even after a severe 
disease. In lethal cases, death occurs between 1 and 8 days after the onset of 
clinical signs, and it is generally the consequence of an acute pulmonary 
ooedema, pneumonia or in some cases the results of the prolonged debilitation 
caused by the disease. 
1.4.1.2 Clinical pathology 
Clinical pathological findings in BTV infected sheep have only rarely been 
assessed. A transient leukopenia between 6 and 8 dpi is a common finding during 
the course of BTV infection, which is generally characterised by a marked 
lymphopenia (MacLachlan et al. 2008; Sánchez-Cordón et al. 2015; Umeshappa, 
Singh, et al. 2010; Ellis et al. 1990). Lymphopenia has been described as the 
result of a decrease in the pool of circulating CD4, CD8 and γδ T-lymphocytes 
(Sánchez-Cordón et al. 2015; Umeshappa et al. 2010; Ellis et al. 1991). The 
mechanism underlying a decrease in the absolute number of circulating 
lymphocytes has not been fully identified yet. Another possible explanation is an 
apoptosis-induced depletion, as suggested by in vitro study where sheep 
peripheral blood mononuclear cells were infected with BTV ( Umeshappa et al. 
2010). In addition, other common causes of lymphopenia such as the migration 
of lymphocyte towards inflamed tissues or their loss through lymph extravasation 
should be kept into consideration. The observed lymphopenia during BTV can 
induce a transient immune suppression, during the early phases of infection, 
which has been reported to predispose the animal to secondary infection, 
leading to a worsening of the clinical disease (Umeshappa et al. 2010). Short 
after the initial lymphopenia, it is generally observed an increase in CD8 T-
lymphocytes around 10-14 dpi (Sánchez-Cordón et al. 2015; Umeshappa et al. 
2010; Channappanavar et al. 2012; Ellis et al. 1991). 
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In experimentally infected sheep, thrombocytopenia is also often reported 
between 5 and 10 dpi, however the decrease in platelets number does not seem 
to be associated with alteration in coagulation factors (McColl & Gould 1994; 
Sánchez-Cordón et al. 2013; Maclachlan et al. 2008). These findings rule out the 
hypothesis that a consumptive coagulopathy, resulting from BTV-induced 
endothelial damage, could be implicated in the manifestations of disease in 
sheep, as instead observed during the fulminant form of Bluetongue in white-
tailed deer (Karstad & Trainer 1967; Howerth et al. 1988) . In sheep, the 
mechanism at the basis of platelet depletion and its implication in the 
development of disease is still to be clarified. 
A recent study in experimentally infected sheep, reported for the first time a 
correlation between the increase of acute phase proteins (such as serum amyloid 
and haptoglobin) in serum and the presence of overt clinical disease, suggesting 
the possibility to employ these proteins as marker of tissue damage induced by 
BTV (Sánchez-Cordón et al. 2013). Other possible markers, present in the most 
severe case of BTV, have been identified in creatine phosphokinase, glutamic 
pyruvic transaminases and aldolase. They are all suggestive of skeletal myopathy 
and an increase in their serum levels have been associated with fatal cases of 
bluetongue probably as a consequence of a severe endothelial damage (Erasmus 
1975).  
1.4.1.3 Gross Pathology 
Gross pathological lesions are generally associated with the clinical disease and 
its complications. In the digestive system, ooedema and ulcerations are present 
in the upper tract, mainly in the mouth and tongue, associated with the 
presence of necrotic tissue. A diffuse hyperaemia is commonly observed in the 
digestive system, including rumen and reticulum, while in the abomasum and 
gall bladder this is accompanied by petechial haemorrhages. In the respiratory 
tract the most frequent pathological finding is pulmonary ooedema, with 
presence of white froth extending into the trachea (Sánchez-Cordón et al. 2013; 
Maclachlan et al. 2008). Pneumonia is also frequent and generally the results of 
inhalation of ingesta or as a consequence of secondary infections that have been 
frequently reported during bluetongue and attributed to the debilitating and 
immunosuppressive effect of BTV on T-lymphocytes (Umeshappa et al. 2010). In 
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the cardiovascular system hyperaemia and haemorrhages are often observed in 
the large vessels, especially in the tunica media of the pulmonary arteries 
(Sánchez-Cordón et al. 2013; Erasmus 1975). Subepicardial and endocardial 
haemorrhages may be present, especially involving the papillary muscles of the 
left ventricle ( Sánchez-Cordón et al. 2013; Erasmus 1975). Petechiae can also 
be observed on the serous membrane of heart and lungs where hydropericardium 
and hydrotorax can be present. The lymph nodes are commonly enlarged and 
present haemorrhages, especially the ones draining the area of the head and 
neck (Darpel et al. 2012; Erasmus 1975). Spleen and thymus could also appear 
enlarged and display subcapsular haemorrhages. The skin is generally 
characterised by an ooedematous aspect that extends to the subcutaneous 
layers. Hyaline degeneration of the skeletal muscles can be observed in the most 
severe cases, which is responsible for the emaciated aspect of the animals; at 
times muscular lesions are replaced by fibrous tissue in necrotic areas (Erasmus 
1975). Congestion and petechial haemorrhages can also be found in the urinary 
tract, in the bladder, kidneys and urethra.  
1.4.1.4 Histopathology 
Limited information is available about the histopathological changes induced in 
sheep by BTV, since very few studies have assessed the microscopic aspect of 
the tissues following BTV infection.  
In the skin, the presence of ooedema of both dermis and epidermis with 
multifocal perivascular petechiated haemorrhages has been described. A 
moderate to marked diffuse pericapillary dermal inflammation with infiltration 
of plasma cells, lymphocytes, eosinophils and neutrophils has also been observed 
in the dermis (Darpel et al. 2012; Lee et al. 2011). The presence of granulomas 
in the superficial dermis has been reported solely when BTV inoculation was 
performed through the bites of Culicoides (Darpel et al. 2012). In a different 
study, labial and oral tissues, collected 7 dpi, showed an increase in the number 
of perivascular mononuclear cells in the dermis and lamina propria, which 
reverted to normality by 14 dpi (Ellis et al. 1991) 
As for gross pathological studies, histological studies report of multifocal 
haemorrhages and necrosis in course of Bluetongue in the heart, kidney, skeletal 
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muscles and lymph nodes (LNs) of sheep (Lee et al. 2011; MacLachlan et al. 
2008). In the digestive tract, ulceration and necrosis were reported in the 
mucosa of the oral cavity, along the upper gastrointestinal tract and in the 
forestomachs (MacLachlan et al. 2008). In the lung it has been described the 
presence of ooedema and inflammation of the peribronchial connective tissue 
with infiltration of lymphocytes and plasmacells (Darpel et al. 2012). Mild to 
moderate interstitial pneumonia has also often observed (Lee et al. 2011). 
The muscle fibres of the tongue, trapezius and cardiac muscle have often been 
found affected by perivascular ooedema and mononuclear cells infiltration 
accompanied by moderate degeneration of muscle fibres (Umeshappa et al. 
2011). In general, it has been observed that the extensive ooedemas that occur 
in sheep are not accompanied by histologic evidence of destruction of small 
blood vessels or necrosis, suggesting that the ooedemas results from increased 
vascular permeability without direct endothelial damage (MacLachlan et al. 
2008). 
1.4.2 Bluetongue in goats 
Although BTV infection was first described in goats more than 100 years ago 
(Spreull 1905), very few studies have been conducted in this species. Contrary to 
sheep, the clinical presentation of BT is generally mild in goats or completely 
unapparent. In 1905, Spreull firstly reported that no fever or any other visible 
sign occurred in naturally or experimentally infected goats, despite being able to 
confirm the presence of viraemia in these animals between 5 and 20 days after 
experimental infection by injecting goat blood into a susceptible sheep (Spreull 
1905). Only few reports describe the presence of occasional clinical signs of BT 
in goats during naturally occurring outbreaks (Erasmus 1975). An exception is the 
recent outbreak of BTV-8 in Northern Europe, a particularly virulent strain that 
occasionally induced disease in goats with an approximate 25% case/fatality rate 
(Conraths et al. 2009). In experimental settings, goats tend not to present 
clinical disease when inoculated intradermally with the same strain and dose of 
BTV used to induce disease in sheep (Caporale et al. 2014; Koumbati et al. 
1999), although a different study reported the presence of disease in both sheep 
and goats inoculated intravenously with infectious blood  (Backx et al. 2007). 
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Regardless of the route of inoculation and the type of inoculum used, goats 
develop a persistent viraemia similarly to sheep. 
New attention has been driven towards goats in recent years due to the 
discovery of new BTV serotypes that seem to preferentially replicate in this 
animal species. BTV-25, initially named Toggenburg virus (for the Swiss city 
where was first isolated), was found to circulate exclusively in the goat 
population in 2008 without causing disease (Hofmann et al. 2008). Subsequently, 
a novel BTV serotype (BTV-26) closely related to BTV-25, was isolated in Kuwait 
in 2010 from the blood of goats and sheep. Subsequent studies demonstrated 
that BTV-26 induce only mild disease in sheep and that it tends to produce an 
higher viraemia in experimentally infected goats compared to sheep (Batten et 
al. 2012). Moreover, there is evidence that goats experimentally infected with 
BTV-26 could transmit the virus to susceptible goats without the need of an 
arthropod vector (Batten et al. 2014; Batten et al. 2013). Following these 
reports an additional BTV serotype was isolated in 2015 in Corsica, likely 
constituting a putative 27th serotype, the virus was circulating once again in the 
goat population. Although pathogenicity studies are still missing, sequence 
analysis revealed similarities with the previously described BTV serotypes 25 and 
26 (Jenckel et al. 2015). 
1.4.2.1 Histopathology 
While not many information is available on the histopathology of bluetongue in 
sheep, a recent studies provided insightful information about the lesions 
presented by goat tissues in natural occurring BTV infection with BTV-1(Sánchez-
Cordón, Pedrera, et al. 2013), a serotype circulating in Spain in 2007 that was 
able to induce severe disease in both goat and sheep (Allepuz et al. 2010). 
The authors reported a separation of connective tissue and muscle fibres as a 
consequence of ooedema, with mononuclear infiltrates and haemorrhages in 
various tissues, including skin (sampled from nostril, face, lips and coronary 
band), skeletal muscles of hindlimbs and tongue, cardiac muscle, lungs (with 
alveolar ooedema and haemorrhages), pulmonary artery, urinary bladder and 
along the whole gastro-intestinal system (Sánchez-Cordón, Pedrera, et al. 2013). 
The capillary endothelial cells of the skin were reported to appear swollen and 
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vacuolated, often surrounded by perivascular mononuclear infiltrates mainly 
comprising macrophages and lymphocytes (Sánchez-Cordón, Pedrera, et al. 
2013). In the hepatic parenchyma, the authors found evidence of micro-vacuolar 
degeneration and congestion together with small haemorrhages and 
mononuclear infiltrates (Sánchez-Cordón, Pedrera, et al. 2013). 
The examination of the lymph nodes (pre-scapular, submandibular, mediastinal, 
ileocecal and gastrohepatic) revealed distended sinuses with numerous 
mononuclear cells, often accompanied by cortical haemorrhages and medullary 
hyperaemia. Interestingly, the authors reported that both in the lymph nodes 
and spleen, lymphoid follicles presented clear signs of depletion that were not 
generally accompanied by lymphocyte destruction, such as pyknosis or cell 
fragmentation (Sánchez-Cordón, Pedrera, et al. 2013), however the underling 
cause of this depletion was not investigated.  
Goats’ kidneys also appeared affected by the infection, displaying glomerular 
congestion, with red blood cells and clumped protein present in Bowman's space 
and in the tubules. Interstitial mononuclear nephritis and interstitial 
haemorrhages were also observed (Sánchez-Cordón, Pedrera, et al. 2013). 
Overall, most of the lesions described in this study appear to be re-conducible to 
an endothelial dysfunction, either caused by the direct cytopathic effect of the 
virus or by the action of inflammatory chemical mediators produced by BTV-
infected cells. However, research on the pathogenesis of BTV would benefit of 
further in vivo studies of different BTV serotypes and in various ruminant 
species.  
 
1.4.3 Bluetongue in cattle 
Bluetongue in cattle generally does not induce overt clinical disease, although 
occasionally symptoms have been reported (Hourrigan & Klingsporn 1975). When 
present, the signs reported do not differ from the mild clinical form displayed by 
sheep. These include a rise in the body temperature, laminitis and stiffness, 
ulcerative lesions of the tongue, mouth and muzzle, ooedema of the lips, 
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hypersalivation and nasal discharge. In some cases ulcers are also present on the 
udders (Hourrigan & Klingsporn 1975).  
Infected cattle develop a persistent viraemia that has been reported to last 
much longer than in sheep. Most of the circulating virus seems to be associated 
with platelets and red blood cells up to approximately 200 dpi. Furthermore, 
some species of Culicoides preferentially feed on cattle instead of other 
ruminants, making this species a perfect reservoir for BTV and the transmission 
of disease (MacLachlan 1994). 
In a series of studies aiming to reproduce clinical disease in cattle, the animals 
were firstly sensitised with an inactivated BTV in combination with an 
immunomodulator (cimetidine hydrochloride or levamisole) and subsequently 
infected with the same BTV strain. The obtained results suggested that BTV signs 
in cattle originate from a type I hypersensitivity reaction, accompanied by the 
production of virus-specific IgE, histamine and prostaglandins which determine a 
exudative dermatitis and ulcerations (Stott et al. 1982; Anderson et al. 1987). 
Interestingly, the inoculation of virus without prior sensitization failed to 
produce disease in the tested animals. Furthermore, these studies also 
demonstrated that the intradermal inoculation of an hyperimmune serum 
together with a cell culture adapted virus was able to reproduce the disease in 
non-sensitised calves, indicating the role of antibodies in the pathogenesis of 
disease (Anderson et al. 1987). Subsequent studies identified that in cattle the 
main serum component responsible for this outcome, the serum IgE produced 
during a BTV infection, are mainly directed towards the viral VP5 (Odeón et al. 
1999). 
BTV infection in dams has been frequently associated with reproductive sequelae 
such as abortion and congenital malformations of the calves (Osburn 1994; Dal 
Pozzo et al. 2009). Foetuses infected in the first half of gestation develop 
cerebral malformations that range from hydranencephaly and cerebellar 
hypoplasia to poroencephaly. These malformations are thought to be the 
consequence of the tropism of BTV for neuronal and glial precursors in the 
developing brain (MacLachlan 1994).  
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1.4.4 Bluetongue in wild ruminants 
Most wild ruminants and camelids are susceptible to BTV infection. However, 
they generally do not display the clinical signs of disease therefore could serve 
as a reservoir for BTV persistence and transmission (Falconi et al. 2011). Wild 
African ruminants, such as blesbock (Damaliscus pygargus) and mountain gazelle 
(Gazelle gazelle) present in area where BTV is endemic, are resistant to 
infection, and do not show clinical disease after either natural or experimental 
infection. Similarly, the American black tailed deer (Odocoileus hemionus 
columbianus), the North American Elk (Cervus elaphus canadensis) and the 
European red deer (Cervus elaphus) present a mild or asymptomatic infection.  
In Europe, serological studies have highlighted the presence of BTV neutralising 
antibodies in many wild ungulates (free ranging or farmed) in Belgium, Spain, 
France and Italy. Animals tested positive included: red deer (Cervus elaphus), 
fallow deer (Dama dama), Spanish ibex (Capra pyrenaica), roe deer (Capreolus 
capreolus), mouflon (Ovis aries musimon), ibex (Capra ibex) and Southern 
chamois (Rupicapra pyrenaica) (Falconi et al. 2011). The BTV serotypes generally 
involved included serotype 1, 4 and 8 with the highest seroprevalence in red 
deer and fallow deer, both belonging to the Cervinae family. Numerous studies 
have also detected BTV RNA in the blood of red deer in Spain, France and 
Belgium (Linden et al. 2010; Rossi et al. 2014; García-Bocanegra et al. 2011). 
Infection of European wild mammals is in general completely asymptomatic and 
does not seem to affect the population dynamics of these species. The sole 
exception is represented by mouflons, which tends to develop clinical signs of 
inflammation of the mucous membranes, congestion, swelling and haemorrhages 
during BTV infection (Fernández-Pacheco et al. 2008). Mouflons are closely 
related to domestic sheep and their genetic similarity may therefore be 
implicated in the observed susceptibility (Chessa et al. 2009). The widespread 
and elevated antibody prevalence of BTV in wild ruminants indicate these 
species could serve not only as reservoir of infection but also as good BT 
sentinels in surveillance plans in European countries.  
In the Americas, wild ruminants appear to be more susceptible to BT infection, 
compared to African and European species. Serological prevalence and virus 
isolation studies have identified infection in: black-tailed deer (Odocoileus 
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hemioneus columbianus), white-tailed deer (Odocoileus virginianus), American 
bison (Bison bison), pronghorn antelope (Antilocapra americana), mule deer 
(Odocoileus hemionus), bighorn (ovis canadensis) and North American elk 
(Cervus elaphus canadensis) (Falconi et al. 2011). Elk and black-tailed deer are 
relatively resistant to Bluetongue while a particularly severe form of the 
disease, with a high mortality rate, is generally observed in white-tailed deer 
and pronghorn antelopes (Thorne et al. 1988; Vosdingh et al. 1968; Karstad & 
Trainer 1967). Experimental infection of white-tailed deer elicits severe clinical 
signs, including increased temperature, erythema, facial ooedema, coronitis, 
and stomatitis. Widespread haemorrhages and hematomas begin to be observed 
at 8 dpi. These findings are associated with an alteration of the coagulation 
process as indicated by progressive prolongation of activated partial 
thromboplastin time (PTT) and prothrombin time (PT), and concomitant 
reduction of Factors VIII and XII plasma activities. High concentrations of 
fibrinogen degradation products were also detected between 3 and 6 dpi. The 
coagulation abnormalities are indicative of a consumptive coagulopathy that 
predispose to bleeding and multiple organ failure, and might therefore play a 
role in the most severe cases of BTV (Howerth et al. 1988). Further 
haematological findings include a marked thrombocytopenia starting at 6 dpi, 
leukopenia, lymphopenia, neutrophilia, and low total plasma protein 
concentration. Surprisingly, no virus-specific antibodies were detected in the 
deer included in the experiment.  
In white-tailed deer, the histopathological changes have been well characterised 
(Karstad & Trainer 1967). Haemorrhages, necrosis and thrombosis were the most 
recurrent findings, which were principally described in the tongue, heart, 
spleen, kidneys and lymph nodes. Fibrin, platelets and mixed thrombi where 
present in several tissues and were associated with tissue necrosis and 
haemorrhages. In the tongue and heart, hyaline degeneration of muscle fibres 
was present that proceed to necrosis as a consequence of thrombosis. 
Haemorrhages were also frequent in the spleen and sometimes accompanied by 
necrosis of the follicles. In the LNs haemorrhages were reported in the medullary 
sinuses, accompanied with erythrophagocytosis by macrophages. In the digestive 
tract, haemorrhages and extensive necrosis was found in the rumen, abomasum 
and intestines (Karstad & Trainer 1967).   
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1.5 Pathogenesis of bluetongue 
1.5.1 Virus dissemination in the mammalian host 
Experimental infections in ruminants have been used to understand the tropism, 
at organ and cellular level, of BTV and its sequential dissemination in the 
infected host. Some of the key studies have investigated the tissue distribution 
of BTV after experimental inoculation (subcutaneously in the head and neck 
region) by euthanizing animals at intervals after infection. The presence of the 
virus was then evaluated in various tissues by using virus isolation techniques or 
BTV antigens detection (Pini 1976; Barratt-Boyes & MacLachlan 1994; Darpel et 
al. 2012).  
The dynamics of infection appears to be similar in sheep and cattle. Once BTV is 
inoculated in the skin of a susceptible host, it initially replicates locally in the 
dermis (Darpel et al. 2012) then migrates to the regional lymph nodes where 
additional replications take place (Darpel et al. 2012; Pini 1976; Barratt-Boyes & 
MacLachlan 1994).  Thereafter, the virus is likely transported by the bloodstream 
to peripheral tissues, which constitutes sites of secondary replication.  
Therefore, the first organs to be infected after the skin are the lymph nodes, 
followed by the spleen (at 4 dpi) that generally yields the higher viral titres. At 
6 dpi other organs appears infected, including lungs, kidney, liver, intestinal 
mucosa, tongue and testicles. In some occasions BTV was also isolated from the 
bone marrow after the 10th dpi (Barratt-Boyes & MacLachlan 1994). 
The regional lymphatic system appears to cover an important function during the 
early phases of infection. BTV distributes to the regional lymph node draining 
the site of infection with the afferent lymph. In a single study, through 
catheterization of the afferent lymph duct, the cells responsible of carrying the 
virus from the inoculation site to the draining lymph node have been identified 
as conventional dendritic cells (cDC), with the highest cell-associated viral load 
detected between 4 and 5 dpi (Hemati et al. 2009). Few infected CD1+ and 
CD11c+ cells, described as cDC, were also found in the parenchyma of the lymph 
node, supporting a role of these cells in carrying the virus to the regional lymph 
nodes (Hemati et al. 2009).  
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In an attempt to understand how BTV leaves the lymph node, it was noted that 
the cannulation of the efferent lymphatic vessel draining the site of infection, 
and the consequent disruption of the lymph circulation, can delay the onset of 
viraemia of 3-4 days (Barratt-Boyes & MacLachlan 1994). Only rare infected cells 
were detected in the efferent lymph, these cells leaving the lymph node were 
thought to be responsible for the dissemination of BTV to the peripheral tissues, 
but they have not been characterised (Barratt-Boyes & MacLachlan 1994). 
The onset of viraemia occurs generally 48 h after the draining LNs infection. 
Viraemia is highly cell-associated, during the first week post-infection BTV can 
be detected in association with the cellular fraction of the blood, including both 
peripheral blood mononuclear cells (PBMC), erythrocytes and platelets but rarely 
in granulocytes (MacLachlan et al. 1990; Barratt-Boyes & MacLachlan 1994). BTV 
is generally not detectable in blood plasma. During the later stages of viraemia 
(after the initial 10 days) BTV tends to circulate solely in association with 
erythrocytes and it is no longer detectable in PBMC (Barratt-Boyes & MacLachlan 
1994). Ultrastructural studies suggested that BTV particles could rapidly be 
sequestrated in invaginations of the erythrocytes membrane (Brewer & 
MacLachlan 1992; Brewer & MacLachlan 1994). Brewer and colleagues observed 
that erythrocytes-absorbed viral particles were not any longer labelled by 
immunogold staining. Hence, they postulated that, in a similar manner, 
neutralising antibodies are not able to reach BTV virions hidden into cell 
membrane invaginations (Brewer & MacLachlan 1992). Interestingly, BTV 
particles associated with ruminant erythrocytes often resemble morphologically 
viral cores, lacking the VP2 and VP5 proteins that form the outer capsid; core 
particles are not infectious to mammalian cells but they might still be infectious 
to the insect vector, as demonstrated in vitro (Xu et al. 1997). This mechanism 
would allow the virus to circulate in the presence of neutralising antibodies for 
long time but still remaining infectious for the insect vector. In experimentally 
infected animals, it has been documented that it is possible to detect BTV RNA 
in blood by qPCR for more than 100 days (111-222 dpi) in both sheep and cattle. 
This period of time appears to be consistent with the life span of ruminants red 
blood cells (160 days) (Bonneau et al. 2002). However, the time in which it is 
possible to isolate infectious virus in vitro from the blood of a viremic animal is 
much shorter and this is also believed to be the time for which a viremic animal 
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is infectious to Culicoides midges (Bonneau et al. 2002; Singer et al. 2001). This 
might suggests that membrane absorbed virions lose infectivity over time. 
Despite the broad epidemiological consequences of this aspect, not many studies 
have thoroughly assessed the potential infectivity of blood. Currently, based on 
the available information, the World Organization for Animal Health have 
adopted a legislation considering 60 days as the longest period during which an 
affected animal can be a source of infection (OIE - World Organisation for Animal 
Health 2016b).  
1.5.2 BTV tropism 
Immunohistochemical studies of experimentally infected cattle or sheep had 
identified BTV infected cells mainly as endothelial cells lining small vessels, 
perycites and mononuclear phagocytes (MacLachlan et al. 1990; Stair 1968; 
Darpel et al. 2012; Mahrt & Osburn 1986; Meltzee 2016). However, attempts to 
identify BTV antigens in ruminant tissues have often been unsuccessful and 
generally have returned contrasting results, making the identification of 
infected cells and the evaluation of virus antigen distribution difficult to 
interpret. 
A recent study employed confocal laser scanning microscopy (CLSM) and 
immunolabeling of structural (VP7) and non-structural (NS2) proteins of the virus 
in order to identify the cells in which BTV is replicating (Darpel et al. 2012). This 
study indicates that at the inoculation site, BTV replicates in endothelial cells of 
capillaries in the dermis at 3 dpi and at a later time (6-9 dpi) in CD45+ agranular 
leukocytes, similarly to what previously described (Mahrt & Osburn 1986). On the 
contrary, VP7 but not NS2 could be detected on the membrane of erythrocytes, 
confirming virus adherence but lack of replication in these cells (Darpel et al. 
2012). 
In one study, cDCs have been identified as early targets of infection; these cells 
have been assumed to get infected by BTV in the skin, and have been found in 
the lymph draining the inoculation site (identified as CD11c+ cells) in association 
with viral RNA between 4 to 6 dpi. Hence, cDCs have been hypothesised to be 
the main responsible of BTV dissemination from the skin to the peripheral LNs 
(Hemati et al. 2009). However, these cells have not been reported to express 
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viral non-structural proteins in vivo, even though, during experimental isolation 
and in vitro infection they appear to sustain BTV replication. Interestingly, the 
physiology of the cells does not seem to be affected by BTV. After in vitro 
infection, cDCs are activated and contrary to infected endothelial cells they do 
not appear to undergo apoptosis (Hemati et al. 2009). In the attempt to localise 
infected DCs at their arrival point, in the lymph node, the authors describe the 
presence of BTV NS2 in some CD1+ and CD11c+ cells at this site, and report the 
lack of infection of other cell populations such as CD4 T cells, γδ T cells, B cells 
and CD11b positive cells. Interestingly, the presence of infected cells that do not 
appear to express any of these markers was also reported, the impossibility to 
classify these cells in one of the most represented leukocyte populations was 
therefore attributed to a shutoff of surface protein synthesis induced by BTV 
(Hemati et al. 2009).  
Lymphoid tissues of BTV infected animals often present the higher viral loads 
early after infection, independent of the route of infection (subcutaneous or 
intravenous) (Pini 1976; Barratt Boyes et al. 1992; Stair 1968; MacLachlan et al. 
1990; Worwa et al. 2010). Certain subsets of leukocytes populating these tissues 
are therefore thought to represent primary cellular targets for the initial viral 
replication. Early histochemical studies described the presence of infected cells 
in the lymph nodes which localise in the medullary sinuses and in the paracortex 
(Stair 1968). In contrast, subsequent histochemical and immunofluorescence 
experiments only succeeded to detect few infected leukocytes at these sites 
together with the more prominently infected endothelial cells, however the 
number of infected cells present in the LNs was limited, consisting only of 3 to 
10 cells per section (Darpel et al. 2012; Hemati et al. 2009).  
Similarly, in the spleen the presence of BTV infected cells has only occasionally 
been reported (Darpel et al. 2012; MacLachlan et al. 1990).  Here, the infected 
cells often localise at the periphery of lymphoid follicles and rarely in the red 
pulp (MacLachlan et al. 1990). Using subcutaneous inoculation, a recent study 
that employed in-situ hybridization, identified the presence of infected cells in 
the marginal zone and red pulp of spleen starting at 7 dpi (Lee et al. 2011). The 
morphology and localization of the infected cells indicates them as marginal 
zone macrophages. At later time, at 11 dpi, a strong positive signal was also 
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localised in the spleen follicles, in two different types of cell, one likely to be 
small lymphocytes and the other compatible for morphology with tingible body 
macrophages or follicular dendritic cells (FDC) (Lee et al. 2011). 
In support of the data obtained in experimental infection, Sanchez-Cordon and 
colleagues have recently reported in detail the localization of infected cells in 
naturally infected animals (goats and sheep). The tested samples were collected 
during the BTV-1 outbreak in Spain 2010, and key elements to facilitate the 
detection of BTV antigens in the collected tissues were identified as the use of 
Bouin's fixative solution (instead of formalin) and of an appropriate antigen 
retrieval method (Sánchez-Cordón et al. 2010). In this work, BTV infected cells 
were identified in spleen as capillary endothelial cells, macrophages, 
lymphocytes and occasionally fibroblasts in the splenic trabeculae. In lymph 
nodes, infected cells were present in the medulla and in the cortex, in lymphoid 
follicles and interfollicular area. These cells were identified principally as 
endothelial cells, macrophages and some lymphocytes; furthermore the 
infection of an unidentified population of stellate cells, most likely stromal or 
reticular cells, was also reported. In other tissues where BTV was also detected 
(lungs, ileum, and liver), infected cells were mainly identified as endothelial 
cell, macrophages and stromal cells (Sánchez-Cordón et al. 2010).  
The varied and conflicting results reported in these studies are difficult to 
interpret, and do not provide a clear picture of the tropism of BTV in skin and 
lymphoid tissues. It is likely that the different techniques employed offered 
different sensitivity for the identification of the virus in tissues. Moreover, 
different BTV serotypes, different routes of inoculation and the time of 
collection of the analysed tissues are all factors that may have contributed to 
varying degrees to the different results described. 
Since BTV infected animals present a high and persistent viraemia, some studies 
focused on the identification of the cells responsible for supporting the presence 
of the virus in the bloodstream. A number of authors focused on determining the 
target cells of BTV infection in PBMC in cattle. However, PBMC demonstrated a 
degree of resistance to BTV infection (Ellis et al. 1993), since the virus was able 
to replicate only on the adherent fraction of PBMC, constituted by monocytes 
and the resulting macrophages (Whetter et al. 1989; Drew et al. 2010; Barratt 
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Boyes et al. 1992). On the contrary, infection of the non-adherent fraction of 
PBMC (constituted by lymphocytes) did not result in a productive infection 
(Barratt Boyes et al. 1992). BTV was shown to be absorbed into the cell 
membrane of lymphocytes 15 minutes after infection, but on the contrary to 
other cell types, infection did not progress beyond this stage during the 
following 48 h (Brewer & MacLachlan 1994). A productive infection of 
lymphocytes was achieved only after stimulation of these cells with IL-2 
(interleukin 2) after BTV absorption (Stott et al. 1990). The phenotype of the 
infected cells was characterised as constituted mainly by CD4 T-lymphocytes 
expressing IL-2 receptor, hence indicating that only activated T-cells are 
permissive to BTV infection (Stott et al. 1990; Barratt Boyes et al. 1992) at least 
in in vitro experiments. On the contrary, BTV was found to infect poorly CD8 and 
 T-lymphocytes even after stimulation with IL-2 or Con-A (Concanavalin A). 
Resting B cells do not appear to be infected by BTV but their infection after 
activation has not been tested.  
Studies on the susceptibility of PBMC to BTV infection have only been performed 
in cattle and no equivalent information on these subsets is available for sheep. 
In sheep, studies have principally focused on  T-lymphocytes. It has been 
observed that circulating and skin  T-cells, collected during the initial 2 weeks 
after infection, can persistently harbour infectious viral particles. The latent 
infection can be converted into a lytic one through activation of lymphocytes 
with IL-2, by interaction with skin fibroblasts or by cross-linking the surface 
protein WC-1 (Takamatsu et al. 2003).  
1.5.3 BTV-induced lesions 
Given the virus tropism for endothelial cells, it is believed that BT associated 
lesions are principally the results of a direct damage of the virus to the host 
vasculature. Endothelial lesions can induce an increase in vascular permeability 
and could eventually account for the haemorrhages, ooedemas and effusions 
associated with the disease. When the lungs (the shock organ in ruminants) are 
severely involved as a result of BTV infection, respiratory distress associated 
with the insurgence of pulmonary ooedema can rapidly lead to the death of the 
animal, within a week from infection (MacLachlan et al. 2009). 
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BTV is a cytopathic virus, that can induce cell death (apoptosis and necrosis) in 
microvascular bovine and ovine endothelial cells (DeMaula et al. 2001), 
monocytes (Barratt Boyes et al. 1992) and activated T-cells (Takamatsu et al. 
2003) in vitro. Induction of apoptosis as a consequence of infection has also 
been demonstrated in vivo in PBMC and spleen (Umeshappa, Singh, et al. 2010). 
The mechanism of viral uncoating seems to be sufficient to trigger the apoptosis 
cascade (Mortola et al. 2004). Accordingly to this model the level of virus 
replication and the extent of the damage induced to the infected cells should be 
proportional to the degree of clinical disease observed in the animal. However, 
this is not always the case, suggesting that other factors (a part from the solely 
cytopathic damages) are influencing the clinical outcome of disease. 
It has been hypothesized that, like for other haemorrhagic fevers, a prominent 
role in the pathogenesis of disease could be played by a so called "cytokine 
storm", a cascade of cytokines released by activated or damaged cells, that can 
result in increased vascular permeability as a consequence of a deregulated 
immune response. The role of pro-inflammatory cytokines in the pathogenesis of 
BT has been investigated using different methods in primary cell culture.  
Initial studies addressed species-specific differences during the infection of 
endothelial cells collected from sheep and cattle. Infection with BTV induces 
activation of endothelial cells and subsequent production of inflammatory 
mediators (Russell et al. 1996; DeMaula et al. 2002). It has been observed that 
upon infection, endothelial cells taken from different tracts of the respiratory 
system, expressed various rates of apoptosis and necrosis in sheep and cattle 
(DeMaula et al. 2001). Furthermore, upon BTV infection, both ovine and bovine 
endothelial cells express an high level of vasoactive mediators and pro-
inflammatory factors, such as IL-1, IL-6, IL-8, cycloxigenase-2 (COX-2) and 
inducible nitric oxide synthase, together with the expression of cells adhesion 
molecules (like for example E-selectin) (DeMaula et al. 2001). However, in cattle 
it was observed a higher production of prostacyclin, which has an antithrombotic 
and vasodilator activity. It has been speculated that prostacyclin could likely 
counteract the adverse effect that inflammation and cell death could have in 
the insurgence of thrombosis, DIC (disseminated intravascular coagulation), and 
haemorrhagic diathesis.  Thus, these factors could confer a certain resistance to 
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the cattle to the consequences of microvascular injury (DeMaula et al. 2002). In 
vivo, the presence of IL-1α and TNF-α in tissues taken from naturally infected 
goats, was assessed by immunohistochemistry and it appeared to be enhanced in 
the presence of viral protein expression (Sánchez-Cordón et al. 2013). Overall, 
the contribution of inflammation and related mediators may play an important 
role in the pathogenesis of bluetongue but no conclusive data have been 
presented so far during in vivo infection. 
1.6 Host immune response to BTV infection 
Currently there is a limited knowledge of the host immune response to BTV 
infection. Animals that recover from BT have a long lasting protection to re-
infection with homologous serotypes of BTV that is attributed to both humoral 
and cellular immunity (Schwartz-Cornil et al. 2008; Jeggo 1986).  
 
1.6.1 Innate immune response 
Innate immune response constitutes the first line of defence against a viral 
incursion. Scarce information is available on the innate immune response against 
the virus in vivo. Bluetongue virus is considered a strong inducer of type-I IFN 
production both in vitro and in vivo, however its involvement in restricting viral 
replication in the ruminant host is still largely unknown, considering that 
viraemia continues beyond the detection of IFN in serum (MacLachlan 1994). In 
experimentally infected sheep, IFN starts to be detectable in serum around 4 dpi 
and it rapidly disappear at 10 dpi. The peak of IFN has been registered between 
4 and 8 dpi, which is in correspondence of the peak of viraemia (Foster et al. 
1991). In cattle, a similarly transient IFN response is detected during the early 
phases of infection preceding the peak of viraemia; therefore it is reasonable to 
assume its implication in controlling viral spread. Increased levels of type-I IFN 
were also observed in lymph draining the skin of sheep inoculated intradermally 
with BTV-2 and BTV-8, with a peak detected at 5-6 dpi (Ruscanu et al. 2012). In 
sheep infected with BTV, the cells responsible for the higher production of α/β-
IFN in blood and lymph have been identified as a population of B-/CD11c-
/CD45RB+ cells, and identified as plasmacytoid DCs (pDCs), a small subset of DC 
present in blood and lymphoid tissues (Ruscanu et al. 2012). In pDCs BTV 
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internalization and endo/lysosomal acidification was required to trigger type-I 
IFN production, and this was achieved even in the presence of inactivated virus 
(Ruscanu et al. 2012). 
DCs are “professional” antigen presenting cells, representing the key link 
between innate and adaptive immunity. Historically, mononuclear cells capable 
of supporting BTV replication have been exclusively identified as monocytes and 
activated lymphocytes (Whetter et al. 1989; Barratt-Boyes et al. 1992). 
However, more recently, due to increased availability of new ovine-specific 
antibodies it has become possible to investigate the role of sheep dendritic cells 
in the pathogenesis of this disease. 
Recent studies have shown that mononuclear cells, present in the efferent 
lymph coming from the area of inoculation of the virus, can be infected and 
support BTV replication, these cells have been identified has cDCs (Hemati et al. 
2009). This study suggests that cDCs are among the first cell type to become 
infected by BTV in the efferent lymph and that they could have a pivotal role in 
virus diffusion, contacting the virus at the entry site and then spreading to the 
rest of the body. 
Due to the stimulation of an inflammatory reaction, in response to the insect 
bite or the virus presence, the initial BTV infection could also act as a 
chemoattractant for DCs, since an increase in the percentage of cDCs in skin and 
(draining) lymph has been detected after virus inoculation (Hemati et al. 2009). 
In contrast to endothelial cells, cDCs can support viral infection without 
undergoing apoptosis and maintaining their functionality (DeMaula et al. 2001; 
Hemati et al. 2009), indeed expression of surface co-stimulatory molecules and 
production of IL-1β, IL-6 and IL-12 is increased in vitro after BTV infection, 
denoting their activation. Infected cDCs also seem capable to trigger the 
proliferation of CD4 and CD8 T-cell and stimulate the synthesis of IFN-γ and IL-
10 (Hemati et al. 2009). No difference was found in the DCs response to 
infection with either wild type or attenuated BTV strains, suggesting that the 
behaviour of these cells is not modified by the virulence of the virus. 
Gene expression profile of pDCs and cDCs has been evaluated in sheep 
experimentally infected with BTV. Results indicate a possible involvement of 
these cells in the inflammatory process. In particular, circulating DCs presented 
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a proinflammatory signature that could potentially be implicated in the systemic 
inflammation and vascular permeability observed during pathology (Ruscanu et 
al. 2013). 
 
1.6.2 Humoral immune response 
Antigen specific antibodies can target viral proteins to limit virus infectivity and 
to activate effector cells. Upon BTV infection, infected ruminants develop a 
prompt humoral immune response towards both structural and non-structural 
viral proteins (Huismans & Erasmus 1981; Richards et al. 1988). Passive serum 
transfer studies showed that neutralizing antibodies, which normally appear 
between 7 and 14 dpi, are able to confer serotype-specific protection, and can 
completely prevent the onset of viraemia (Jeggo, Wardley & Taylor 1984; 
Letchworth & Appleton 1983). Virus neutralising epitopes are mainly expressed 
on VP2, which is one of the components of the virus outer capsid (Huismans et 
al. 1987; DeMaula et al. 2000). Some of the VP2 targeted epitopes appear to be 
conformational dependent and are due in part to VP2 folding and in part to the 
interaction between VP2 and VP5 (DeMaula et al. 2000). VP2 and VP5 are the 
proteins implicated in cell membrane binding and BTV entry, hence it is logical 
to think that neutralization antibodies would provide a steric obstruction that 
prevent membrane attachment. 
The outer capsid proteins are the most variable viral proteins and are therefore 
considered the main determinants of BTV serotype. This means that antibodies 
raised against a specific serotype generally do not provide protection against 
heterologous serotypes. However, the presence of common neutralization 
epitopes has been proved by serological cross-reactivity between certain viral 
serotypes, furthermore animals sequentially immunised with multiple serotypes 
can develop a broader neutralising antibodies against a previously unchallenged 
serotype (Rossitto & MacLachlan 1992; Gould & Pritchard 1990). Unfortunately, 
the simultaneous immunisation with a combination of serotypes has proven 
ineffective to elicit a similar broad neutralising response, providing protection 
only towards some of the serotypes used.  
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Studies using a synthetic biology approach or reverse genetic system have 
achieved methods to express recombinant BTV proteins used alone or in 
association with core proteins to immunise animals. These experiments further 
confirmed that serotype specific protection and neutralising antibodies can be 
achieved through the immunisation of the animals with only the outer core 
proteins VP2 and VP5 (Boone et al. 2007; Stewart et al. 2012; Nunes et al. 2014). 
Neutralising antibodies do not have the capacity to clear BTV from the blood of 
infected animals, indeed neutralizing antibodies are present in conjunction with 
viraemia for several weeks (Richards et al. 1988; Caporale et al. 2014). As 
mentioned before, it has been reported that BTV can be absorbed into 
invagination of the cells membrane in resting lymphocytes, platelets and 
erythrocytes. This mechanism could limit the capacity of neutralising antibodies 
to bind viral particles hence delaying the clearance of virus associated with cells 
membrane (Brewer & MacLachlan 1992). 
Ruminants also develop antibodies towards a variety of other BTV proteins; in 
particular VP7 and NS1 have epitopes that are shared among the different 
serotypes. Currently, competitive ELISA tests are available on the market and 
widely used to detect VP7 antibodies to screen the seropositivity of suspected 
animals. Despite the role of non-neutralising antibodies in the host immune 
response is still obscure, there is evidence suggesting that they could have a 
protective role. Animals immunized with virus like particles expressing the core 
protein VP3 and VP7 presented a mild illness and a lower viraemia upon 
challenge compared to unvaccinated animals (Stewart et al. 2012). Similarly, 
animals vaccinated with a capripoxvirus expressing BTV VP7 showed partial 
protection against challenge with heterotypic virus (Wade-Evans et al. 1996). It 
is possible that non-neutralising antibodies are implicated in a process of 
complement activation or antibody-dependent cell-mediated cytotoxicity 
(ADCC), thus activating effector cells (such as natural killer and macrophages) to 
lyse the labelled infected cells. Only few unsuccessful attempts have been 
performed to demonstrate ADCC (Jeggo, Wardley & Taylor 1984). However, since 
limited experiments have been performed to evaluate the concomitant role of 
cell-mediated immunity in protection and its contribution to the development of 
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a specific humoral immune response, no final interpretation of these studies can 
be made. 
1.6.3 Cellular immune response 
Cell-mediated immunity can limit viral spread by targeting and eliminating 
infected cells. The role of effector T-cells during the course of BTV infection has 
not been widely investigated. The presence of BTV specific CD8 T-cells has been 
demonstrated following infection both in sheep and mouse models, and contrary 
to antibodies they demonstrate a certain degree of cross-reactivity with 
heterologous serotypes (Takamatsu & Jeggo 1988; Jeggo & Wardley 1982; Ghalib 
et al. 1985). An increase of circulating CD8 T-cell population is generally noted 
around 10-15 dpi (Umeshappa et al. 2010; Sánchez-Cordón et al. 2015). Indeed, 
sheep develop short-term cytotoxic T-lymphocytes (CTL) anti-BTV that peak at 
12-14 dpi. Jeggo and colleagues, in order to study the in vivo role of CTL, 
performed the adoptive transfer of lymphocytes, taken from the thoracic duct of 
sheep at 7 and 14 days after experimental BTV infection, into monozygotic 
susceptible sheep (Jeggo, Wardley & Brownlie 1984). This experiment 
demonstrated the capacity of lymphocytes present at 14 dpi (but not at 7 dpi) to 
confer a partial protection to infection in recipient sheep. Sheep that received 
lymphocytes presented an earlier production of neutralising antibodies and a 
marked reduction of pyrexia and viraemia when challenged with a homologous 
BTV serotype. Furthermore, these animals showed complete protection (i.e. 
neither viraemia nor pyrexia) when challenged with a different BTV serotype. 
This observation reinforced the idea of an heterotypic protection conferred by 
CTL (Jeggo, Wardley & Brownlie 1984). However, since the cells transferred in 
this study were not characterised, it was not possible to completely rule out the 
presence and influence on the acquired protection of other subset of 
lymphocytes and of antibody producing plasma cells that were probably present 
among the transferred cells. 
VP2 and NS1 have been identified as major CTL immunogens in sheep, with NS1 
specific CTL being the main responsible for cross-protection (Andrew et al. 1995; 
Janardhana et al. 1999). On the contrary, in mice experimentally infected with 
BTV, cross protective CTL are developed against NS1 and NS2 (Jones et al. 1997; 
Jeggo & Wardley 1982). The difference in epitopes targeted by sheep and mouse 
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CTL indicate that is present a certain degree of species-specificity in the 
immune response. 
 
1.7 Mouse models of infection 
Studies on the pathogenesis of bluetongue can benefit from the use of the 
natural target specie of infection to reproduce the disease. However, large 
animal experiments have limitations imposed by the number of animals that is 
ethically acceptable to include in the study, elevated costs, the limited 
knowledge and the lack of tools for the analysis of the ruminant immune system. 
Therefore, more practical models of infection have been investigated and used 
for various purposes.  
Neonatal mice have been used as a model to study the virulence of BTV strains 
(Waldvogel et al. 1986; Waldvogel et al. 1987; Caporale et al. 2011; Narayan & 
Johnson 1972). The initial purpose of these studies was to define a model to 
replicate sheep foetal infection and related cerebral malformations.  In newborn 
mice, after intracranial inoculation, BTV replicates selectively in immature cells 
of the subventricular zone of the forebrain and spread along cell migratory 
pathways to the olfactory bulbs, caudate/putamen, hippocampus and areas of 
cerebral cortex (Narayan & Johnson 1972). Infection of foetal mice led to more 
severe cerebral malformation, while infection of 2-week-old mice results in very 
limited infection, demonstrating an affinity of BTV for undifferentiated cells 
that are gradually lost after birth (Narayan & Johnson 1972). Subcutaneous BTV 
infection of newborn Balb/c mice caused fatal necrotising encephalitis when 
virulent strains were used. Further studies, clarified that virulence was not due 
to the capacity of the viral strain to infect neural cells, but rather to their 
capacity to gain access to the brain from the skin inoculation site (Waldvogel et 
al. 1986; Waldvogel et al. 1987). This model was further used to determine the 
genetic determinants of BTV neuroinvasiveness, likely associated with VP5 and 
virus tropism (Carr et al. 1994). Intracerebral inoculation of neonatal mice 
proved useful in comparing BTV strain virulence, and attenuated vaccine safety 
(Franchi et al. 2008), however they do not reflect the viral dissemination and 
the associated pathology as it happens in the natural host. 
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Adult mice are resistant to BTV infection and viraemia is not observed in mice 
when inoculated either intravenously or subcutaneously (Ortego et al. 2014). 
However, blocking IFN-α/β activity in mice has been proved useful in increasing 
dramatically their sensitivity to many viruses. Hence, recently a mouse model of 
IFNAR(−/−) mice was developed for BTV. These mice are lacking IFN-α/β receptor 
and therefore cannot respond to IFN production. Mice with a C57BL/6 genetic 
background (Calvo-Pinilla, Rodríguez-Calvo, Anguita, et al. 2009) proved 
susceptible to various BTV serotypes, but only when inoculated intravenously. 
Whereas interestingly, IFNAR(−/−) mice with a SV129 genetic background showed 
the same susceptibility to BTV infection when inoculated subcutaneously, 
intravenously or even orally (Calvo-Pinilla et al. 2010). 
Infected mice present clinical signs characterized by ocular discharges, anorexia 
and apathy and the disease progression led to animal death. In general, the 
strain virulence observed in the field in the ruminant hosts can be 
representatively reproduced in this mouse model, as the animal mortality rate 
gives an indication of the degree of BTV serotype/strain pathogenicity (Ortego et 
al. 2014; Caporale et al. 2011; Ratinier et al. 2011; Calvo-Pinilla, Rodríguez-
Calvo, Anguita, et al. 2009; Janowicz et al. 2015). For this reason, recent studies 
have done extensive use of IFNAR(-/-) mice to help identifying the molecular 
determinants of BTV virulence (Caporale et al. 2011; Janowicz et al. 2015).  
BTV distribution in IFNAR(-/-) mice mimics BTV infection in cattle and sheep. 
After intravenous infection BTV can be detected in spleen at 24 hpi, before its 
dissemination to other organs such as lungs, thymus, lymph nodes and blood 
(Calvo-Pinilla, Rodríguez-Calvo, Anguita, et al. 2009). The presence of viraemia 
after BTV inoculation is dependent on the viral dose administered, with only 
mice infected with high viral dose presenting viraemia, appearing at 2 dpi (24h 
after spleen infection) and peaking at 4 dpi (Calvo-Pinilla, Rodríguez-Calvo, 
Anguita, et al. 2009). 
Histological analyses of BTV infected mice at 48 hpi showed many similarities 
with lesions described in natural hosts. Widespread oedema, petechiae and 
haemorrhages can be observed, especially in spleen and lungs. A 
bronchointerstitial pneumonia it is often present. The enlargement of secondary 
lymphoid organs, which can indicate immune activation, is accompanied by a 
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severe lymphoid depletion, that has not been further characterized, and a loss 
of the architecture of thymus (Calvo-Pinilla, Rodríguez-Calvo, Anguita, et al. 
2009).  
IFNAR(-/-) mice proved useful also in vaccine protection studies, since upon 
immunization they develop neutralizing antibodies and cytotoxic T-cells 
targeting varies viral proteins, and are protected against lethal challenge with 
virulent BTV strains (Calvo-Pinilla, Rodríguez-Calvo, Sevilla, et al. 2009; Marín-
López et al. 2014).  
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2 Aims  
The aims of this research project were to investigate the early events of BTV 
infection in experimentally infected animals and determine how they affect viral 
pathogenesis and the clinical outcome of disease. 
More specifically we aimed to: 
1. Identify the sites (both at the tissue and cellular level) where BTV 
replicates in experimentally infected sheep.  
2. Characterise immunopathological changes induced by BTV in 
experimentally infected sheep.  
3. Characterise the humoral immune and immunopathology in sheep and 
goats infected with different strains of BTV.  
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3 Material and Methods 
3.1 Cell Culture 
3.1.1 Maintenance of cell culture 
Sterile standard conditions of tissue culture were maintained throughout the 
experiments. 
African green monkey kidney (Vero), Baby hamster kidney (BHK-21) cells and BSR 
cells (a variant of BHK-21 cells) were maintained in Dulbecco's Modiﬁed Eagle's 
Medium (DMEM, Thermo Scientific) supplemented with heath inactivated 10% 
(v/v) foetal bovine serum (FBS) (Thermo Scientific), 4 mM stabilized L-glutamine 
(GlutaMAX, Gibco), 25 mM dextrose, 1 mM pyruvate, 100 U/ml penicillin and 100 
g/ml streptomycin (Thermo Scientific). 
Ovine choroid plexus cells (CPt-Tert) are sheep cells immortalised with simian 
virus 40 (SV40) T antigen and human telomerase reverse transcriptase (Arnaud et 
al. 2010; Caporale et al. 2014); cells were maintained in Iscove's Modified 
Dulbecco's Medium (IMDM, Thermo Scientific) supplemented as above for DMEM. 
Culicoides sonorensis (KC) cell line (Wechsler et al. 1989) was grown in 
Schneider’s Insect Medium (Thermo Scientific) supplemented with 15% FBS 
(Thermo Scientific). 
Mammalian cells were maintained in incubators at 37 °C with 5% CO2 humidified 
atmosphere, while insect cells were maintained at 28 °C without CO2. Cells were 
routinely grown in 225 cm2 flasks and passaged when reaching confluence. For 
propagation, cell monolayer was rinsed twice with phosphate buffered saline 
(PBS), and then incubated with a 0.05% trypsin solution containing 200 mg/L 
Ethylenediaminetetraacetic acid (EDTA), for 10 min at 37 °C (Thermo Scientific). 
Once detached cells were re-suspended in fresh media and transferred to a new 
sterile flask or used for assays. 
For long term storage in liquid nitrogen, harvested cells were pelleted at 400xg 
for 10 minutes and re-suspended in 90% (v/v) FBS, 10% (v/v) dimethyl sulfoxide 
(DMSO) (Thermo Scientific). The suspension was divided in 1 ml aliquots (1x106 
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cells/vial), gradually brought at -80°C over 24 hours before being transferred to 
liquid nitrogen. 
3.1.2 Viruses 
Experiments were performed using different isolates of BTV serotype 8 (BTV-8).  
BTV-8NET2006 (Pirbright Institute for Animal Health, reference collection number 
NET2006/04) is a virulent strain isolated from a naturally infected sheep in the 
Netherlands, during an outbreak occurring in Northern Europe in April 2006 and 
previously described (Caporale et al. 2014; Ratinier et al. 2011). Here it will be 
referred to simply as BTV-8. 
BTV-8NET2007(blood) is whole blood obtained from the spleen of a sheep 
experimentally infected with blood derived from a naturally infected cow in the 
Netherlands during the 2007 BTV-8 outbreak as previously described (Caporale et 
al. 2014). Here it will be referred to as BTV8blood. 
BTV-8IT2008 is a naturally attenuated strain, circulating in Italy during 2008 and 
isolated from an asymptomatic sheep and has been already described (Caporale 
et al. 2014). Here this will be referred to as BTV8ita.  
BTV-8p65 is an in vitro attenuated strain, produced by 65 sequential passages of 
BTV-8NET2006 in BSR cells that has been previously described (Janowicz et al. 
2015). Here this will be referred to as BTV8H (H for “highly passaged”). 
All viruses sourced from the field (naturally infected animals) were initially 
isolated on KC cells and subsequently passaged on BHK-21 cells. Afterwards, 
virus stocks were grown in BHK-21 cell lines. BHK-21 cells were grown in 175 cm2 
flasks until 90% confluent, then growth media (DMEM) was removed and the cell 
monolayer washed once with DMEM without FBS. Next, 100 µl of stock virus were 
diluted in 20 ml of DMEM (without serum and antibiotics) and added to the cells 
which were incubated at 37 °C for 4 to 5 days, until complete destruction of the 
cellular monolayer. Supernatant was harvested and centrifuged at 500xg for 10 
minutes to remove cellular debris, then transferred to tubes for storage at 4 °C. 
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All viruses used in this study for animal infection, a part from BTV8H, have the 
same passage history (1 passage in KC cells and two passages in BHK-21 cells) 
unless indicated otherwise. 
3.1.3 Virus titration 
Virus titre was determined by plaque assay or by end point dilution assay as 
previously described (Caporale et al. 2014; Nunes et al. 2014; Ratinier et al. 
2011). 
3.1.3.1 Plaque Assay titration 
Plaque assay allows the determination of virus titre by scoring the number of 
plaque forming unit (PFU) generated by a virus stock in a standardised tissue 
culture. Each BTV-8 virus stock use in this work was quantified in triplicate. 
Tenfold serial dilutions of virus stock were prepared in serum-free DMEM, from 
10-1 to 10-7. 250 µl of each dilution was added to an 80% confluent monolayer of 
Vero cells (5x105 cells/well) in a 6 well plate and incubated for 1 hour at 37 °C 
to allow virus absorption. After virus removal and a wash with PBS, the cells 
were covered with a semisolid overlay medium prepared with a 50/50 dilution of 
2.4% (w/v) Avicell (FMC BioPolymer, Belgium) with 2x Minimum Essential Media 
(MEM) supplemented with 4% (v/v) FBS. Plates were incubated for 72 hours at 37 
°C, 5% (v/v) CO2 to allow the appearance of cytopathic effect (CPE). Cells were 
then fixed with 4% formaldehyde in PBS for 20 minutes followed by staining with 
Crystal Violet, 0.1% (w/v) in PBS to visualize plaques. Plaques were counted in 
the wells showing the best discrimination and their dilution taken in account to 
calculate the virus titre. Virus titre was determined as the number of plaque 
forming units per ml (PFU/ml) of virus. 
3.1.3.2 End point dilution assay 
Tissue Culture Infectious Dose 50 (TCID50) is an endpoint dilution assay that 
allows virus quantification, in which the virus is required to produce a cytopathic 
effect in 50% of inoculated tissue cultures. It is generally expressed as 
TCID50/ml. Each virus stock used was titrated in quadruplicate. Serial tenfold 
dilutions of the virus stock were performed from 10-1 to 10-8 in DMEM in a flat 
bottom 96 well plate; to these, 100 µl of a suspension of Vero cells containing 
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2.5x104 cells in DMEM with 10% FBS were added and incubated at 37 °C with 5% 
CO2 atmosphere. After 4 days the CPE was assessed with the use of an inverted 
microscope, with BTV infected cells rounding up and detaching from the bottom 
of the wells, showing partially or completely confluent foci of destruction in the 
monolayer. Positive well (showing CPE foci) and negative wells (presenting an 
intact cells monolayer) were recorded. Virus titre was determined using the 
Reed-Muench method (Reed & Muench 1938) and expressed as log10 tissue 
culture infectious dose 50 per ml of virus (log10 TCID50/ml). 
 
3.2 In vivo experiments 
Due to the restriction imposed by animal health regulations on exotic and 
notifiable animal diseases (SAPO and Animal Health Act) the in vivo part of this 
project was carried out by collaborators in other EU countries. All the 
experimental infections of sheep, goats and mice were carried out by Dr. Marco 
Caporale at the Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise 
“G. Caporale” (Teramo, Italy) and, only were specifically stated, by Dr. Noemi 
Sevilla at the Centro de Investigación en Sanidad Animal (Madrid, Spain) in 
accordance with locally and nationally approved protocols regulating animal 
experimental use (protocol numbers 7440; 11427; 12301 in Teramo and 
10/142792.9/12, CBS2012/06 and PROEX 228/14 in Madrid).  In addition, and to 
minimize the number of animals under experiment, some of the animal samples 
used for this study were sourced from previous experimental infections 
(Janowicz et al. 2015; Caporale et al. 2014). Experimental infections in sheep 
and goats were conducted in an insect-proof isolation unit (in BSL-3 facilities) 
supported by continuous veterinary care. Sheep and goats included in these 
studies were sources from local farms. Prior to the infections the animals were 
confirmed to be seronegative for BTV using a competitive ELISA (cELISA), and 
the absence of circulating virus was assessed by Real-Time Quantitative Reverse 
Transcription-PCR (qRT-PCR) on blood samples, as previously described 
(Caporale et al. 2014). 
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3.2.1 Viral localization studies in sheep and goats 
Study 1. In order to follow the temporal dissemination of the infection in the 
natural host, sheep (n=23) were infected intradermally (ID) with a total of 2x106 
PFU of BTV8 in 5 ml of cell culture media (MEM, Thermo Fischer Scientific) by 
multiple inoculations (100 µl per inoculation) in four different areas in the inner 
legs and in the forearm, in areas drained by the corresponding inguinal and 
prescapular LNs. Control animals (n=8) were infected with 5 ml of mock-infected 
cell culture supernatant (MEM). Animals were monitored daily for clinical signs 
and body temperature recorded every day until the end of the experiment. 
Blood samples were collected (in EDTA) daily in order to detect viremia. Animals 
were humanely euthanized at 4, 8, 24, 48, 72, 96, 120 and 168 hpi (n=3 per each 
time point with exception of 96 h were n=2). Tissue samples of tongue, heart, 
aorta, spleen, lung, kidney, liver, skin and various lymph nodes (mediastinal, 
prescapular, inguinal, popliteal, retromandibular) were collected during post-
mortem examination and fixed in 10% (v/v) neutral buffered formalin or zinc 
salts solutions (BD Pharmigen) and embedded in paraffin for further histological 
assays, while tissues used for RNA extraction and detection of viral nucleic acid 
were stored at -20°C in RNAlater (Thermo Fisher) until processed. In order to 
assess the effects and localization of an inactivated virus, two additional control 
sheep were inoculated with 2x106 PFU of UV-inactivated BTV8 and euthanized 
respectively at 24 and 48 hours post infection (hpi). 
Study 2. In order to follow the tissue dissemination of BTV-8 in goats, domestic 
goats (n=18) were inoculated with BTV8 as detailed above and euthanized at 8, 
24, 48, 72, 96 and 168 hpi (n=3). Blood and tissue samples were collected as 
above.  
Study 3. In order to follow the tissue dissemination of an attenuated strain of 
BTV-8, sheep (n=13) were inoculated with BTV8H (Janowicz et al. 2015) as 
detailed above and euthanized at 8, 24, 48, 72, 96 and 168 hpi (n=2, except 
from 168 h were n=3). Blood and tissue samples were collected as above for 
detection virus localization by qPCR and for histological assays. 
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3.2.2 Virus localization studies in mouse model 
In order to limit the number of sheep and goats to include in the study, we 
tested weather a mouse model of BTV infection could recapitulate the 
localization of the virus in the draining lymph nodes as observed in ruminants. 
Adult NIH Swiss mice and transgenic mice (129sv IFNAR-/-,
 B&K Universal Ltd.), 
deficient in type I interferon-alpha/beta receptor (IFNAR) described to be 
susceptible to BTV infection (Calvo-Pinilla, Rodríguez-Calvo, Anguita, et al. 
2009; Caporale et al. 2011) were maintained at biosafety level 3 at the IZS 
(Teramo, IT). In order to identify BTV localization in the LNs in mouse models of 
BTV infection, groups of adult mice (n=6 for NIH Swiss and n=8 for IFNAR-/-), age 
and sex-matched, were inoculated subcutaneously in the thighs with 300 PFU of 
BTV8 in 200 μl of cell culture media (100 μl each injection) or an equivalent 
volume of mock infected cell culture medium as a control. Mice were examined 
for clinical signs daily until the experiment was terminated (day 2) and/or the 
animals euthanized. Two challenged and one control mouse per group were 
euthanized at 4 (IFNAR-/- mice only), 8, 24 and 48 hours post-inoculation, 
inguinal lymph nodes draining the site of inoculation were collected and fixed in 
10% neutral buffered formalin for histological assessment and for virus detection 
by confocal microscopy (as described below). 
3.2.3 Long-term serological studies in sheep and goats 
Study 1. In order to compare antibody responses in goats and sheep infected 
with virulent and attenuated strains of BTV-8, 3 sheep and 3 goats were 
inoculated with 2x106 PFU of BTV8 and an additional group of 3 sheep was 
inoculated with 2x106 PFU of BTV8ita . Animals were monitored for 28 days, body 
temperature recorded, and blood samples collected as above at day 7, 14, 21 
and 28 post infection for detection of virus RNA and viremia assessment. Serum 
samples were collected daily until day 14 and then at day 21 and 28 and were 
used to evaluate BTV-specific antibody response by ELISA, neutralization titres 
and serum avidity. 
Study 2. In order to expand the range of our observations on specificity and 
avidity of antibody responses to BTV infection to a larger number of animals and 
to limit the number of newly infected animals, we analysed serum samples 
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collected during previously published studies (Caporale et al. 2014; Janowicz et 
al. 2015).  In the first study, a group of 5 Sardinian sheep were inoculated with 5 
ml of infected blood (BTV8blood) and serum samples collected daily until day 28 
post infection. In a second study a group of 5 Sardinian sheep, were inoculated 
with 5x105 PFU of BTV8H and serum from these animals collected at day 7, 14, 
21, 28. In both experiments serum was stored at -80 °C after collection and 
tested for the presence of BTV neutralising antibodies, and BTV specific IgG and 
IgM and their avidity by ELISA (see 3.5). 
Study 3. Performed at the Centro de Investigación en Sanidad Animal (Madrid, 
Spain). In order to assess the B-cell response against a second antigen during the 
course of BTV infection, two groups of sheep (n=5 per group) were inoculated 
with BTV-8 as detailed above then immunised with 20 mg of ovalbumin (OVA) at 
either 24 or 72 hpi respectively. Ova is a T-dependent antigen and therefore 
requires the presence of T-helper cells and the initiation of a GC reaction for the 
production of antibodies. Hence, OVA was chosen to test the function of GCs in 
infected animals. The administered concentration of OVA was determined by 
preliminary immunisation experiments that assessed the capacity of OVA to 
induce antibody titres detectable by ELISA, without the use of adjuvants. OVA 
was inoculated via the intradermal route a few centimetres apart from the area 
of BTV inoculation to prevent confounding effects that could originate from BTV 
infection in the skin. A third group of sheep (n=5) was immunized with OVA (20 
mg) with no prior BTV infection and served as a control. Blood and serum 
samples were collected at 7, 14, 21 and 28 days post-OVA immunization. The 
number of OVA-specific antibody producing cells (ASC) in the peripheral 
circulation was quantified by B cell ELISPOT (see below) and OVA-specific IgM, 
IgG and their avidity was quantified by ELISA (see below).  
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3.3 Nucleic acids extraction, quantification and 
amplification 
3.3.1 RNA purification 
RNA was extracted and purified from blood and tissue samples collected from 
sheep and goats experimentally infected with BTV as described below.  
3.3.2 Extraction of RNA from blood samples using “High Pure 
Viral Nucleic Acid Kit” 
To lyse red blood cells and release viral particles, 1 ml of distilled water was 
added to 0.5 ml of whole EDTA blood. Samples were vortexed and incubated 10 
minutes on ice before centrifuging at 13,000xg for 10 minutes. The pellet was 
re-suspended in 200 µl of Binding Buffer provided with the High Pure Viral 
Nucleic Acid Kit (Roche, UK). Lysates where then processed accordingly to the 
recommended manufacturer protocol. Briefly, 200 µl of Binding Buffer 
supplemented with Poly(A) carrier RNA and 50 μl Proteinase-K were added to the 
samples. In addition, to control extraction efficiency, 5 µl of a 1:100 dilution of 
Armored RNA, West Nile Virus HNY1999 (Asuragen) NS5-2region were added to 
each sample. Samples were then incubated at 72 °C for 10 minutes before being 
mixed with further 100 µl of binding buffer. Samples were then transferred to a 
High Pure Filter tube and the RNA bound to the column membrane by 
centrifugation at 8000xg for 1 minute. After washing the column once with 500 
µl of Inhibitor Removal Buffer and twice with 450 µl of Wash Buffer, the RNA was 
eluted by centrifugation in 50 µl of Elution Buffer.  
3.3.2.1 Extraction of RNA from tissue samples using TRIzol® and purification 
with Qiagen RNeasy mini Kit® 
Tissue sections were collected and trimmed immediately after euthanasia in the 
post mortem room, transferred to RNA-later® stabilization solution (Thermo 
Fisher Scientific) and stored at -20 °C until extraction. After defrosting, one-
hundred and fifty (150) mg of tissue were transferred to a 2 ml tube containing 
1.5 ml of TRIzol® Reagent (Thermo Fisher Scientific) and lysed using glass beads 
in a Precellys® 24 homogeniser at 6800 rpm, until complete dissolution. Debris 
were removed by centrifugation at 12,000xg for 10 minutes at 4 °C; supernatant 
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was collected and transferred to a new tube containing 300 μl of chloroform and 
mixed for 15 seconds. After a 3 minutes incubation at room temperature samples 
were centrifuged at 12,000xg for 15 minutes at 4°C, after which the mixture 
separates into a lower red phenol-chloroform phase, a white interphase, and a 
colourless upper aqueous phase containing RNA. The upper phase was collected 
and transferred to a new tube for RNA precipitation by addition of 500 l of 
100% isopropanol.  
RNA purification was performed accordingly to the RNeasy mini kit (Qiagen®) 
protocol. Briefly, samples were loaded into RNeasy mini-spin columns and RNA 
bound to the column membrane by centrifugation at 8000xg for 30 sec. The 
membrane was washed once with 700 µl of Buffer WT1 and twice with 500 µl 
Buffer RPE (provided with the kit). The RNA was then eluted into a new 
microcentrifuge tube with 50 µl RNase-free water pipetted directly onto the 
silica-gel membrane of the column and centrifuged at 13000xg. 
3.3.3 RNA quantitation and storage 
RNA eluted from the columns (3.3.2 and 3.3.2.1) was quantified using a 
spectrophotometer (NanoDrop™ 1000, Thermo Scientific). The ratio of 
absorbance at 260 nm and 280 nm were used to assess the purity of RNA. A ratio 
of ~2.0 was considered acceptable for “pure” RNA. Extraction was repeated if 
the elute did not meet the expected standard. Samples were then stored in 
RNAse-free, low binding tubes at -80°C until further use. 
 
3.3.4 Quantitative real time PCR 
Quantification of virus copy number in tissues of animals experimentally infected 
with BTV was determined by quantitative real time polymerase chain reaction 
(qRT-PCR) using a previously described method (Jimenez-Clavero et al. 2006; 
Caporale et al. 2014). 
To standardise qRT-PCR reactions, a standard curve was prepared using tenfold 
dilutions of BTV segment-1 RNA, from 101 to 108 copies per 2 μl, aliquots for 
each dilution were prepared and stored at -80°C until needed. The standard 
dilutions were included in triplicates in plate.   
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Primers and TaqMan® probes were designed to recognise highly conserved 
regions of the target sequences (BTV seg-1, West Nile Armored RNA seg-5 and 
mammalian β-actin). A list of primers and probes used for this study are detailed 
in Table 3-1. 
Table 3-1 - List of primers and probes used for qRT-PCR 
 6-carboxyfluorescein (FAM), tetramethylrhodamine (TAMRA). HEX
TM
 (from Eurofins Scientific). 
BTNS1 (bluetongue virus segment-1), WNNS5 (West Nile virus segment-5), B-ACT (β-actin),  
Sequence  Name Oligonucleotides 
BTV seg-1 
Probe BTNS1-P 
FAM–5’-CGC TTT TTG AGA AAA TAC AAC 
ATC AGT GGG GAT–3’-TAMRA 
Forward 
primer 
BTNS1-F 5'-TGG CAA CCA CCA AAC ATG G-3' 
Reverse 
primer 
BTNS1-R 5'-CCA AAA AAG TCC TCG TGG CA-3' 
West Nile 
Armored 
RNA seg-5 
Probe 
WNNS5-
2P 
HEX-5’-CCA ACG CCA TTT GCT CCG CTG -
3’-TAMRA 
Forward 
primer 
WNNS5-
2F 
5'- GAA GAG ACC TGC GGC TCA TG -3' 
Reverse 
primer 
WNNS5-
2R 
5'- CGG TAG GGA CCC AAT TCA CA -3' 
β-actin 
(GenBank: 
FQ232650.1) 
Probe B-ACT-P 
HEX-5’-CCT GGC CTC ACT GTC CAC CTT 
CCA-3’-TAMRA 
Forward 
primer 
B-ACT-F 5’- TCT GTG TGG ATT GGT GGC TCT A-3’ 
Reverse 
primer 
B-ACT-R 5’- CTG CTT GCT GAT CCA CAT CTG -3’ 
 
A duplex reaction was set up to quantify at the same time virus copy number 
and an internal (β-Actin, housekeeping) or external (West Nile Armored RNA) 
control reference gene. No template controls (NTC), including all reagents 
except RNA template, were included in each plate to exclude accidental 
contamination. 
The PCR assays were performed with a one-step qPCR kit, where reverse 
transcription and PCR amplification are carried out in the same tube.  RT-PCR 
reactions were set up in 25 μl using the SuperScript™ III Platinum® One-Step 
Quantitative RT-PCR System (Thermo Fisher Scientific, UK), accordingly to 
manufacturer’s instructions.  Reaction mix was prepared as described in Table 
3-2. 
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Table 3-2 - Reaction mix prepared for the detection of BTV seg1 (BTNS1) copy number and 
internal (β-actin, B-ACT) or external control (West Nile seg.5, NS5) 
Reagent Initial 
Concentration 
Final 
Concentration 
Volume per 
Reaction 
2X Reaction Mix 2X 1X 12.5 µl 
SSIII/Platinum TaqMix - - 0.5 µl 
Probe BTNS1-P 50 µM 250 nM 0.13 µl 
Primer BTNS1-F 100 µM 450 nM 0.1 µl 
Primer BTNS1-R 100 µM 450 nM 0.1 µl 
Probe NS5-2P or B-ACT-P 20 µM 150 nM 0.19 µl 
Primer NS5-2F or B-ACT-F 50 µM 200 nM 0.10 µl 
Primer NS5-2R or B-ACT-R 50 µM 200 nM 0.10 µl 
ROX dye 50X 1 nM 0.05 µl 
Nuclease-free Water - - 1.23 µl  
 
A fixed amount of RNA (250 ng) in nuclease free water in a final volume of 10 μl 
was used for each reaction. An initial (pre-PCR) heating step was carried out at 
95°C for 5 minutes to denature ds-RNA molecules. 
Reactions were performed in duplicate in 96-well PCR plates (Applied Biosystem) 
using an Applied Biosystems® 7500 Fast Dx Real-Time PCR Instrument with the 
cycling program detailed in Table 3-3.  
Table 3-3 - Thermal cycle used for qRT-PCR 
 Function Temperature Time Cycles 
First Step 
cDNA 
synthesis 
50°C 15 min 
Hold 
95°C 2 min 
Second Step 
Denaturation 95°C 15 sec 
45 Cycles 
Annealing 60°C 30 sec 
 
The threshold was set up at 10 times the standard deviation of the baseline, in 
the region of the exponential growth of PCR product. Threshold cycle (Ct) values 
were automatically calculated using the AB SDS® software for each sample and 
defined as the point where the amplification curve crossed the threshold line 
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(Figure 3-1). Assuming equal PCR efficiency, Ct values are inversely correlated to 
the logarithm of the initial copy number. For the calibrators, a Ct value of 35±2 
was expected and no amplification was expected from NTC samples. If these 
parameters were not met, the samples were re-tested. For the BTV seg-1 
(BTNS1) reaction, samples with a Ct value >40 were considered negative, 
because under the detection limit of 1x102copies/reaction. Valid Ct values were 
interpolated by the software with the standard curve to calculate quantitative 
values; results were expressed as log10 copy number per 1 μg of total RNA (Figure 
3-2). 
 
Figure 3-1 Amplification plot of qRT-PCR standard curve for BTV segment 1.  
Rn is the fluorescence of the reporter dye divided by the fluorescence of the passive reference dye 
(ROX). ΔRn is Rn minus the baseline. ΔRn is plotted against PCR cycle number. 
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Figure 3-2 Standard curve alignment for BTV segment 1 
 
 
3.4 Microscopy 
3.4.1 Preparation of animal tissues for microscopy 
Tissue samples were collected immediately after euthanasia in the post mortem 
room as described above. For immunohistochemical analysis fresh samples were 
trimmed to 0.5 cm in thickness for 1 cm square, and placed into processing 
cassettes. 
 
3.4.1.1 Fixation 
Cassettes containing tissue samples were immersed for 48 hours in a 10% neutral 
buffered formalin solution before further processing. For zinc salt fixation, 
cassettes with tissues were instead placed directly in 1% zinc fixative solution 
(BD Pharmingen) and allowed to sit for 24-48 hours at room temperature before 
processing. 
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3.4.1.2 Dehydration, clearing and embedding 
After 48 hours, tissues were removed from formalin or zinc fixative solution and 
dehydrated in increasing concentration of ethanol (from 0 to 100%) then cleared 
in xylene and embedded in paraffin blocks as per standard histology protocols. 
3.4.2 Immunohistochemistry 
3.4.2.1 Sectioning 
Tissue sections were cut with a microtome (4 µm thickness) and mounted on 
microscope slides. Sections were dewaxed with multiple passages in xylene, and 
re-hydrated in decreasing concentration of ethanol: 100%, 95%, 75%, 50%, and 
finally rinsed in water. 
3.4.2.2 Antigen Retrieval Technique 
Formalin fixation induces protein cross-linking which can results in 
conformational changes of antigenic epitopes, leading to an absent or decreased 
antibody reactivity. To restore the immunoreactivity of the epitopes and break 
formalin-induced methylene bridges, two methods are currently available: heat 
induced epitope retrieval (HIER) and protease induced epitope retrieval (PIER). 
Different types of antigen retrieval techniques were tested on formalin fixed, 
paraffin embedded tissues to unmask specific epitopes.  
3.4.2.3 Citrate buffer - HIER 
Heat induced antigen retrieval was performed in the pathology department of 
the School of Veterinary Medicine Diagnostic Services at the University of 
Glasgow. Sections were treated with Access Retrieval Unit (Menarini) in Buffer 
Sodium Citrate pH6, for 1 min 30 sec at 125⁰C at full pressure. Then rinsed in 
Tris buffer pH7.5. 
3.4.2.4 Proteinase K - PIER 
Proteolytic digestion of formalin-fixed tissues was performed using a ready-to-
use solution of proteinase-K in 0.05 M Tris-HCl, 0.015 M sodium azide, pH 7.5 
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(Dako, UK). Tissues were incubated for 10 minutes at 37 °C with the pre warmed 
solution of proteinase K, and then rinsed with PBS.  
3.4.2.5 Trypsin - PIER 
For Trypsin-PIER antigen retrieval treatment slides were held in water a 37 °C 
until transferred to a pre-warmed (37 °C) trypsin solution (0.05% trypsin, 1% 
CaCl2, and 0.05% chymotrypsin, pH 7.8 (all reagents form Sigma, UK) and 
digested for 20 minutes then rinsed with PBS.  
3.4.2.6 Sample labelling for immunohistochemistry (IHC) 
After antigen retrieval, the tissue sections were permeabilised with a PBS 
solution of 1% Triton-X (Sigma) for 10 minutes at room temperature. To quench 
endogenous peroxidase activity slides were then treated for 30 minutes at RT 
with an aqueous solution of 3% hydrogen peroxide. After four washes with PBS 
0.05%/Tween 20 (PBS T20, Sigma) the sections were incubated for 80 minutes 
with a blocking buffer containing 5% bovine serum albumin in PBS to block 
unspecific binding sites. Primary antibodies specific or cross-reactive with sheep 
and goat antigens were diluted in blocking buffer accordingly to Table 3-4 and 
incubated with the tissue sections overnight at 4 °C. Excess primary antibodies 
were removed with several washes in PBS T20. 
For primary antibody detection, sections were incubated with appropriate 
secondary antibodies conjugated either with horseradish peroxidase (HRP) or 
with alkaline phosphatase (AP), for one hour at room temperature (RT). This was 
followed by a 5-10 minute incubation with 3,3’-diaminobenzidine (DAB) 
substrate-chromogen (EnVision+ System, Dako) which produces a brown coloured 
precipitate at the antigen site or with Permanent Red chromogen (EnVision G|2 
System/AP, Dako) which develops in a red coloured precipitate. Tissues were 
counterstained using Mayer's haematoxylin and mounted with clear resin and 
coverslips for long-term storage. 
Tissue sections were screened using an optical microscope at different 
magnifications and images captured using cell^D software (Olympus). 
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Table 3-4 - List of research or commercial primary antibodies used in IHC and IF.  
Required antigen retrieval method (AR): Citrate HIER (C), Proteinase-K PIER (K), Trypsin PIER 
(T). Fixative (FIX) used: formalin (F) or zinc salt (Z). Mouse (Mo), Rabbit (Rb) 
Target Clone Isotype Producer 
Working 
dilution 
AR FIX 
MHCII SW73.2 Rat Moredun 1:100 C F 
CD3 F7.2.38 Mo IgG1 Dako 1:200 C F 
CD79a HM57 Mo IgG1 AbD Serotec 1:100 C F 
CD163 EDHu-1 Mo IgG AbD Serotec 1:100 C F 
WC1 CC15 Mo IgG2a AbD Serotec 1:20 C F 
IFN-γ 7B6 Mo IgG1 AbD Serotec 1:20 C F 
Ki-67 MIB-1 Mo IgG1 Dako 1:100 C F 
CD68 EBM11 Mo IgG1 Dako 1:100 T F 
CD169 - 
Siglec-1 
HSn 7D2 Mo IgG1 
Santa Cruz 
Biotech 
1:10 - Z 
Cleaved 
Caspase 3 
D175-5A1E Rb Cell Signaling 1:200 C F 
CD1w2 CC20 Mo IgG2a AbD Serotec 1:20 - Z 
CD45 1.11.32 Mo IgG1 AbD Serotec 1:20 - Z 
CD1 20:27 Mo IgG1 AbD Serotec  - Z 
CD83 HB15e Mo IgG1 AbD Serotec 1:50 C F Z 
CD11b CC126 MoIgG2b AbD Serotec 1:20 - Z 
CD21 CC21 MoIgG1 AbD Serotec 1:50 - Z 
CD8 CC63 MoIgG2a AbD Serotec 1:100 - Z 
Desmin DE-U-10 Mo IgG1 Sigma-Aldrich 1: 20 C F 
Fascin 55K-2 Mo IgG1 Dako 1:20 C F 
Podoplanin D2-40 Mo IgG1k Dako 1:10 - Z 
VWF - Rb IgG Dako 1:200 K F 
Vimentin Vim3B4 Mo IgG2ak Dako 1:60 C F 
B cells Dak-Pax5 Mo IgG1 Dako 1:20 C F 
FDC CNA.42 Mo IgM Dako 1:20 C F 
CD208 - DC 
lamp 
1010E1.01 Rat IgG2a Dendritics 1:80 C F 
TLR3 - CD283 713E4.06 Mo IgG1 Dendritics 1:20 - Z 
ICAM-1 CD54 117G12 Mo IgG1 Dendritics 1:20 - Z 
Perlecan A71 Mo IgG1 Source bio 1:40 C F 
Cleaved 
Caspase 3 
Asp175 Rb poly Cell Signalling 1:200 C F Z 
S100 - Rb poly Dako 1:100 C F Z 
PCNA PC10 Mo IgG2a AbD Serotec 1:100 C F 
Jam-A - Rb Poly AbD Serotec 1:50 C F 
β-actin - Rb IgG AbD Serotec 1:50 - F 
SMA 1A4 Mo IgG2a Cell signaling 1:50 C F 
CD8 38.65 Mo IgG2a Dako 1:50 - F Z 
CD4 44.38 Mo IgG2a AbD Serotec 1:100 - Z 
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3.4.3 Immunofluorescence 
Tissue sections were treated as previously described for IHC with the following 
modifications. After primary antibody incubation, sections were rinsed in PBS 
T20 and incubated with appropriate anti-mouse, rabbit or rat species or isotype-
specific fluorescently labelled secondary antibodies (AlexaFluor, Thermo Fisher) 
(Table 3-5) for one hour at RT. Excess secondary antibodies was removed by PBS 
T20 washes and sections were mounted using a liquid antifade mountant 
(Prolong Gold, Thermo Fisher) containing 4',6-diamidino-2-phenylindole (DAPI) 
for the staining of chromatin. The sections were stored at 4 °C and read within a 
week from preparation.  
Table 3-5 - List of secondary antibodies used for immunofluorescence 
Target Host species Conjugate Manufacturer 
Mouse IgG1 Goat Alexa Fluor 488 Thermo Fisher 
Mouse IgG1 Goat Alexa Fluor 555 Thermo Fisher 
Mouse IgG1 Goat Alexa Fluor 594 Thermo Fisher 
Mouse IgG1 Goat Alexa Fluor 633 Thermo Fisher 
Mouse IgG2a Goat Alexa Fluor 488 Thermo Fisher 
Mouse IgG2a Goat Alexa Fluor 555 Thermo Fisher 
Mouse IgG2a Goat Alexa Fluor 633 Thermo Fisher 
Mouse IgG2b Goat Alexa Fluor 488 Thermo Fisher 
Mouse IgG2b Goat Alexa Fluor 594 Thermo Fisher 
Mouse IgM Goat Alexa Fluor 488 Thermo Fisher 
Mouse IgM Goat Alexa Fluor 555 Thermo Fisher 
Mouse IgM Goat Alexa Fluor 594 Thermo Fisher 
Mouse IgM Goat Alexa Fluor 633 Thermo Fisher 
Rat IgG Goat Alexa Fluor 488 Thermo Fisher 
Rat IgG Goat Alexa Fluor 555 Thermo Fisher 
Rat IgG Goat Alexa Fluor 633 Thermo Fisher 
Rabbit Goat Alexa Fluor 488 Thermo Fisher 
Rabbit Goat Alexa Fluor 555 Thermo Fisher 
Rabbit Goat Alexa Fluor 594 Thermo Fisher 
Rabbit Goat Alexa Fluor 633 Thermo Fisher 
Guinea Pig Goat Alexa Fluor 488 Thermo Fisher 
 
Viral proteins were detected with the use of a tyramide signal amplification 
(TSA) system (Thermo Fisher). Custom produced antibodies directed against 
structural and non-structural BTV proteins (Table 3-6) were applied to sections 
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overnight at 4°C. After washing excess primary antibody off, the sections were 
incubated with secondary donkey anti-rabbit antibodies conjugated to HRP (GE 
Healthcare Life Sciences) for 1 hour at RT then washed again with PBS T20. TSA 
reagent was then incubated for 10 minutes at RT with the sections to create a 
fluorescent precipitate. Sections were mounted using Prolong Gold antifade 
reagent as previously described, and the coverslip sealed using nail polish for 
medium term storage in the dark, at 4 °C. 
Table 3-6 - List of antisera raised against different BTV proteins and their concentration 
used in immunohistochemical and immunofluorescence studies 
Target Protein Antiserum Produced In Working Dilution 
BTV-VP7 Rabbit 1:8000 
BTV-NS1 Rabbit 1:7000 
BTV-NS2 Rabbit 1:7000 
BTV-NS2 Guinea Pig 1:8000 
BTV-NS3 Rabbit 1:7000 
BTV-NS4 Rabbit 1:6000 
 
 
3.4.4 Confocal Microscopy 
Fluorescently labelled samples were examined using a Zeiss LSM710 confocal 
microscope, equipped with 405, 458, 488, 514, 561, 633 nm lasers lines and 
Differential interference contrast (DIC) filters. Image were captured and 
processed with Zeiss Zen software. Rendering of Z-stack acquisitions were 
elaborated using Imaris (Bitplane) and FIJI (Image J) software.  
3.5 Serology 
3.5.1 Serum collection and heat inactivation 
Blood samples were collected and kept at room temperature for 30 minutes to 
promote clot formation then centrifuged at 1,500xg for 10 minutes at 20 °C to 
separate the serum; serum supernatant was collected and stored frozen at -80°C 
until further use. Before use, serum samples were aliquoted and heat-treated at 
56 °C for 30 minutes to inactivate the complement and any residual viral 
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particle. Heat inactivated serum samples were used throughout the 
experiments. 
3.5.2 Neutralization Assay 
The presence of neutralizing antibodies in experimentally infected sheep was 
assessed by micro-neutralization assay as recommended in the OIE guidelines 
(OIE - World Organisation for Animal Health 2016a) 
To obtain the neutralization titre, serial dilution of the sera were prepared in 
DMEM supplemented with 3% FBS and diluted by a factor of 2, starting from 1:4 
until 1:16,384 in a total volume of 100 μl. The serum was then incubated with 
100 TCID50 of BTV-8Net2006 in 50 μl of DMEM for 1 hour at 37 °C.  
In each well of a 96-well flat bottom plate, 50 μl of a suspension of Vero cells 
containing 4x105cells/ml in DMEM/3% FBS were added to 150 μl of the 
serum/virus mixture prepared as above and incubated at 37 °C with 5% CO2. 
After 6 days the plates were fixed with 5% formaldehyde and stained using a 
Crystal Violet solution (0.1%). The level of CPE was quantified for each well by 
eye, and a well was considered protected when displayed more than 75% CPE 
neutralization in the cell monolayer (accordingly to OIE guidelines) (OIE - World 
Organisation for Animal Health 2016a) 
Each sample was tested in quadruplicates, and each experiment also included a 
“negative control serum” obtained from a BTV naïve animal (tested by cELISA), a 
“positive control serum” coming from a BTV vaccinated and experimentally 
challenged animal, a “CPE control” were wells contained no serum but only cells 
and virus, and finally a “cells only control” with Vero cells suspension only.  
The neutralization titre for each sample was calculated using the Reed and 
Muench method (Reed & Muench 1938) and expressed as 50% protective dose 
(PD50), defined as the dilution of antiserum required to protect 50% of Vero cell 
cultures from BTV infection. Samples under the detection limit of 2.23 log10 
PD50 were considered negative.  
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3.5.3 Neutralization assay on ovine choroid plexus cells 
Since there are evidences that BTV can use different receptors to enter target 
cells, we tested the ability of the sera to neutralise virus entry on a more 
relevant cell line, originated from sheep (CPt-Tert). The neutralization titre of 
sheep and goat serum was assessed as described above replacing Vero cells, with 
50 μl/well of a suspension of CPt-TERT cells containing 2.5x105cells/ml in IMDM 
with 3% (v/v) FBS.  
3.5.4 ELISA quantification of serum IgG and IgM against BTV VP7 
The amount of serum IgG and IgM was quantified with an indirect enzyme-linked 
immunosorbent assay (ELISA).  Flat bottom 96-well plates coated with 
recombinant VP7 protein were purchased from IDVet (Innovative Diagnostics, ID 
Screen® Bluetongue Milk Indirect).  Plates were incubated for 30 minutes with a 
blocking solution of PBS T20 containing 3% (w/v) dried skimmed milk (Marvel, 
Premier Foods). Appropriate dilutions of serum (from 1:100 to 1:5,000) were 
prepared in blocking buffer and chosen in order to obtain results fitting in the 
linear portion of the standard curve (see below).  100 μl of the serum dilution 
were added to the well in duplicate and incubated for 1 hour at room 
temperature. Plates were washed 5 times with PBS T20. 
For IgG detection 100 μl of a secondary antibody directed against sheep IgG, 
conjugated with HRP (polyclonal donkey anti sheep/goat IgG, AbD Serotec) and 
diluted 1:16,000 in PBS T20 and was added to the wells for 1 hour.  
For IgM detection, 100 ul of a 1:30,000 dilution of a secondary antibody directed 
against sheep IgM (Rabbit anti sheep IgM, AbD Serotec), conjugated with HRP 
was added to the wells and incubated as above. 
Plates were washed five times with PBS T20, then 100 μl of TMB (3,3', 5,5;-
tetramethylbenzidine) chromogen solution (Novex) were added to each well and 
incubated in the dark for 25 minutes for the colour to develop. The reaction was 
stopped by addition of an equal amount of 1 N hydrochloric acid. Absorbance at 
OD450nm (optical density) was assessed for each well by mean of a PHERAstar FS 
HTS microplate reader (BMG LABTECH).  
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3.5.4.1 Standard curve and quantification 
To normalise data across different plates a standard curve was generated and 
included in duplicate in each plate. Sera from animals having a high antibody 
titre were selected to generate a reference standard. For the IgG ELISA a pool 
was made with sera obtained from five sheep, which had been vaccinated and 
subsequently challenged with BTV8, and sera collected at 10 days after 
infection. For IgM quantification, a standard curve was produced by using a pool 
of five sera, collected from sheep at 11 days after BTV experimental infection. 
Standard serum was aliquoted and stored at -20°C until required.  
Standard serum was diluted in two-fold steps from 1:50 to 1:3,200 in blocking 
buffer. For IgG quantification, at the lowest dilution (1:50) of the standard was 
attributed a value of 100 ELISA units, and the values of the successive dilutions 
were calculated accordingly. For IgM quantification, the value of 100 ELISA units 
was attributed to the first dilution (1:100) and the successive dilutions were 
calculated accordingly. Serum from a naïve animal was used as a negative 
control and 2 wells did not receive any serum and were used as blank controls. 
The relationship between the reciprocal of the dilution tested and its OD405 was 
used to determine the serum titre (in units), by fitting into a 4-parameter 
logistic (4PL) curve; when the R2 of the standard curve fit was less than 0.997 
the entire assay was repeated.  
Once the titres of the standard serum were determined, the value was used to 
assess the relative concentration of the experimental samples tested by ELISA, 
using MARS data analysis software (BMG Labtech). A cut-off value was 
determined at 3 standard deviations (SDs) from the value of the negative 
control. Samples were considered negative when returned an OD value inferior 
to the cut-off value. 
3.5.5 ELISA quantification of serum IgG and IgM against 
ovalbumin 
ELISAs for anti-OVA antibodies were performed by Dr. Noemi Sevilla and Dr. 
Veronica Martin at the Centro de Investigación en Sanidad Animal (Madrid, 
Spain).  Antibodies against OVA were detected using ELISA plates (Maxisorp, 
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Nunc) coated for 1h at room temperature with 100 l/well of 20 g/ml of OVA 
(Sigma-Aldrich) in 0.1 M carbonate buffer (pH 9.6). Serial dilutions of sera from 
inoculated sheep were added to the plates and incubated for 1 hour at room 
temperature, after blocking with blocking buffer (PBS with 1% Tween-20 and 4% 
skimmed milk) for 1h at room temperature and washing five times with 1% 
Tween-20 in PBS. The presence of OVA-specific IgG or IgM was detected using a 
secondary donkey anti-sheep IgG conjugated to horseradish peroxidase (1:2000, 
Serotec, Oxford, UK) or rabbit anti-sheep IgM also conjugated to horseradish 
peroxidase (1:20,000, Bethyl). After washing ten times with 1% Tween-20 in PBS, 
signal was developed using 100 μl of TMB Liquid Substrate System (Sigma) and 
the reaction was stopped with 100 μl of 3M sulfuric acid before reading. Optical 
density (OD) was determined at 450 nm on a FLUOstar Omega (BMG Labtech) 
ELISA plate reader. All IgG/IgM measurements were made in triplicate and assays 
were only considered valid when standard deviations were below 10% of the 
average. IgG/IgM binding to OVA was considered positive only when the OD 
obtained was at least twice the OD obtained with the pre-immune serum from 
the same sheep. 
3.5.6 Avidity of the IgG directed against BTV VP7 and ovalbumin 
Antibody avidity was assessed by ELISA, using previously described protocols 
(Nair et al. 2007; Pullen et al. 1986). Low avidity IgG binding dissociation was 
achieved using the chaotropic agent ammonium thiocyanate (NH4SCN). After 
incubation with serum samples, as described above, plates were washed with 
PBS and incubated at room temperature for 15 minutes with 100 μl of increasing 
concentration of NH4SCN (0.5, 1, 1.5, 2, 2.5 and 3 M). The absorbance readings 
in the absence of NH4SCN were considered to represent the total binding of VP7 
specific IgG, and subsequent absorbance readings in the presence of increasing 
concentrations of NH4SCN were converted to the corresponding percentage of 
the total bound antibody. The data were fitted to a curve of percentage binding 
vs. molar concentration of NH4SCN using a 4PL non-linear regression model. An 
avidity index (AI) was calculated as the molar concentration of NH4SCN required 
to reduce by 50% the VP7-specific IgG binding.  Samples with absorbance 
readings of <0 .4 ODs in the absence of NH4SCN were within 3 SDs of the 
threshold value and were therefore excluded from avidity analysis. An identical 
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method was used to measure antibody avidity against ovalbumin with the 
exception that plates were coated with OVA as described above. 
 
3.5.7 Quantification of anti-ovalbumin-specific IgG-secreting cells 
by ELISPOT 
ELISPOTs were performed by Dr. Noemi Sevilla and Dr. Veronica Martin at the 
Centro de Investigación en Sanidad Animal (Madrid, Spain). MSIPS4510 plates 
(Millipore) were activated using sterile 35% ethanol for 1 min and, after thorough 
washing with sterile water, incubated overnight at 4C with 20 g/ml OVA 
(Sigma-Aldrich) in 0.1 M carbonate buffer pH 9.6. Plates were washed then 
blocked with PBS containing 4% (w/v) dried skimmed milk for 2 hours at 37C. 
Fresh PBMCs were suspended at 5x106 cells/ml and 1:2 dilutions were performed 
in RPMI medium (supplemented with L-glutamine, 1 mM sodium pyruvate, 25 mM 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), non-essential amino 
acids and 10% inactivated foetal calf serum) to a concentration of 1.56x105 
cells/ml. 100 l per well of each cell suspension (in triplicate) was incubated 
overnight at 37°C, 5% (v/v) CO2. After discarding the cells and washing with PBS, 
membranes were incubated with anti-sheep IgG conjugated to horseradish 
peroxidase (Serotec, Oxford, UK) and incubate for 3 hours at room temperature. 
After 5 washes in PBS, membranes were developed using TMB substrate 
(Mabtech). Once spots were formed, membrane were washed with abundant 
distilled water and allowed to dry in the dark. Results were expressed as the 
number of antigen specific ASC per 106 PBMCs.  
 
3.5.8 Statistical analyses 
Non-parametric two-tailed Mann Whitney rank U test was used to compare two 
unpaired groups.  Paired t-test was used to compare two paired groups. One-way 
ANOVA was used to compare two or more unmatched groups. Data analyses were 
performed using Prism 6.0 (GraphPad Software Inc. San Diego, CA, USA). 
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4 Kinetics of bluetongue virus infection in 
experimentally infected animals 
4.1 Introduction 
Skin and LNs have long been identified as sites of BTV replication at early times 
after infection (Pini 1976). The skin surrounding the inoculation site is described 
as the first site of viral replication (Darpel et al. 2012), thereafter BTV is 
thought to be disseminated to the draining lymph nodes (LNs) by DCs (Hemati et 
al. 2009; Ruscanu et al. 2012; Ruscanu et al. 2013), before disseminating further 
to peripheral tissues (MacLachlan et al. 2009). However, the cell populations 
targeted by the virus and the events taking place in the LN immediately after 
virus arrival during bluetongue infection remain poorly defined. Draining LNs are 
an important stopping point along the route followed by pathogens that gain 
access to the host after breaching the skin barrier before systemic 
dissemination. LNs are the sites where the immune response is initiated and 
shaped, for this reason they are crucial in limiting pathogen spread. 
In the skin, the plasma fraction of the blood is filtrated from the vasculature in 
the capillary bed and becomes interstitial fluid. This is then percolated through 
the interstitium into the afferent lymphatic vessels where it becomes the 
afferent lymph. The fluid flow is a function of Starling’s forces and the 
molecular architecture of the dermis. The lymphatic vessels actively pump 
interstitial fluid out of the tissue and, by actively keeping low the hydraulic 
pressure of the dermal interstitium, they guarantee an unidirectional flow from 
the blood vessels to the lymph vessels (Swartz 2001). The process is facilitated 
by the fact that unlike blood vessels, lymph vessels openly communicate with 
the interstitium without the presence of a continuous basal membrane to 
restrict the movement of solutes. The backflush of fluid is also prevented by a 
system of semilunar valves located at different levels in the lumen of the 
lymphatic vessels. This convective stream counteracts entry into the blood 
circulation by flushing particles away from blood vessels and conveying them 
directly into the subcapsular sinus (SCS) of the lymph nodes (Lämmermann & Sixt 
2008). 
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From the skin, soluble molecules or particles can reach the draining LNs with the 
interstitial fluid flow or carried by cells. DCs are the principal cells that carry 
antigens to the LNs. Resident dendritic cells in the skin can be distinguished into 
Langherans cells and dermal DCs. In addition, as a consequence of inflammation, 
monocytes can be attracted to the skin and differentiate into a third type of DCs 
(called inflammatory DCs) (Zaba et al. 2009). In steady state, resident DCs 
survey the environment for the presence of danger signals and, if activated, can 
phagocytose and process antigens. The DCs then acquire a more motile 
phenotype accompanied by the upregulation of CCR7 that drives them towards 
the lymphatics expressing the CCR7 ligand (CCL21) (Randolph et al. 2005). Once 
in the lymphatic vessels, cells and solutes are passively transported by the flow 
of the afferent lymph to the LN. 
For drainage to the LN, multiple afferent lymph vessels combine to the lumen of 
the SCS that surrounds the cortical area of the LN. From here, the lymph flows 
along cortical sinuses running along the connective trabecules spanning from the 
capsule into the cortex and dividing the LN into separate lobules (Gretz et al. 
1997). The cortical sinuses are in communication with medullary sinuses that 
surround the medullary cords and accomplish the task of collecting the lymph 
from all the lobules into a single efferent lymphatic vessel exiting from the 
hilum of the LN. Since each afferent lymphatic collects lymph from a different 
drainage area, each lobule is potentially exposed to a different set of antigens, 
APCs and inflammatory mediators. Therefore, as a result of varying stimuli, 
lobules within the same lymph node may have different levels of immunological 
activity conferring a non-uniform appearance within the LN (Lämmermann & Sixt 
2008). 
Lymphoid lobules are the anatomical units of the LNs of superior mammals. 
Three distinct functional zones compose each lobule: the cortex, paracortex and 
medulla (Willard-Mack 2006). In the apical part, separated from the capsule by 
the SCS, is the cortical area. The cortical area is generally divided into a 
superficial cortex where B-cells cluster around follicular dendritic cells into 
spherical structures called follicles, and a deep cortex, often named the 
paracortex, where the majority of T-cells and DCs reside. In the area 
surrounding the hilum, named the medulla, lymphocytes collect before exiting 
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the LN (Willard-Mack 2006). The LN is therefore an important hub whose 
compartmentalisation favours the interactions between antigens, lymphocytes 
and antigen presenting cells leading to the initiation of the immune response via 
the activation and expansion of specific lymphocyte populations. 
LNs have a highly dynamic structure where lymphocytes recirculate continually. 
Blood arteries enter the LN through the hilum and deliver lymphocytes to the 
cortical area via specialized blood vessels called high endothelial venules (HEV) 
(Girard et al. 2012). Lymphocytes then exit via specialized sinuses, and after 
reaching the medulla, leave the LN via the efferent lymphatic. The efferent 
lymph is then drained to the subsequent lymph nodes (if part of a lymphatic 
chain), or directly to the cisterna chyli and finally reaching the venous blood 
circulation through the thoracic duct. LNs function as fluid filter systems that 
constantly receive cells, antigens, pathogens, cytokines and chemokines from 
peripheral tissues.  
In this chapter we aimed to track the distribution of BTV in experimentally 
infected sheep at different times post-infection. We show that after inoculation 
in the skin, BTV is rapidly transported to the draining LNs where it infects cells 
present in the subcapsular and cortical area very early after infection. We then 
aimed to compare the in vivo distribution of a virulent and an attenuated BTV-8 
strain, showing that the LN is a gateway for the virus to reach the blood and 
systemic dissemination. Furthermore we compared the virus distribution in 
goats, a BTV natural host that generally does not develop the clinical disease. 
Finally, we aimed to compare the results obtained in ruminants with the 
localization of BTV in mouse models currently used for BTV virulence studies. 
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4.2 Results 
4.2.1 Early localization of BTV RNA in the tissues of 
experimentally infected sheep 
Sheep were inoculated with a virulent strain of BTV (BTV-8) in order to identify 
the distribution of the virus in the tissues of the infected animals over time. The 
in vivo infections, sample collection and part of the qPCR analysis were carried 
out at the "Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise" 
(Teramo) by Dr. Marco Caporale. Experimental infections were performed in 
sheep (n=23) by multiple intradermal inoculations of BTV-8 into the shoulders 
and thighs (Caporale et al. 2014), areas drained by the corresponding inguinal or 
prescapular LNs (referred as “draining LNs” from here on), in order to mimic the 
pattern of insect bites in the natural environment. Rectal temperatures of 
infected animals were monitored for 7 days, while viremia was assessed by qRT-
PCR. In order to monitor the distribution of the virus in different anatomical 
compartments and to identify the route followed by BTV to disseminate within 
the infected host, sheep were euthanized at 4, 8, 24, 48, 72, 96, 120 and 168 
hpi, with n=3 per time point, except from 96 h where n=2. During the post-
mortem examination, tissues were collected and either preserved in RNA-later 
solution for qRT-PCR analysis or fixed for histopathology, immunohistochemistry 
and confocal microscopy.  
All of the infected sheep exhibited an increase in body temperature at 120 hpi 
equating to a 2°C increase over the average body temperature that persisted 
for the following two days (Figure 4-1A). Low levels of BTV-8 RNA were initially 
detected in some of the infected animals at 24 hpi. Virus RNA levels started to 
increase exponentially at 72 hpi and reached a plateau at 120 to 168 dpi (107 
copies/μg RNA, Figure 4-1A). The increase in body temperature therefore 
corresponded to the peak of viremia. 
Using qRT-PCR, BTV RNA was detected and quantified in several organs sampled 
during post-mortem examination (Figure 4-1B). BTV was detected in the skin 
near the inoculation site and in the corresponding draining LN as early as 4 hpi. 
The levels of viral RNA in the skin were relatively constant at all time points 
analysed (ranging between 2x105 and 8x104 copies), with only a slight decrease 
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at 7 dpi (3.1x103 copies). In draining LNs, BTV RNA levels reached a peak at 24 
hpi (3.12x104 copies/μg of RNA in inguinal LNs on average) that was maintained 
until 4 dpi and then gradually decreased until reaching 103 copies by 168 hpi 
(Figure 4-1B). 
At 72 hpi, corresponding to the beginning of viremia, BTV was also detected at 
low levels in other tissues such as the spleen and lungs (Figure 1B). Since the 
spleen contains large quantities of blood, BTV titres in spleen paralleled the 
trend observed for the viremia peaking at 5-7 dpi (1x104-3x105 copies). At 7 dpi 
BTV RNA was distributed in most of the peripheral tissues analysed including 
lungs (2x102 copies), kidneys (3x102 copies), tonsils and non-draining LN (50 
copies) (Figure 4-1B). 
 
 
Figure 4-1 Progression of BTV-8 infection in experimentally infected sheep  
Twenty-three sheep were intradermal (ID) inoculated with 2x10
6
 PFU of BTV-8 in three 
independent experiments and sacrificed at different times after experimental infection from 4 to 168 
hours (for each time point n=3, a part from 96h where n=2). A. Graph showing body temperature 
and viremia in experimentally infected animals. Rectal temperature was registered daily and 
viremia was assessed by qRT-PCR, values shown represent average ±SD. B. Heat-map showing 
the tissue distribution of BTV RNA over time. Tissue samples were collected after euthanasia and 
viral RNA was detected by qRT-PCR, average values are expressed as Log10 copy number per µg 
of total RNA. 
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4.2.2 Detection of viral proteins in tissues of infected sheep 
4.2.2.1 Optimization of an immunohistochemical technique for the detection 
of BTV proteins 
Quantitative RT-PCR allowed the localization of BTV RNA in several sheep 
organs. However this technique does not provide evidence of virus replication 
and moreover does not allow the identification of infected cells. Therefore, we 
optimised an immunohistochemical technique to detect the presence of a non-
structural protein of BTV in fixed tissues. Viral non-structural proteins are 
expressed in cells only during active viral replication, and therefore are 
excellent markers to identify infected cells. 
Seven polyclonal antisera targeting different BTV proteins that were in current 
use in the laboratory (and had been previously shown capable of detecting viral 
antigens by western blot and immunofluorescence of virus-infected cultured 
cells) were then tested (Ratinier et al. 2011). An appropriate antibody dilution 
was determined through titration experiments and a working concentration was 
selected to achieve a robust specific signal and minimize non-specific 
background (Table 4-1).  
 
Target Protein Antiserum Produced In Working Dilution 
BTV-VP7 Rabbit 1:8000 
BTV-NS1 Rabbit 1:7000 
 BTV-NS2 Rabbit 1:7000 
BTV-NS2 Guinea Pig 1:8000 
BTV-NS3 Rabbit 1:7000 
BTV-NS4 Rabbit 1:6000 
Table 4-1 - List of antisera raised against different BTV proteins and their concentration 
used in immunohistochemical studies 
 
Detection of viral proteins in formalin fixed paraffin embedded tissue was 
unsuccessful without the use of an appropriate antigen retrieval process.  As 
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described in the Material and Methods, three different types of antigen retrieval 
techniques were tried, including proteinase K treatment, trypsin treatment, and 
HIER with citrate buffer. Only the use of HIER treatment allowed detection of a 
strong positive signal for BTV proteins in the absence of any significant 
background. 
As formalin fixation can affect epitope configuration, part of the tissue samples 
were also fixed using a zinc salts solution. As expected, the immunolabeling of 
viral proteins in zinc salt fixed tissue did not required antigen retrieval, however 
the HIER treatment of sections increased the sharpness of the signal (Figure 
4-2). 
To further assess the specificity of the signal for the virus proteins, sequential 
sections of tissue were stained with various polyclonal antibodies targeting 
different BTV proteins (Figure 4-2). Both structural and non-structural proteins 
tended to localise in the same areas of the tissue. Mock-infected animals were 
used as negative controls and no staining was detected in these animals in any of 
the tissues tested with the specific antibodies used to target BTV proteins (data 
not shown). Minimum background staining and the clear detection of a positive 
staining was obtained using the polyclonal antibodies (made in rabbits and 
guinea pigs) towards the BTV NS2 (Figure 4-2). Hence these antibodies were used 
throughout the course of this study to identify virus-infected cells. 
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Figure 4-2 Localization of structural and non-structural BTV protein in infected tissues 
Photomicrographs (x10) of IHC-stained sections, showing the localization of structural (VP7) and 
non-structural (NS2 and NS3) BTV proteins in LNs sequential sections obtained from sheep 
experimentally infected with BTV-8. LNs were fixed in zinc salt solution and the staining was tested 
with or without heat induced antigen retrieval (HIER). HIER treatment was not strictly required but it 
enhanced the specific signal. Note that both structural and non-structural proteins were expressed 
in similar areas. The best specific signal was obtained using antibodies targeting NS2. 
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4.2.3 BTV infects the lymphatic endothelial cells of the deep 
dermal plexus of the skin 
The cells infected by BTV were characterised using IHC and confocal CLSM. We 
initially focused on the skin, the first site of virus replication. In all the 
experiments described in this study, we specifically targeted NS2, one of the 
BTV non-structural proteins. BTV NS2 was detected mainly in fibroblasts and in 
the endothelial cells of the deep dermal plexus (Figure 4-3A) in cells forming 
vessels with a very thin wall and lacking red blood cells in their lumen. These 
structures are consistent with lymphatic, rather than blood vessels (Figure 4-3A). 
BTV NS2 was specifically detected in endothelial cells but not in pericytes 
(differentiated by the expression of desmin) which are contractile cells that 
envelope the surface of capillaries (Figure 4-3B). BTV NS2 was detected in the 
skin of the sheep up to 7 dpi, with the number of infected cells gradually 
decreasing until being almost undetectable at 7 dpi. Infected cells did not 
express the pan-leukocyte marker CD45, the macrophage marker CD163 (Figure 
4-4A) nor the major histocompatibility complex class II (MHC-II) (Figure 4-4B), 
ruling out a substantial involvement of antigen presenting cells in supporting 
virus replication in the skin at this stage Hence, cells of non-hematopoietic 
origin, likely fibroblasts and endothelial cells, are the primary target of BTV 
infection. 
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Figure 4-3 BTV infects endothelial cells in the deep dermal plexus.  
A. Representative photomicrographs of IHC-stained sections showing BTV localization in skin 
sections of experimentally infected sheep. BTV NS2 (brown) localises in the dermis, mainly in the 
capillaries of the deep dermal plexus, infected vessels resemble lymphatics due to their anatomical 
structure. B. Representative confocal micrographs of the deep dermal plexus in skin section of 
experimentally infected sheep. The sections were stained for BTV NS2 (red) and desmin (green), 
highlighting the replication of the virus in endothelial cells surrounded by uninfected desmin
+
 
perycites. 
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Figure 4-4 BTV does not infects antigen-presenting cells in the skin. 
Representative confocal micrographs of the deep dermis of sheep skin, sections collected BTV-8 
infected sheep. A. Sections were stained for monocytes and macrophages (CD163, green) and 
BTV NS2 (red), B. Sections were stained for MHC-II (green) and BTV NS2 (red).  Numerous 
phagocytes arrive in the skin after infection, although in close proximity with infected cells they do 
not appear infected.  
 
 
4.2.4 BTV rapidly infects the cortical area of the lymph nodes 
draining the site of infection 
The qRT-PCR data shown in Figure 4-1B indicate that BTV dissemination in the 
draining LNs of infected animals occurs within few hours of the initial infection. 
Therefore, we used IHC to identify sites of viral replication within the LNs by 
detecting the BTV NS2 in different areas of the LNs (Figure 4-5). 
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Figure 4-5 Sheep lymph node areas  
Diagram showing different LN areas and IHC micrographs showing the appearance of the different 
areas in LN sections taken from mock-infected sheep and stained for BTV NS2 (pictures are 
representative of 7 animals, 6 sections per animal). No viral protein was detected in LN of control 
animals. Scale bars represent 50µm, for the SCS area scale bars are 20µm. 
 
 High levels of expression of BTV NS2 were detected in the cortical area of the 
draining LNs as early as 4 hpi (Figure 4-6). Between 4 to 8 hpi BTV NS2 was also 
found in the subcapsular sinus and along the trabecular sinuses that deepen 
inside the LN cortex (Figure 4-6). These data suggest that the virus arrives to the 
LN within the afferent lymphatic vessels as the sinuses collect the incoming 
lymph fluids. In addition, at 4 hpi only small and discontinuous segments of the 
SCS were infected. However the affected areas gradually expanded and at 24 hpi 
the majority of the SCS displayed NS2 positive cells. At the same time point, BTV 
infected cells were present in the parenchyma of the LN, where the virus 
localised around and inside the B-cell follicles of the cortex (Figure 4-6). The 
presence of BTV in the sinuses was detectable until 72 hpi, while at later time 
points BTV was detected exclusively inside the follicular area (Figure 4-6). The 
virus was not present in the medulla of the draining LN during the first 5 dpi. By 
7 dpi no more infected cells were present inside the follicular area, however at 
this time BTV NS2 was detected in the medullar area, in correspondence of 
capillary structures (Figure 4-6).  
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Figure 4-6 Time course of BTV infection in sheep draining lymph nodes 
Immunohistochemistry micrographs showing the localization of BTV NS2 (brown), in sections of 
lymph nodes draining the sites of inoculation (inguinal and prescapular LNs), at different time 
points. BTV infected areas and likely infection route are schematically depicted in the diagrams (on 
the left). The BTV NS2 is highly expressed along the subcapsular sinus, trabecular sinuses and in 
the follicles from 4h to 2 dpi. At 3-4 dpi the sinuses are almost cleared and the virus persists in the 
follicular area. At 7 days the cortical and paracortical areas are cleared, and few capillaries express 
BTV NS2 in the medulla. Arrow indicates a positive cell in the medulla, highlighted in the inset. 
Scale bars represent 50µm, for the SCS area scale bars are 20µm. 
 
BTV was not detected in the skin and draining LNs of mock-infected sheep (n=8; 
1 sheep per time point) (Figure 4-7). As an additional control, in order to 
exclude the possibility of detecting non-replicating virus, sheep (n=2) were 
inoculated with UV-inactivated BTV. As expected, no BTV-8 positive cells were 
detected by IHC or confocal microscopy in skin or draining LNs of the inoculated 
sheep (Figure 4-7).  
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Figure 4-7 BTV NS2 was in sheep infected with UV-inactivated BTV-8 
Immunohistochemistry micrographs showing detection of BTV NS2 in lymph nodes (LNs) sections 
from sheep infected with virulent BTV-8 or UV-inactivated BTV-8. Micrographs representative of 
different areas of the LN are shown. Scale bars represent 200 µm in the overview, 20 µm in the 
subcapsular sinus and 50 µm in all the other panels. BTV NS2 was not detected in LNs of animals 
infected with UV-inactivated virus at 24 and 48 hpi. 
 
 
Viral infections are generally accompanied by expression of antiviral mediators 
such as type I interferon (IFN-I). Hence, to further confirm the presence of BTV 
in the LN, we assessed the production of IFN-I by testing the expression of MX-1, 
an interferon-induced GTPase with antiviral activity. MX-1 overexpression, as 
assessed by IHC, was evident as early as 4 hpi in some limited areas of the LN 
cortex (Figure 4-8). MX-1 was rapidly expressed in the whole parenchyma of the 
LN of infected animals by 24 hours and was maintained until 7 dpi. Mock-
infected sheep exhibited only low levels of MX-1 expression in LNs throughout 
the course of the experiment (Figure 4-8). These data provide evidence for an 
interferon-mediated host response in the LNs draining the infected skin, 
simultaneously with virus arrival. 
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Figure 4-8 MX-1 expression in sheep draining lymph nodes 
Representative immunohistochemistry micrographs showing the expression of MX-1 (brown) in 
draining LNs sections taken at different times from mock-infected and BTV-8 infected sheep. Note 
the gradual expansion of the positive areas over time. Scale bars represent 200 µm (top row) or 50 
µm (bottom row). 
 
 
 
 
4.2.5 The hematic dissemination of BTV leads to the infection of 
peripheral tissues 
In agreement with qRT-PCR data, BTV NS2 was only detected in non-draining LN 
(far from the inoculation site, such as mediastinal LN) at later time points by 
immunohistochemistry (5-7 dpi). Interestingly, in these LNs the localisation of 
infected cells was limited to the medulla and paracortical area and, contrary to 
draining LNs, infected cells were not present in the sinuses or in the cortical 
area. The infected cells were mainly constituted by few endothelial cells lining 
small vessels (Figure 4-9). Thus, the localization and the timing of infection of 
the non-draining LNs of infected sheep suggest that BTV reaches these organs via 
the haematogenous, rather than lymphatic route.  
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Figure 4-9 BTV infection of non-draining lymph nodes in sheep  
Representative immunohistochemistry micrographs showing the localization of BTV NS2 in non-
draining LNs (mediastinal, retromandibular, popliteal) sections taken from sheep inoculated with 
BTV-8, at 7 days pi. The images show the presence of few BTV NS2 positive capillaries in the 
medulla. Note that no positive cells were detectable at earlier times (pictures are representative of 
3 animals, 6 sections per animal). Scale bars represent 50 µm, for the SCS area scale bars are 20 
µm. 
 
At 7 dpi BTV replication was detected in peripheral tissues (spleen, lung and 
kidneys) (Figure 4-10). In the spleen, the virus was found in relatively few 
infected cells lining small capillaries (Figure 4-10A). This is in contrast to the 
relatively high levels of viral RNA detected in this organ by qPCR, which suggests 
the presence of a large quantity of non-replicating virus in this organ. In the 
lungs, BTV was present mostly in capillaries and in some alveolar pneumocytes 
(Figure 4-10B). In the kidney, BTV was detected in small capillaries surrounding 
the nephrons in the cortical area (Figure 4-10C). 
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Figure 4-10 BTV infection of sheep tissues at 7 day post-infection 
Representative immunohistochemistry micrographs showing the localization of BTV NS2 (brown) in 
(A) spleen, (B) lungs and (C) kidneys of experimentally infected sheep, at 7 dpi. (A) Few infected 
capillaries are present in the spleen. (B) Infected cells were identified as capillaries and 
pneumocytes in the alveoli of the lungs.  (C) Small vessels in the cortical area of the kidney 
expressed BTV NS2. Arrows indicate infected cells. Scale bar is 100µm. 
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4.2.6 Early BTV localization in sheep experimentally infected with 
the attenuated strain BTV8H 
We next wished to determine whether an attenuated strain of BTV-8 (named 
BTV8H) (Janowicz et al. 2015) displayed the same tropism of BTV-8 in 
experimentally-infected sheep. Sheep were experimentally infected with BTV8H 
as described before (see Material and Methods chapter). As observed in previous 
studies (Janowicz et al. 2015), BTV8H induced neither fever nor viremia in 
infected sheep (Figure 4-11A).  We followed the progression of BTV8H infection 
by sacrificing infected sheep at different times post-infection (at 8, 24, 48, 72, 
96 and 168 hpi; n=2 per time point with the exception of the 168 hpi where 
n=3). As assessed by qRT-PCR, we were able to detect the presence of BTV8H in 
the skin and in the respective draining LN at the same time-points as observed in 
animals infected with the BTV-8 strain (from 4 hpi to 7 dpi) (Figure 4-11B). The 
virus RNA levels in these tissues were similar to the ones detected in BTV-8 
infected animals, with a peak between 24 and 48 hpi (3.12x104 copies).  
However, at 7 dpi the virus RNA levels in the draining LNs of BTV8H infected 
sheep were lower compared to those of BTV-8 infected sheep  (20 copies 
compared to 5x103 copies in inguinal LNs on average) (Figure 4-11B). BTV8H was 
not detected in any other peripheral organs since infected sheep did not develop 
viremia (Figure 4-11B).  
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Figure 4-11 Progression of infection in sheep experimentally infected with attenuated BTV8H 
Thirteen sheep were ID inoculated with 5x10
5
 PFU of BTV8H and sacrificed at different times after 
experimental infection from 8 to 168 hours (for each time point n=2, a part from 168h where n=3). 
(A) Graph showing body temperature and viremia in experimentally infected animals. Rectal 
temperature was registered daily and viremia was assessed by qRT-PCR, values shown represent 
average ±SD. (B) Heat-map showing the tissue distribution of BTV RNA over time. Tissue samples 
were collected after euthanasia and viral RNA was detected by qRT-PCR, average values are 
expressed as log10 copy number per µg of total RNA. 
 
 
We checked the cellular localization of the attenuated virus in draining LN by 
IHC, and we detected viral proteins in a similar location as observed in BTV-8 
infected animals. BTV8H was found to infect cells in the subcapsular area, the 
trabecular sinuses and the follicles (Figure 4-12) of the draining LNs of infected 
sheep. Overall these results indicate that, after inoculation via the skin, the 
attenuated virus maintains the capacity to reach the draining LNs, where it 
shows a tropism similar to the BTV-8. However, the titres of BTV8H in draining 
LNs decreased at 7 dpi and, strikingly, BTV8H was never detected in the 
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bloodstream, suggesting the presence of a bottleneck at the LN level that can 
restricts systemic distribution. 
Collectively, these findings support the evidence that the blood stream is the 
main route of dissemination of BTV8 to peripheral tissues, while LNs draining the 
infection site are likely reached by BTV through the lymph fluids.  
 
 
 
Figure 4-12 Localization of infected cells in draining lymph nodes of sheep experimentally 
infected with attenuated BTV8H 
Representative immunohistochemistry micrographs showing the localization of BTV NS2 (brown) in 
sections of draining LNs taken from sheep infected with attenuated BTV8H, at 24 hpi. The virus 
localization resembles the one obtained in sheep infected with BTV-8. 
 
4.2.7 BTV localisation in experimentally infected goats 
Goats are susceptible hosts for BTV infection but they rarely develop the clinical 
signs of disease (Erasmus 1975; Caporale et al. 2014). In order to understand if 
BTV presents a different tissue tropism in distinct susceptible animal species, we 
experimentally infected goats (n=17) as described for sheep. After intradermal 
inoculation of BTV-8, we followed the progression of infection by euthanizing 
infected goats at different time points (8, 24, 48, 72, 96 and 168 hpi; n=3 per 
time point with the exception of the 8h time point where n=2). Clinically, no 
significant increase in the body temperature was detected in the experimentally 
infected goats (Figure 4-13A). BTV RNA was detectable in blood in 2 out of the 
10 goats at 24 hpi but levels started to rise significantly only at 5 dpi (48h later 
than sheep). Goats developed lower titres of viremia compared to sheep at all 
the time points tested, reaching an average titre of 103 copies at 7 dpi (Figure 
4-13A). Detection of BTV RNA in goat tissues, as assessed by qPCR, indicated 
that the dissemination of the virus follows different kinetics to the one observed 
in sheep (Figure 4-13B). Similarly to sheep, the virus rapidly localised in the skin 
and corresponding draining LNs at 8 hpi (first time point tested in goats), 
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however BTV RNA levels in draining LNs, after reaching a peak at 24 hpi (average 
of 3.9x104 copies in draining LNs, 15 times lower than in sheep) rapidly 
decreased to lower titres (average 1.6x103 copies in inguinal LNs) that were 
maintained until 7 dpi (Figure 4-13B). Furthermore, most of the peripheral 
tissues, including non-draining LNs, were not infected before 7 dpi, indicating a 
slower progression of the infection compared to sheep (Figure 4-13B). 
Importantly, only one of the three goats euthanized at 7 dpi presented the virus 
in peripheral tissues, and the same animal was the only one with high BTV levels 
in blood (3.9x105 compared to 8.7x102 and 101 in the other goats), indicating a 
large inter-animal variability.  
 
Figure 4-13 Progression of BTV-8 infection in experimentally infected goats 
Seventeen goats were ID inoculated with 5x10
5
 PFU of BTV-8 in three independent experiments 
and sacrificed at different times after experimental infection from 8 to 168 hours (for each time point 
n=3, a part from 8h where n=2). (A) Graph showing body temperature and viremia in 
experimentally infected animals. Rectal temperature was registered daily and viremia was 
assessed by qRT-PCR, values shown represent average ±SD. (B) Heat-map showing the tissue 
distribution of BTV RNA over time. Tissue samples were collected after euthanasia and viral RNA 
was detected by qRT-PCR, average values are expressed as Log10 copy number per µg of total 
RNA. 
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We then identified sites of viral replication by immunohistochemistry in the skin 
and LNs of goats. In skin, BTV localised in endothelial cells of the deep dermal 
plexus and in fibroblast disseminated in the dermis, similar to sheep. In the 
draining LNs, we detected BTV infected cells along the SCS, trabecular sinuses 
and in the follicles, as early as 8 hpi, similar to sheep (Figure 4-14). However, 
contrary to what observed in sheep, in goats the lymphatic endothelial cells 
lining the sinus walls did not show a high degree of infection and most of the 
infected cells morphologically resembled phagocytes, located inside the 
lymphatic sinuses. In addition, numerous scattered cells were also found to be 
infected in the paracortical area of the goats draining LNs, contrary to 
observations in sheep where the paracortical area was not visibly affected by 
BTV infection (Figure 4-15) 
 
Figure 4-14 Time course of BTV infection in goat draining lymph nodes 
Immunohistochemistry showing the localization of BTV NS2 (brown), in sections of lymph nodes 
draining the sites of inoculation (inguinal and prescapular LNs), at different time points. The BTV 
NS2 is highly expressed along the subcapsular sinus, trabecular sinuses and in the follicles from 
4h to 96 hpi. Scale bars represent 50µm, for the SCS area scale bars are 20µm. 
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Figure 4-15 Comparison of the patter of infection in goat and sheep lymph node 
Representative immunohistochemistry micrographs showing the localization of BTV NS2 (brown) in 
sections of draining lymph nodes in goat and sheep, at 48 hpi. In goat, many infected cells localise 
in the paracortical are (arrows), these cells are not infected in sheep.  
  
4.2.8 BTV localization in mouse lymph nodes 
In order to define if the localization of the virus was similar in a mouse model of 
disease we inoculated mice subcutaneously in the thighs with 300 PFU of BTV-8 
and we collected the inguinal LNs at 8, 24 and 48 hpi. We tested two different 
strains of mice: NIH-Swiss and IFNAR(-/-) mice, lacking the β subunit of the 
interferon α/β receptor. Adult NIH-Swiss mice do not succumb to BTV infection 
while IFNAR(-/-) mice are known to support BTV replication and have been widely 
used for pathogenicity studies (Caporale et al. 2011; Calvo-Pinilla, Rodríguez-
Calvo, Anguita, et al. 2009; Ortego et al. 2014).  
Confocal microscopy of LN sections stained for BTV NS2 protein indicated that no 
detectable virus replication was present in NIH-Swiss mice at any time after 
infection (Figure 4-16). On the other hand, infected cells were detectable in the 
draining LNs of IFNAR(-/-) mice starting at 24 hpi. At this time point, infected 
cells localised mainly in the follicles, but also in the paracortical and medullary 
areas. However, no infected cells where present along the SCS, demonstrating 
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an important difference in comparison with sheep LN infection. At 48 hpi, 
infected cells constituted approximately 30% of the whole LN section and were 
localised both in the cortical, paracortical and medullar area (Figure 4-16). At 
this time we also observed a significant expansion of the size of infected LNs, 
compared to those of mock infected control IFNAR(-/-) mice and those of BTV-8 
infected NIH-Swiss mice (Figure 4-16). This observation suggests that active BTV 
replication can trigger either an inflammatory process or lymphocyte activation 
and proliferation in the LNs.  
 
 
Figure 4-16 BTV-8 infection of mouse lymph nodes 
Confocal images of whole LNs sections of mice subcutaneously inoculated with BTV-8. Sections 
were stained for BTV NS2 (red) and cell nuclei were stained with DAPI (blue). NIH Swiss mice did 
not support BTV replication in draining LNs between 24 and 48 hpi. On the contrary, the LNs of 
IFNAR
(-/-)
 mice were rapidly infected by BTV and presented many positive cells both in the cortical 
and medullary areas. Scale bars represent 300 µm. 
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4.3 Discussion 
In this chapter we followed the progression of BTV-8 infection in experimentally 
infected sheep, goats, and mice (conventional and type-I IFN α/β-receptor 
deficient). We identified the distribution of the virus by qRT-PCR and localised 
the sites of viral replication by IHC and immunofluorescence. Our results identify 
the skin near the inoculation site and the corresponding draining LNs as sites of 
replication as early as 4 hpi. 
Skin and LNs have long been recognised as sites of BTV replication by detection 
of viral genome or by virus isolation (Pini 1976; Barratt-Boyes & MacLachlan 
1994; MacLachlan et al. 1990; Sánchez-Cordón et al. 2010; Darpel et al. 2012). 
Nevertheless, most of the previous histological studies failed to detect 
significant amounts of infected cells in LNs sections by immunohistochemistry or 
immunofluorescence (Hemati et al. 2009; Darpel et al. 2012). This discrepancy 
may be due to the time after infection when these organs were sampled, and to 
a different sensitivity of the techniques used in most of these studies. Indeed, 
we noted that an antigen retrieval process is required for the correct detection 
of BTV proteins in fixed tissues, in agreement with a previous study (Sánchez-
Cordón et al. 2010). Furthermore, it is possible that a lack of correspondence 
between the presence of viral RNA and actual virus replication (with expression 
of non-structural proteins) in some of the tissues contributed to the observed 
differences. To overcome this issue, we combined qRT-PCR with an optimised 
IHC technique in order to identify the sites of virus replication during the in vivo 
infection.  For example, in sheep spleen we detected high level of BTV RNA but 
very few infected cells; the spleen is an organ rich in blood with hemochateretic 
function, and BTV can be absorbed in the membrane of circulating red blood cell 
without active replication (Brewer & MacLachlan 1992), this observation could 
provide a possible explanation for the discrepancies observed by using different 
techniques. 
Moreover, we demonstrate that the skin near the inoculation site and the 
corresponding draining LNs are capable of sustaining virus replication very early 
after infection in both sheep and goats. Our IHC results indicate that there is a 
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short time window in which numerous infected cells are present in the cortical 
area of the lymph nodes draining the infected skin (between 4 hours to 3 dpi), 
while at later time points only few capillaries appear to be infected in the 
medullary cords. Therefore, the histochemical observation of the LNs of infected 
animals at later time points, as done in previous studies (Darpel et al. 2012; 
Hemati et al. 2009; Sánchez-Cordón et al. 2010) might have missed the early 
phases of infection and underestimated the entity of the infection at these sites.  
In sheep, by 4-8 hpi we observed numerous BTV infected cells in the cortical 
area of the LNs draining the infected skin, in correspondence of the subcapsular 
and trabecular sinuses. The cortical sinuses collect the incoming lymph from 
peripheral tissues. Therefore it is likely that virus particles get passively 
transported with the lymph fluids from the skin to the LNs.  
DCs have been described as one of the key target cells infected by BTV and 
identified as the main carriers of BTV in the lymph (Hemati et al. 2009; Ruscanu 
et al. 2013). Once DCs reach the SCS, they have the capacity to cross the sinus 
walls and move into the T-cell area, where they finally localise. However the 
time required for a DC to pick up antigens in the skin, became activated and 
move towards the lymphatic vessels is considered to be roughly 12-18h (Itano et 
al. 2003; Randolph et al. 2005), which is not compatible with the time of virus 
arrival to the SCS observed in our study. This suggests that large part of the virus 
is freely transported within the lymph draining the infected skin rather than in 
association with DCs. Furthermore, in sheep we only rarely identify infected 
cells in the T-cell area (at any of the considered time points), where DCs should 
localise once they have accessed the LN (Braun et al. 2011). 
Other organs presented infected cells only at later time points, once the viral 
RNA levels in the blood had increased. It is therefore evident that BTV undergoes 
an initial replication phase in the skin and then in the draining LNs, reached by 
the virus carried with the lymph flow. Subsequently, BTV reaches the 
bloodstream and it is distributed systemically to peripheral tissues like spleen, 
which contains large part of the circulating blood, and organs equipped with a 
capillary bed such as kidney and lung. The use of an attenuated virus (BTV8H) 
that does not induce viremia, further strengthen this point, considering that 
peripheral tissues are not reached by this virus that shows a similar tropism as 
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BTV-8. It is therefore likely that for reaching the bloodstream the virus needs to 
overcome a bottleneck represented by the draining LNs, if it fails to do so, the 
systemic dissemination is prevented and with it the development of disease.  
Different experimental settings have been used to reproduce the course of 
bluetongue in susceptible animals. We preferred the intradermal inoculation 
over the subcutaneous or intravenous route, to mimic insect bites and in order 
to start the infection in the anatomic compartment of the natural infection. The 
route of inoculation has been found to alter considerably the clinical outcome of 
experimental BTV infection as, for example, intravenous inoculation often fails 
to induce clinical signs (Umeshappa et al. 2011). These observations suggest that 
bypassing the skin and the LN can alter the pathogenesis of disease, and 
strengthen the idea that virus replication in skin and LNs is critical for the onset 
of disease.  
Indeed, our IHC data show that the localization of BTV in non-draining LNs, that 
are reached by the virus between 3 to 7 dpi, during the viremic phase, is not in 
the sinuses or in the cortical area but in the medullar area. Therefore the 
tropism of the virus for specific areas of the LNs seems to be determined by the 
route of dissemination. 
It has to be to consider that timing and localization of the virus in infected 
animals may have been influenced by kind of experimental setting used. For 
example, we did not analyse animals infected through the bite of Culicoides 
midges, the natural source of infection, that in previous occasions have been 
demonstrated to be able to enhance virus infectivity (Darpel et al. 2011) by VP2 
cleavage, and to promote viremia and clinical symptoms expression (Pages et al. 
2014) by delaying IFN-induced gene expression and delaying neutralizing 
antibody responses. Moreover, the inflammatory reaction generated by 
arthropod saliva has been recently identified as an important chemoattractant 
for cells susceptible to infection, such as mononuclear phagocytes, and it is 
therefore implicated in the amplification of similar arboviral diseases (Pingen et 
al. 2016). Furthermore, for experimental infections in sheep and goat we used 
2x106 PFU of BTV-8 (Caporale et al. 2014) as this dose was previously shown to 
be sufficient to cause disease. However, it is not currently known what is the 
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dose of BTV-8 inoculated by midges during the natural infection and on which 
extent this can be implicated on the clinical outcome. 
We characterised BTV-8 distribution in experimentally infected goats, which 
generally do not present clinical disease (Caporale et al. 2014; MacLachlan et al. 
2009). In goats, BTV RNA levels in draining LNs, after peaking at 24 hpi, rapidly 
decreased to lower levels compared to sheep (approximately 100 fold 
difference) indicating a possible difference in virus replication in goat tissues. 
This difference was also reflected in the delayed onset of viremia in goats, 
which reached significant titres only at 5 dpi and never equalled the titres 
observed in infected sheep (103 vs 107 copies at 7 dpi). This likely accounted for 
the lower level of viral distribution in peripheral tissues observed in goats. Viral 
replication, as assessed by IHC, was localised in similar areas of the LNs in 
infected sheep and goats. However, we observed some significant differences. 
First, the intensity of NS2 staining in lymphatic endothelial cells lining the 
sinuses walls was lower in goats compared to the equivalent cells in sheep. In 
addition, we observed numerous infected cells in the paracortical area of the 
LNs in goats while in sheep there were no visible infected cells in this area. A 
diverse tropism of the virus for different cell populations in these two animal 
species could explain the slower progression of infection observed in goats and 
possibly account for the mild or asymptomatic infection displayed in this animal 
species. However, the different BTV-8 tropism detected in sheep and goats could 
be the consequence of multiple variables, such as a different efficiency of the 
innate and intrinsic immunity, the virus strain specificity and adaptation, the 
level of expression of the cell receptor, or the presence of adaptive immunity, 
just to mention some possibilities. Further studies are needed to identify the 
weight of each factor on the final effect.  
Undoubtedly, BTV studies involving the natural ruminant hosts are limited by the 
complexity of the system, the limited knowledge of ruminants’ immune system, 
and the need to have a large animal facility with BSL-3. To overcome some of 
these issues, murine models that support BTV replication have been developed 
(Calvo-Pinilla, Rodríguez-Calvo, Anguita, et al. 2009). To evaluate if 
pathogenicity studies can be performed in a more manageable model of disease, 
we compared the pattern of infection and virus distribution obtained in sheep 
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and goats with BTV-infected mice, testing both NIH-Swiss mice and IFNAR(-/-) 
mice.  
In NIH-Swiss mice, whose immune system is intact, BTV replication was not 
detected in draining LN, indicating that BTV is unable to replicate in mice with a 
fully working innate immune system. These data support the evidence that this 
type of mouse cannot be used for BTV studies and indicate the importance of an 
intact innate immune response that can restrict virus replication in non-natural 
species.  
In IFNAR(-/-) susceptible mice (Calvo-Pinilla, Rodríguez-Calvo, Anguita, et al. 
2009), BTV infected cells were detected in draining LNs  but the anatomical 
localization of these cells did not resemble the one observed in infected sheep 
or goats. The subcapsular sinus was not infected and only few virus-positive cells 
were present inside B-cells follicles. Furthermore, a clear discrimination of the 
virus differential localisation in the cortical, paracortical or medullar area was 
not observed and virus-infected cells were abundantly present in each area. 
These data indicate that mouse models of BTV infection cannot fully replicate 
the viral tropism and the pathogenesis of disease that we observe in the natural 
ruminant hosts.  
Furthermore, our results add to the notion that IFN is an important determinant 
of BTV susceptibility. We show that type-I IFN stimulation can completely 
abrogate BTV replication in a mouse model, this suggests that IFN could also be 
implicated in determining the range of infected cells not only in mouse but also 
in the target animal species, therefore interferon-stimulated genes and species-
specific restriction factors may be implicated in defining host species range of 
BTV.  Viral tropism is generally determined by a combination of two major 
factors: a host cell must be both permissive (allow viral replication) and 
susceptible (possess the receptor needed for viral entry) for a virus to establish 
infection. The receptor for BTV is still unknown, however, in vitro BTV is able to 
replicate in a variety of cell lines, derived from different hosts, indicating that 
the receptor must be widely expressed in different cells and in different animal 
species. This suggests that BTV can use a very evolutionary conserved receptor, 
or alternatively, that the virus is able to use more than one type of receptor 
depending on its availability in the surrounding environment. A role of heparan 
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sulphate in BTV-cell binding has been demonstrated (Janowicz et al. 2015; 
Mecham & McHolland 2010), and structural studies have also identified sialic-
acid binding domains on the VP2 outer capsid protein (Zhang et al. 2010) but 
functional studies are still missing. Here we observed that numerous mouse cells 
were susceptible to BTV in absence of type-I IFN. Hence, the presence of the 
cellular receptor it is unlikely to be a determinant factor in restricting virus 
tropism in mouse, on the contrary, the permissiveness of the mouse cells seems 
to be determined by their innate immune response against BTV.  
In summary, the data presented in this chapter show BTV distribution over time 
in experimentally infected sheep and goats. The results obtained underline the 
importance of the passive stream of free viral particles within the lymph flow at 
the initial stages of experimental BTV infection, and the role of the bloodstream 
in the systemic dissemination of the virus. We identify the draining LNs as having 
a crucial role during the initial stages of infection, before the onset of clinical 
signs. Interestingly, we found a different pattern of viral infection in goats 
compared to sheep LNs, and this key difference could account for the large 
variability in the clinical outcome of disease between these two species.  
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5 Characterization of BTV-8 infected cells in sheep 
lymph node  
5.1 Introduction 
In chapter 4, we have shown that soon after inoculation into the skin, BTV 
replicates in the draining LNs of the infected host. Draining LNs are essential 
stops along the journey of the virus toward its systemic dissemination. Inside the 
LN, lymphocytes encounter cognate antigens and these events lead to the 
initiation of the immune response. Hence, the way in which BTV interacts with 
the immune system inside the LN can shape the immune responses and it is of 
paramount importance to understand arbovirus pathogenesis. 
The highly ordered architecture of the lymph node maximizes the chance that a 
lymphocyte will encounter antigens (Junt et al. 2008; Lämmermann & Sixt 
2008). Different subsets of stromal cells (Malhotra et al. 2012) form the three-
dimensional scaffolding of the LN and are responsible for the organization of 
distinct functional zones through secretion of specific chemokines and cytokines 
driving lymphocytes migration and contributing to the development of an 
appropriate immune response (Mueller & Germain 2009; Bajenoff et al. 2006; 
Link et al. 2007).  For example, in the paracortical area, the place where DCs 
and T-cells get in contact, fibroblastic reticular cells (FRC) drive T-cells and DCs 
chemotaxis through secretion of chemokine ligand 19 (CCL19) and CCL21, which 
in turn recruit chemokine receptor 7 (CCR7) expressing cells (T-cells and DCs). 
On the contrary, follicular dendritic cells (FDC) and marginal reticular cells 
(MRC) are the stromal cells deputed to the maintenance of the B-cell follicle, 
producing the CXCL13 homing signal for B-cells expressing the chemokine 
receptor 5 (CCR5) and driving germinal centre formation and B-cell activation. 
Recently, imaging studies have provided insightful information about the early 
events following viral infection and the initiation of immune response (Bousso & 
Moreau 2012). Despite most of the data described in literature are based on 
mouse models, and similar mechanisms in other mammalian species have been 
poorly characterized, some analogies can be drawn. Studies conducted in the 
mouse indicate that, few minutes after inoculation, free antigens and pathogens 
start to reach the SCS of the regional draining LN (Roozendaal et al. 2009; 
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Gonzalez et al. 2010; Junt et al. 2007; Braun et al. 2011; Kastenmüller et al. 
2012; Gonzalez et al. 2015; Iannacone et al. 2010). The SCS forms a barrier 
between the lymph contents and the LN parenchyma, working like a filter to 
avoid uncontrolled access of potentially harmful antigens to the LN cortex. In 
order to access the LN cortex, antigens are screened based on theirs dimensions. 
Small antigens with a molecular weight lower than 70 kDa ( 5 nm radius) are 
allowed free access to the LN parenchyma through a system of tubules that cross 
the subcapsular sinus (SCS) and deepen inside the paracortical area (Sixt et al. 
2005). Antigens flowing through the conduits can then be directly sampled by 
resident DCs and macrophages. A less dense system of tubules was also 
discovered in the follicles (Roozendaal et al. 2009), deputed to deliver the 
antigens to follicular B-cells and FDC.  
On the contrary, larger and particulate antigens (>70 kDa), such as viruses and 
bacteria, once they reach the SCS cannot directly access the conduits and they 
remain trapped in the SCS where are captured by a resident population of 
macrophages (Hirosue & Dubrot 2015). 
Once picked up by SCS macrophages, large, unprocessed antigens can be 
transferred to the underlying B-cell area, where they are directly presented to 
follicular B-cells (Phan et al. 2009). After antigen recognition, cognate B-cells 
migrate either to the outer follicular zone where they present the antigens to T-
cells, or to the light zone of the follicle to deliver the antigens to FDC.  
Only 12-24 hours after these initial events, migratory DCs reach the LN from the 
skin, traverse the subcapsular sinus and head to the paracortical area bringing 
processed antigens (Randolph et al. 2008; Itano et al. 2003; Braun et al. 2011), 
initiating a second wave of antigen presentation which consolidates the initial 
one. In the paracortical area, T-cells have the opportunity to scan DCs for their 
cognate antigen. Once the antigen is recognised, a contact is established 
between the T-cell receptor (TCR) with peptide-MHC complexes on the surface 
of DC. Furthermore, T-cell-DC contact provide co-stimulatory and adhesion 
molecules interactions and production of soluble factors that modulate the 
activation of T-cells. Productive activation of naive T cells by DCs results in their 
clonal expansion and differentiation into effector and memory T-cells (Bousso 
2008). 
  
Chapter 5  124 
 
 
In this chapter we aimed to identify the cell populations infected by BTV in the 
lymph nodes draining the site of virus inoculation. Given the limited amount of 
antibodies available to target ruminant cells in formalin-fixed tissues we firstly 
screened a panel of antibodies to further characterise sheep lymphocytes, 
macrophages, DCs and lymphoid stromal cells. We then used confocal 
microscopy to assess virus replication in these cells at different time after 
infection. Our results indicate that BTV replicates in macrophages and 
endothelial cells lining the sinus walls. Thereafter, BTV access the cortical area 
of the LN by infecting B-cells and the stromal network of cells composing the 
lymphoid follicles where it persists until 96 hpi. Overall we discovered new viral 
targets in the ruminant LN and characterised the progression of BTV infection at 
this site. 
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5.2 Results 
5.2.1 Characterization of cell populations in sheep lymph nodes 
Research in veterinary species is negatively affected by the lack of reagents. The 
relatively limited knowledge of the immune system of ruminants is partially due 
to an incomplete characterization of their immune cell populations. Hence, the 
identification of monoclonal antibodies targeting specific cells populations in 
ruminant species is paramount for the progress of veterinary research. 
5.2.1.1 Screening of antibodies to target sheep cells in paraffin embedded 
lymph nodes  
In order to identify BTV infected cell populations in the LN of sheep we initially 
performed a screening of a panel of 67 antibodies (Table 5-1) to identify cell 
markers reacting with sheep tissues, formalin and zinc salt fixed and then 
paraffin embedded. The results of the screening are summarised in Table 5-1, 
we identified 40 antibodies that work on fixed sheep tissues, 14 of which solely 
work when zinc fixatives are used. The tested antibodies had various species 
specificity, some were specific for sheep, others were defined cross-reactive, 
and others have not been previously tested in sheep tissues. For clones whose 
cross-reactivity in ruminants was not stated by the producers, we performed a 
BLAST (basic local alignment search tool) search against the sheep genome of 
the sequence targeted by the antibody (when stated) or of the whole target 
protein. To blast and compare the sequences we used the PubMed online 
database and we sourced the protein sequences using the Uniprot database 
(Anon n.d.). We then tested by immunohistochemistry the efficacy of those 
antibodies that were raised against proteins sharing at least 70% identity with 
the sheep orthologues. Antibodies were tested initially in zinc fixed tissues, 
since the possibility to detect a specific signal was facilitated by the fact that 
antigen retrieval is generally not required with this type of fixation. To 
determine presence of a positive signal we used initially dilutions between 1:20 
to 1:200. The final working concentration for each antibody was then 
determined based on the results obtained and it is summarised in Material and 
Methods. The specificity of the staining was determined by using histological 
insights checking if the localization of the staining in the tissue matched the 
likely anatomical localization of the targeted cells. However, in some cases, we 
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obtained specific signals in unexpected cell populations. We further 
characterised various cell populations by co-expression of specific markers by 
using a combination of two or three antibodies by confocal microscopy. 
Generally, we associated a well-recognised marker, or a previously characterised 
one, with a newly identified one. This allowed us to identify previously 
uncharacterised markers for sheep stromal cells and mononuclear phagocytes. 
Testing of antibodies in formalin fixed tissues also included the evaluation of 
different antigen retrieval techniques for the unmasking of formalin cross-linked 
epitopes (as described in Material and Methods). The use of different antibodies 
in multicolour immunofluorescence studies was limited by their reactivity using 
the same antigen retrieval technique and by the animal in which they were 
obtained (mouse, rabbit, rat, guinea pig or donkey) or, in case of mouse 
antibodies, by the isotype classes (we used IgG1, IgG2a, IgG2b, IgM). The 
application of unrelated antibodies of the same isotype and concentration was 
used as a negative control to check the specificity of the positive signal. 
Table 5-1 - List of antibodies tested on sheep tissues by immunohistochemistry 
Results of the screening (R): no signal (red), signal in formalin fixed tissues (green), signal in zinc 
salts fixed tissues (blue), Inconstant results (yellow). Mo (mouse), Hu (human), Rb (rabbit), Sh 
(sheep), Bv (bovine), Gt (goat). PL (polyclonal). 
R Marker Clone Host/Target Isotype Manufacturer 
 CD14  TUK4 Mo α Hu  IgG2a Bio-Rad 
 CD14  VPM65 Mo  IgG1 Moredun 
 DEC205  CC98 Mo  IgG2b Bio-Rad 
 SIRPα IL-A24 Mo  IgG1 Moredun 
 MHC-II  SW73.2 Rat α Sh  Moredun 
 CD3 F7.2.38 Mo α Hu  IgG1 Dako 
 CD79a HM57 Mo α Hu  IgG1 Bio-Rad 
 CD163 EDHu-1 Mo α Hu  IgG1 Bio-Rad 
 WC1 CC15 Mo α Bv  IgG2a Bio-Rad 
 IFN-Gamma 7B6 Mo α BV  IgG1 Bio-Rad 
 Ki-67 MIB-1 Mo α Hu  IgG1 Dako 
 CD68 EBM11 Mo α Hu  IgG1 Dako 
 CD169 - Siglec-1 HSn 7D2 Mo α Hu  IgG1 Santa Cruz Biotech 
 Caspase 3 74T2 Mo α Hu  IgG1 Invitrogen 
 Cleaved Caspase 3 D175-5A1E Rb PL Cell Signaling  
 CD1w2 CC20 Mo α Bv  IgG2a Bio-Rad 
 CD45 1.11.32 Mo α Sh  IgG1 Bio-Rad 
 CD1 20:27 Mo α Sh  IgG1 Bio-Rad 
 CD83 HB15e Mo α Hu  IgG1 Bio-Rad 
 CD26 - WC10 CC69 Mo α Bv  IgG1 Bio-Rad 
 CD11b  CC126 Mo α Bv  IgG2b Bio-Rad 
 CD21  CC21 Mo α Bv  IgG1 Bio-Rad 
 CD209 
 
Rb  PL Bio-Rad 
 CD62P AK-6 Mo α Hu  IgG1 Bio-Rad 
 CD62P Psel.KO.2.7 Mo α Hu  IgG1 Bio-Rad 
 CD8 CC63 Mo α Bv  IgG2a Bio-Rad 
 CD209 MR-1 Mo α Hu  IgG1 Bio-Rad 
 LYVE-1 
 
Gt α Hu PL R&D System 
 Desmin DE-U-10 Mo α Hu IgG1 Sigma-Aldrich 
 Fascin 55K-2 Mo α Hu  IgG1 Dako 
 CD31 JC70A Mo α Hu  IgG1k Dako 
 Podoplanin D2-40 Mo α Hu  IgG1k Dako 
 Von Willebrand Factor 
 
Rb  PL Dako 
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R Marker Clone Host/Target Isotype Manufacturer 
 Von Willebrand Factor F8/86 Mo α Hu  IgG1 Dako 
 Vimentin Vim3B4 Mo α Hu  IgG2ak Dako 
 Laminin 4C7 Mo α Hu  IgG2ak Dako 
 B-cells Dak-Pax5 Mo α Hu  IgG1 Dako 
 FDC CNA.42 Mo α Hu  IgM Dako 
 CD21  BAQ15A Mo α Bv  IgM King Fisher 
 CD172a DH59B Mo α Bv  IgG1 King Fisher 
 CD11c BAQ153A Mo use α Bv  IgM King Fisher 
 CD208 - DC lamp 1010E1.01 Rat α Mo  IgG2a Dendritics 
 CD31 CO.3E1D4 Mo α Sh  IgG2a Bio-Rad 
 TLR3 - CD283 713E4.06  Mo α Hu  IgG1 Dendritics  
 ICAM-1 CD54 117G12 Mo α Hu  IgG1 Dendritics  
 ER-TR7 ER-TR7 Rat α Hu IgG2a Thermo  
 Collagen IV CIV22 Mo α Hu  IgG1 Dako 
 JAM-2 1G4 Mo α Hu  IgG1 Sigma-Aldrich 
 Fibroblasts TE-7 Mo α Hu  IgG1 Merk Millipore  
 Perlecan A71 Mo  α Bovine  IgG1 Source bioscience  
 CD83 
 
Rb  PL Biorbyt  
 CD83  HB15a Mo α Hu  IgG2b Biorbyt  
 Desmoplakin DP2.15 Mo α Bv  IgG1 Millipore  
 Cleaved Caspase 3 Asp175 Rb  PL Cell Signalling  
 S100 
 
Rb  PL Dako   
 PCNA (division) PC10 Mo α Hu  IgG2a Bio-Rad  
 Sh IgG HRP 
 
Dk anti Sh/Gt  PL Bio-Rad  
 JAM-A 
 
Rb  PL Invitrogen  
 Lyve-1 
 
Rb  PL Millipore 
 S100 
 
Rb  PL Bio-Rad 
 Beta-actin 
 
Rb α Hu  PL Cell signaling 
 Smooth muscle actin 1A4 Mo α Hu  IgG2a Dako 
 CD8 38.65 Mo α Sh  IgG2a Bio-Rad 
 CD4 44.38 Mo α Sh  IgG2a Bio-Rad 
 PLVAP MECA-32 Rt α Mo IgG2a Bio-Rad 
 Desmin 
 
Rb α Mo PL Abcam 
 CD335 EC1.1 Mo α Sh IgG1 Bio-Rad 
 
 
5.2.1.2 Identification of lymphocyte markers in sheep lymph node 
To detect T-cells, we targeted CD3 by using clone F7.2.38 (Table 5-1) (Al Saati 
et al. 2001) that recognizes an epitope on the intracytoplasmic portion of the ε-
chain of CD3 that is well conserved in mammalian species. In sheep the anti-CD3 
antibody identifies cells that localise in the paracortical area of the LN. As 
expected, some T lymphocytes were also present along the medullary cords but 
not inside the medullary sinuses. CD3 T-cells were not generally present in the 
SCS or along the trabecular sinuses. Antibody targeting CD8, CD4 and WC1 were 
used to detect cytotoxic, helper and γδ T lymphocytes respectively. We 
observed these lymphocytes populations in a similar localization as it was 
previously described (González et al. 2001). Few scattered natural killer (NK) 
cells were identified in the paracortical area of the lymph node by using an 
antibody targeting CD335 (NCR1, natural cytotoxicity triggering receptor 1) 
(Olsen et al. 2015). 
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We also tested antibodies directed against three different markers commonly 
used for the identification of B-cells: CD79a, CD21 and Pax5 (Figure 5-1). CD79a 
(clone HM57) was not considered a reliable marker for B-cells identification, as 
the resulting staining was inconsistent. On the contrary, and as previously 
described, CD21 (complement receptor 2, CR2) was expressed both by mature B-
cells and FDC and by cells localised in the follicles of the cortical area of the LN. 
However, it was not possible to differentiate B-cells from FDC based only on the 
use of antibodies detecting this marker (Figure 5-1). The clone Dak-pax5 
(Agostinelli et al. 2010) identifies the PAX-5 protein, also termed B-cell specific 
activator protein (BSAP), a member of the highly conserved paired box (PAX)-
domain family of transcription factors. BSAP plays an essential role for B-cell 
commitment, since it is involved in the repression of non-B lymphoid genes and 
the activation of genes needed for B-cell differentiation (Agostinelli et al. 2010). 
BSAP is expressed in the nucleus of B-cells in all the maturation stages, but not 
in plasma cells. Similarly to CD21, anti-Pax5 antibody identified cells in the 
follicles of the LN but it does not stain FDC (Figure 5-1) and was therefore 
chosen as specific marker for B-cells. 
 
Figure 5-1 Identification of markers for sheep B-cells 
Representative immunohistochemistry micrographs of sheep lymph node sections collected from 
uninfected control animals and fixed using zinc salt solution. Sections were stained for CD21 and 
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PAX-5 (BSAS protein), both markers identify sheep B-cells. Scale bars 500µm in top raw images, 
200µm in the bottom raw 
 
5.2.1.3 Identification of markers for mononuclear phagocytes (macrophages 
and dendritic cells) in the sheep lymph node 
A broad variety of markers have helped to characterise different populations of 
myeloid cells in mouse and human. In ruminants species there are limited 
information about the mononuclear phagocytes residing in the LN. Hence, we 
decided to systematically test a panel of antibodies, which prove useful in other 
mammalian species, to identify the localization of dendritic cells and 
macrophages in sheep LNs. The clone SW73.2 (Hopkins et al. 1986) reacts with a 
monomorphic epitope on both HLA-DQ (human leucocyte antigen) and -DR beta 
chain of sheep and cattle MHC class II (MHC-II), which are constitutively 
expressed on antigen presenting cells such as dendritic cells, B lymphocytes, 
monocytes, macrophages and may be induced on a range of other cell types by 
interferon gamma. SW73.2 was used to identify antigen presenting cells: MHC-II 
was broadly expressed by cells of the cortical area, in particular by 
interdigitating cells present in the paracortex and at a lower level by the B-cells 
present in the follicles. We then screened markers considered specific for sheep 
macrophages. CD163 (Figure 5-2) is a glycoprotein belonging to the scavenger 
receptor cysteine-rich superfamily, it is considered to be exclusively expressed 
by sheep macrophages and not expressed by neutrophils (unlike for example 
CD68) (Elnaggar et al. 2016; Herrmann-Hoesing et al. 2010). CD163 was 
expressed by few cells in the paracortical area and by numerous cells present 
along the trabecular and medullary sinuses (Figure 5-2). Another marker, CD11b 
was also expressed by cells in a similar location, along the trabecular and 
medullary sinuses (Figure 5-2). Therefore CD11b and CD163 likely stain the same 
population of macrophages, although it was not possible to use the two markers 
together (being both mouse IgG1 monoclonal antibodies). The sialoadhesin 
CD169 is a lectin with Ig superfamily domains that binds sialic acid and is 
expressed exclusively by macrophages. In mouse LNs, CD169 characterises two 
different types of macrophages, SCS and medullary (Martinez-Pomares & Gordon 
2012). These macrophages are strategically placed to allow antigen acquisition 
and delivery to lymphocytes. In sheep, the anti-CD169 antibody (clone HSn 72D) 
labelled a population of macrophages that was present along trabecular and 
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medullary sinuses but absent along the SCS (Figure 5-2). Hence, these results 
allowed the identification of 4 markers for sheep macrophages: MHCII, CD11b, 
CD163 and CD169. 
 
Figure 5-2 Identification of markers for sheep macrophages and dendritic cells 
Representative immunohistochemistry micrographs of sheep lymph node sections collected from 
uninfected control animals and fixed using zinc salt solution. Tissues were stained for CD11b, 
CD163, CD169 and fascin.  The expression of these markers in different anatomical areas of the 
lymph node allowed the identification of various populations of mononuclear phagocytes. 
 
Thereafter, we screened antibodies targeting markers expressed by dendritic 
cells.  
CD208 (dendritic cell-lysosomal associated membrane protein, DC-LAMP) is 
specifically expressed by DCs on activation. An anti-CD208 antibody (clone 
1010E1.01) was previously used to identify bovine DCs in formalin fixed tissues 
(Romero-Palomo et al. 2013). In sheep, CD208 was differentially expressed by 
two distinct cell populations residing in the paracortical area of the LN: the first 
population expressed CD208 at significant high levels in the cytoplasm, while the 
second population showed CD208 clustered in a limited perinuclear area (likely 
the Golgi apparatus) (see below Figure 5-5); this second type of expression was 
also detected in cells present along trabecular and medullary sinuses.  
Fascin has been demonstrated to be critical for the antigen presentation activity 
of mature mouse and human DCs (Al-Alwan et al. 2001; Ross et al. 2000) and is 
considered a specific marker for mature DCs that is not expressed by 
macrophages (Vakkila et al. 2005). In sheep LNs, fascin was highly expressed by 
cells present in the paracortical area, with the antibody (clone 55K-2) strongly 
labelling the membrane processes extending outward the main cell body (Figure 
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5-2, see also Figure 5-4B and Figure 5-5B). In the paracortical sinuses, fascin was 
expressed at much lower level (barely detectable) in round shaped cells with no 
visible elongations (Figure 5-2, see also Figure 5-4B and Figure 5-5B).  
CD83 is a broadly used as a maturation marker for human and mouse DCs 
(Breloer & Fleischer 2008), however it is also expressed on a variety of different 
cells, including monocytes and macrophages (Cao et al. 2005), activated B and T 
lymphocytes (Krzyzak et al. 2016; Wolenski et al. 2003; Victora et al. 2012) and 
some epithelial cell populations. In sheep LNs, CD83 displayed a marked 
cytoplasmic localization around the nucleus in cells present in the paracortical 
area, while it was not present in the cells of the sinus. In addition, the anti-CD83 
antibody labelled a reticulum of cells present in the B-cell follicles in the 
cortical area but it was absent on B-cells (Figure 5-4A) 
CD1 is generally considered a specific marker for sheep DCs, however we 
detected its expression also on sheep B-cells as previously reported (Mwangi et 
al. 1991); for this reason CD1 was not used as marker for CDs in the present 
study. On the contrary, CD1w was expressed in cells present in the paracortical 
area, compatible with DCs, however since it was not working in 
immunofluorescence, it was not used extensively (Figure 5-3). 
 
 
Figure 5-3 Localization of CD1w+ cells in sheep lymph node 
Representative immunohistochemistry micrographs of sheep lymph node sections collected from 
uninfected control animals and fixed using zinc salt solution, tissues were stained for CD1w that 
localise in the paracortical area. Different magnification are shown. 
 
In order to further characterise the phenotype of sheep DCs and macrophages, 
we performed double staining with combinations of relevant markers by using 
multicolour confocal microscopy (Figure 5-4 and Figure 5-5). MHCII and CD83 
were both brightly expressed in cells of the paracortical area, characterised by 
long elongations and morphologically consistent with DCs (Figure 5-4A). MHC-
IIhigh cells of the paracortical area tended to express high levels of fascin in their 
elongations (Fascinhigh) (Figure 5-4B). In the follicles, MHCII positive B-cells did 
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not express CD83, which was instead found to be expressed by spindle shaped 
cells, morphologically consistent with FDC (Figure 5-4A).  
 
Figure 5-4 Identification of markers for sheep dendritic cells (MHCII, CD83 and fascin) 
Representative confocal images of sheep lymph node sections collected from uninfected control 
animals. (A) Sections were stained for MHC-II (green) and CD83 (red).  Insets show markers 
expression in different areas of the lymph node at higher magnification. (B) Sections were stained 
for MHC-II (green) and fascin (red) to visualise the extension of DCs in the paracortical area. 
 
Interestingly, the high expression of CD208 and CD163 seemed to be mutually 
exclusive in sheep LN (Figure 5-5A). For example, in the paracortical area, cells 
expressing high levels of CD208 generally did not express CD163 whereas cell 
expressing high levels of CD163 were stained with the anti-CD208 antibody only 
internally in the perinuclear area (CD208int) (Figure 5-5A), these results indicate 
the co-existence of various APCs populations in this area that may represent 
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different maturation stages of the same cells, or alternatively cells possessing 
different functions. A population with the same phenotype (CD163+ CD208int) was 
also present along the medullary sinuses suggesting that these cells may 
represent macrophages. Furthermore, fascinhigh cells also expressed CD208 at 
high levels in the paracortical area, while fascinlow cells along the sinuses 
expressed CD208 only internally in the perinuclear area (Figure 5-5B) providing 
another indication that these cells are indeed macrophages.   
 
Figure 5-5 Identification of markers for sheep antigen presenting cells (CD208, fascin and 
CD163) 
Representative confocal images of sheep lymph node sections collected from uninfected control 
animals. (A) Sections were stained for CD163 (red) and CD208 (green) which identify different 
populations of sheep phagocytes. Insets show markers expression in different areas of the lymph 
node at higher magnification. (B) Sections were stained for fascin (red) and CD208 (green) that 
were both highly expressed in cells residing in the paracortical area (dendritic cells) but not in 
macrophages localised not along the trabecular sinuses. 
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To summarise, the differential expression of combined markers lead to the 
characterization of a variety of APCs populations residing in the sheep LN. Along 
the trabecular and medullary sinuses a population of 
CD163high/CD208int/CD169high/MHC-II+/fascinlow cells represented macrophages. A 
similar population of macrophages has been described in the medullary sinuses 
in other animal species and they work by capturing antigens flowing through the 
LN (Gray & Cyster 2012). Dispersed in the paracortical area of the sheep LN, we 
identified two different populations of APCs. The first one, characterised by 
CD208high/fascinhigh/MHC-IIhigh/CD83+ cells that in some occasions displayed 
perinuclear CD163int/-, presented a phenotype compatible with mature DCs that 
can contribute to the activation of T-cells in the paracortical area of the LN 
(Angel et al. 2009),  while the second one, was less represented and showed a 
phenotype compatible with macrophage CD163+/CD208int/fascinlow. Furthermore 
we could localise, in the B-cell follicles, some follicular macrophages (also called 
tingible body macrophages), expressing both CD208 and CD163. CD208 is 
generally considered a specific marker for DCs but in the ruminant species has 
already been reported in tingible body macrophages (Romero-Palomo et al. 
2013). See Table 5-2 for a summary of the populations characterised. 
5.2.1.4 Identification of stromal cells markers in the sheep lymph node 
Stromal cells provide the supporting network of fibres that form the LN 
structure; moreover, they also provide homing signals to drive leucocyte 
migration and have recently been assigned a role in facilitating the antigen 
presentation process (Hirosue & Dubrot 2015; Turley et al. 2010). New insights in 
the lymphoid stromal cells function shows that this is a non-homogeneous 
population of highly specialised cells (with defined functions and phenotype) 
each one specific for the different functional areas of the LN (Chang & Turley 
2015). However, these phenotypic and functional specialisations have only been 
described in the mouse LN and, until now never been reported in other species. 
Here we aimed to characterise different populations of lymphoid stromal cells of 
the sheep LN, and to identify markers to unequivocally identify them by confocal 
microscopy in fixed tissues. As a result of this, some minor differences emerged 
in comparison with the mouse model mentioned above.  
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Similarly to the mouse, FRC were identified as expressing desmin, (Malhotra et 
al. 2012; Fletcher et al. 2011), delineating a network of stromal cells populating 
the paracortical and medullar area of the LN but absent from the follicular area 
(Figure 5-6). Contrary to the mouse, smooth muscle actin (SMA) was not 
expressed by sheep FRC (Malhotra et al. 2012), but only present in the LN 
capsule and in the pericytes surrounding HEV. Curiously, SMA was also present on 
a population of arc-shaped cells, which delineates the paracortical border of the 
follicle, which has not been previously described. It is reasonable to hypothesize 
that SMA+ cells in this location were pericytes surrounding an artery feeding the 
follicle, but it was not possible to exclude other options. 
 
Figure 5-6 Identification of markers for sheep fibroblastic reticular cells (FRC) and follicular 
dendritic cells (FDC)  
Representative confocal micrograph of a sheep lymph node. Section was stained for desmin (red) 
and CNA.42 (green) to identify fibroblastic reticular cells (FRC) and follicular dendritic cells (FDC) 
respectively. FRC are not present in the follicles where FDC reside 
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In the GCs, it is possible to distinguish two major subtypes of follicular dendritic 
cells (FDC) on the basis of their localization, morphology, and phenotype. FDC 
localised in the light zone display abundant cytoplasmic extensions with a high 
level of membrane-bound immune complexes, whereas in the dark zone they 
display fewer cytoplasmic extensions and present a low capacity to trap immune 
complexes (Allen & Cyster 2008). 
Sheep FDC were found to react positively with the CNA.42 antibody (Figure 5-6), 
as already described in cattle (Romero-Palomo et al. 2013). The epitope 
recognized by CNA.42 antibody is a membrane-associated antigen, of 120 kd, 
resistant to fixation that is expressed on FDC. CNA.42 is commonly used in 
human diagnostic settings for the histological classification of malignancies of 
FDC origin (such as follicular dendritic reticulum cell sarcoma and EBV-positive 
inflammatory pseudotumors) (Raymond et al. 1997; Maeda et al. 2002; Troxell et 
al. 2005). In sheep, this antigen was also expressed by some mononuclear cells 
present in the paracortical area of the LN as described for human tissues 
(Raymond et al. 1997).  We identified sheep FDC as cells forming a reticular 
pattern in the light zone of the germinal centres. Furthermore, FDC in the light 
zone were positively labelled with an antibody targeting CD54 (Figure 5-7A). 
CD54 (also known as intercellular adhesion molecule 1 – ICAM-1) is a 
transmembrane protein expressed in endothelial cells and leucocytes which is 
implicated in the process of transmigration of leucocytes across lymphatic 
vessels (Johnson et al. 2006). Both mouse and human FDC have been described 
to express CD54 and this is the first report in a ruminant species (Fujiwara et al. 
1999; Sukumar et al. 2006). CNA.42 and CD54 co-localise in the same cell 
population in the follicles present in sheep LNs (Figure 5-7A). Furthermore, to 
target FDC we tested the well-recognised marker CD21 (CR2) (Figure 5-7B), 
which is responsible of the uptake and retention of immune complexes 
(Roozendaal & Carroll 2007; Herrmann et al. 2003). However, CD21 is expressed 
in by both FDC and follicular B-cells in sheep lymphoid tissues, similarly to other 
mammalian species (González et al. 2001; Breugelmans et al. 2011), due to this 
lack of specificity it was not used as a preferential marked for FDC. 
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Figure 5-7 Identification of markers for sheep follicular dendritic cells 
(A) Representative confocal micrograph of a sheep lymph node (LN). Sections were stained for 
CD54 (red) and CNA.42 (red). CD54 and CNA.42 are both markers for follicular dendritic cells 
(FDC) and they co-localise in the light zone of the follicle in the merge channel. Scale bars 
represent 100 µm. (B) Representative IHC micrographs of sheep LN sections collected from 
uninfected control animals and fixed in formalin.  Sections were stained for CD21 (clone CC21) 
which is expressed both by FDC and B-cells. Scale bars represent 200 µm (left panel) or 50 µm in 
the insets. 
 
In dark zone of the follicle we could identify a further population of stromal 
cells. These cells have been often described in literature, named “dark zone 
FDC” or “dark zone reticular cells”, but their function remain still obscure (Allen 
& Cyster 2008; Lefevre et al. 2007; Yoshida et al. 1993). We found that these 
cells did not express the classical FDC marker CNA.42, but were positive for 
CD83 and S100 (Figure 5-8 and Figure 5-9). CD83 was also expressed on FDC in 
the light zone but at a slightly lower level, and markers for FDC (such as CNA.42) 
and dark zone reticular cells (S100 and CD83) were co-expressed in the transition 
area (Figure 5-8 and Figure 5-9). This may therefore suggest that FDC in the light 
zone are a more specialised type of reticular cells that differentiate from the 
ones in the dark zone. 
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Figure 5-8 CD83 is a marker for dark zone reticular dendritic cells in sheep follicles 
Representative confocal micrographs of a sheep LN. Sections were stained for CD83 (red) and 
CNA.42 (green). CD83 identified dark zone reticular cells present in the follicle. CNA.42 was 
expressed only by FDC in the light zone of the follicle. This allow to identify a dark (DZ) and a light 
zone (LZ) in the follicles. Note the co-expression of the two markers in cells present at the border 
between dark and light zone. 
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Figure 5-9 S100 is a marker for dark zone reticular cells in sheep lymph node 
Representative confocal micrographs of a sheep LN. Sections were stained for CNA.42 (green) 
and S100 (red). S100 identified dark zone reticular cells present in the follicle. CNA.42 was 
expressed only by FDC in the light zone of the follicle. Note the overlap of the two markers on the 
same cells in the transition area between dark and light zone.  
 
Furthermore, just below the SCS, in correspondence with the follicles, we 
identified an additional population of stromal cells expressing both desmin and 
CD83 (Figure 5-10); these double positive cells (desmin+ CD83+) were branching 
from the SCS, in continuity with sinus lining cells, until they reached the follicle 
area where they contacted FDC. Due to their similarities in the anatomical 
localization, and their expression of both FDC and FRC markers, these cells could 
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be identified as MRC recently described in mouse LNs (Katakai et al. 2008; 
Katakai 2012).  
 
Figure 5-10 Characterization of marginal reticular cells in the sheep lymph node 
Representative confocal images of sheep lymph node sections collected from uninfected control 
animals. Sections were stained for desmin (red), CD83 (green) and smooth muscle actin (blue). 
Marginal reticular cells (MRC) were identified as cells double positive for desmin and CD83 
localised between the subcapsular sinus and the follicles (SCS). Desmin was not expressed by 
cells present in the SCS or in the follicles. On the contrary CD83 labelled the cells present inside 
the SCS, MRC and FDC.  
 
Endothelial cells are also part of the stromal cells composing the LNs; both blood 
and lymphatic capillaries are present in the LN. We could identify blood 
endothelial cells expressing high level of Von Willebrand factor (VWF) protein 
(Figure 5-11A) and lymphatic endothelial cells along the SCS, expressing high 
levels of CD83 and low level of VWF (Figure 5-11A). Plasmalemma Vesicle 
Associated Protein (PLVAP) (Figure 5-11B) and junction adhesion molecule-A 
(JAM-A) were also expressed on the endothelial cell lining the sinus wall. In 
particular, PLVAP returned a delicate staining of a capillary network that from 
the SCS deepen in the underlying follicles likely identifying the initial part of the 
conduit system. See Table 5 2 for a summary of the populations characterised. 
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Figure 5-11 Identification of markers for sheep endothelial cells 
(A) Representative confocal microscopy images of sheep lymph node showing the expression of 
Von Willebrand Factor (VWF, green) in the cortical area of the LN. WVF expression identified cells 
lining high endothelial venules and subcapsular sinus. Note co-expression with CD83. (B) 
Representative immunohistochemistry micrographs of sheep lymph node (LN) sections collected 
from uninfected control animals and fixed in formalin. Sections were stained for plasmalemma 
vesicle associate protein (PLVAP) that identified thin cells lining the subcapsular sinus walls and 
branching inside the follicles underneath. 
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Table 5-2 - List of cell populations identified and markers used 
VWF (Von Willebrand Factor), SMA (smooth muscle actin), JAM-A (junction adhesion molecule-A). 
FRC (fibroblastic reticular cells), MRC (marginal reticular cells), FDC (follicular dendritic cells). 
*Inconsistent results. 
Cell type Markers Localization Identification 
Lymphocytes CD3 Largely in the paracortcal 
area, medullary cords and 
some in the follicle 
T-cells 
Lymphocytes CD8 
CD3 
Mainly in the paracortcal 
area and medullary cords 
Cytotoxic T-cells 
Lymphocytes WC1 
CD3 
Mainly in the paracortcal 
area and medullary cords 
γδ T-cells 
Lymphocytes CD79* 
Pax-5 
MHC-II 
Follicles B-cells 
Lymphocytes CD21 
Pax-5 
MHC-II 
CD1 
Follicles Follicular B-cells 
Lymphocytes CD335 Rare Scattered cells Natural Killer 
Antigen 
presenting cells 
MHC-II Expressed at different 
levels in various areas of 
the LN 
Dendritic cells, 
Macrophages, B-
cells, endothelial 
cells 
Antigen 
presenting cells 
CD208 
MHC-II  
Fascinhigh 
CD83 
CD1w* 
CD1 
Paracortex Dendritic cells 
Antigen 
presenting cells 
CD163 
MHC-II 
CD208int 
CD169- 
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Stromal cells CD83 
PLVAP 
JAM-A 
VWFlow 
Lining subcapsular sinus, 
lining trabecular sinuses, 
enveloping sinus traversing 
conduits 
Sinus lining cells 
 
5.2.2 Identification of sheep cells infected by BTV-8 in lymph 
nodes draining the sites of virus inoculation 
5.2.2.1 BTV infection of subcapsular and trabecular sinuses.  
In order to identify which cell populations were targeted by BTV in the LN, we 
used multicolour confocal microscopy and verified co-expression of BTV NS2 with 
specific cells markers. In accordance with the IHC data showed previously, BTV 
was detected in the subcapsular and trabecular sinuses at the early time points 
after infection (Figure 5-12). The sinuses collect the afferent lymph draining the 
peripheral tissues and are delimited by a layer of lymphatic endothelial cells 
(also called sinus lining cells) organised over a base layer of proteoglycan (Girard 
et al. 2012).  
Initially, we defined the borders of the SCS by immunolabeling of perlecan, one 
of the main components of the basal membrane of the endothelium (Figure 
5-13A). Thereafter, we identified in which area of the SCS BTV localised by 
combining NS2 detection with immunolabeling of different cell populations. 
Between 4 and 72 hpi the majority of the BTV NS2 signal localised in endothelial-
like flat cells (characterised as JAM-A+/CD83+/PLVAP+/Von Willebrand Factorlow) 
lining the SCS delimited by perlecan (Figure 5-13B-C). These endothelium-like 
cells (sinus lining cells), often extend their processes across the SCS to enwrap 
intraluminal conduits also called sinus traversing conduits (Rantakari et al. 
2015). These structures constitute the initial part of the intricate conduit system 
branching inside the LN cortex (Figure 5-13C-D) (Roozendaal et al. 2008; 
Rantakari et al. 2015).  
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Figure 5-12 BTV infects the subcapsular area of the sheep lymph node 
Confocal microscopy (stitched image of confocal tiles) of a whole sheep draining lymph node (LN) 
section collected from a BTV-8 infected sheep at 24 hours post-infection (hpi). BTV-infected cells 
are shown in white, while nuclei are stained with DAPI (blue). Note the localization of the virus 
along the subcapsular area. Insets show and area of the subcapsular sinus and of a follicle at 
higher magnification. 
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Figure 5-13 BTV infects sinus lining cells in the subcapsular sinus 
(A) Confocal micrographs of LN sections stained for BTV NS2 (red). Perlecan (green) identifies the 
basal membrane of the subcapsular sinus (SCS). Infected cells reside mainly inside the sinus. 
Arrows indicate transverse section of infected conduits delimited by perlecan. Note that BTV is not 
detected inside the conduits but only in the surrounding cells. (B) Representative confocal images 
of the SCS of sheep LN showing expression of JAM-A (green) and BTV (red) in sinus lining cells 
and along sinus traversing conduits in infected animals (C) Confocal images of LN sections 
showing expression of JAM-A (green in the left image) or BTV NS2 (green in the right image), SMA 
(white) and perlecan (red). BTV infects the cells lining the traversing conduits. (D) Tridimensional 
rendering of confocal stack images highlighting the structure of the a conduit crossing the SCS of 
sheep LN. Section was stained for perlecan (red), JAM-A (green) and DAPI (blue). 
 
 
Intermingled with the reticular fibres of the SCS, few CD163+/CD169- 
macrophages were also infected although these cells did not form a compact 
layer of macrophages in the SCS as described in mouse (Junt et al. 2007). On the 
contrary, the resident population of CD163+/CD169+/MHCII+ phagocytes present 
along the trabecular sinuses were infected by BTV until 48 hpi (Figure 5-14A-B). 
Given the phagocytic capacity of macrophages, to exclude the possibility that 
the positive signal was resulting from the phagocytosis of cellular debris, we 
performed a staining for BTV NS4, which localise in the nucleus of BTV infected 
cells. CD163+/CD169+/MHCII+ macrophages localised along the trabecular sinuses 
were indeed actively infected by BTV as NS4 was detected in the nuclei (Figure 
5-14C). 
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Figure 5-14 BTV infection of macrophages along the trabecular sinuses 
(A) Representative confocal micrographs of the trabecular sinuses of BTV infected sheep lymph 
nodes (LNs).  The images show BTV infection of CD163
+
 macrophages. LN sections were stained 
for BTV NS2 (red) and CD163 (green). (B) Confocal images of the cortical area of an uninfected 
sheep LN showing the localization of CD169
+
 macrophages (red) along trabecular sinuses. LN 
capsule and trabecular structures are stained with SMA (white). On the right, higher magnification 
images show the localization of CD169
+
 macrophages (red) along the trabecules (SMA, white) 
intermingled with JAM-A
+
 endothelial cells (green, arrows). (C) Representative confocal images of 
the trabecular sinuses of BTV infected sheep stained for MHC-II (green) and BTV-NS4 (red) 
showing the nuclear expression of BTV NS4 in trabecular macrophages. 
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5.2.2.2 BTV infects B-cell and get access to the lymph node parenchyma 
BTV infectious particles are too large to freely access the LN parenchyma by 
using the conduit system. Nevertheless, we found infected cells in the follicles 
of the cortical area very rapidly after inoculation (4-8 hpi). At this early time 
points, in some of the follicles we could detect B-cells (identified by the 
expression of the nuclear B-cell-specific activator protein, BSAP) as the only 
infected cells (Figure 5-15A). However, in other follicles we detected BTV in B-
cells as well as in spindle shaped cells (Figure 5-15B), suggesting the existence of 
a temporal sequence in which B-cells could be infected before the spindle cells. 
Approximately 70% of the infected B-cells localised in close contact with the SCS 
or just beneath it (Figure 5-15C), within the half part of the follicle localised in 
proximity of the capsule. On the other hand, less than 30% of the virus infected 
B-cells were localised in the portion facing the paracortex (Figure 5-15D). These 
data strongly indicates that the subcapsular area is the most likely source of 
infection for B-cell. As previously described in the mouse, B-cells can sample 
antigens in the subcapsular area and then carry them during their migration 
towards the centre of the follicle or to the border between the T/B-cells area 
(Cinamon et al. 2008; Phan et al. 2007). 
At 24 hpi, no residual BTV infected B-cells were found in the cortical area. From 
24 hpi onwards, only spindle shaped cells appeared infected in the follicles, 
forming a reticular pattern and remaining BTV-positive until 96 hpi. These 
results suggest that B-cells are likely to be the first cells to carry the virus inside 
the LN parenchyma from the SCS. 
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Figure 5-15  BTV infection follicular B-cells 
(A-B) Confocal image of LN section collected 8 hpi showing two different patterns of BTV infection 
in the follicle. In (A) only B-cells are infected with BTV while in (B) BTV NS2 is detectable both in B-
cells and in spindle shaped cells. Higher magnification image of the SCS area (C) shows infected 
B-cells in close contact with the SCS. Sections were stained for B-cells (BSAP, red) and BTV NS2 
(green). (D) Localization of BTV-8 infected B-cells in the LN follicles at 8 hpi. Follicles were divided 
in two equal parts (dashed line), one facing the SCS and one facing the paracortical area. The 
number of infected B-cells in the two areas was counted in 6 LNs from 3 different animals (**** 
P<0.0001 by Mann-Whitney U-test).  
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5.2.2.3 BTV infects marginal reticular cells and follicular dendritic cells  
The lack of expression of leucocyte markers in many of the infected cells 
suggested that they were probably not of lymphoid origin. Therefore, in order to 
characterise the infected cells that confer a reticular pattern to the infection in 
the follicles, we used three and four colour immunofluorescence and confocal 
microscopy to stain for sheep stromal cells markers and BTV proteins. 
We detected BTV NS2 in correspondence of the stromal cells in the cortex of the 
LN, composing the B-cell area. Infected cells included MRC, dark zone reticular 
cells and FDC (Figure 5-16A-D). All of these cells in sheep are positively stained 
with the CD83 marker, indicating a possible role of this protein during the 
infection. On the contrary, BTV signal was absent in desmin+ cells (FRC) in the 
paracortical area of the LN; interestingly, these cells do not express the CD83 
protein (as show in the previous paragraph). In addition, BTV was not found in 
endothelial cells composing the HEV or in pericytes, therefore it appears that 
the only stromal cells BTV-positive during the early stages of infection carry the 
CD83 marker.  
We hypothesise that the temporal progression of the infection in the LNs initially 
affected the follicles close to the SCS, and then gradually extended to the 
surrounding areas, to finally deepen inside the cortical area. In support of this, 
we initially detected infected stromal cells at 4 hpi and at all the successive 
time points thereafter (until) 96 hpi and we did not detect virus in FRC or HEV or 
pericytes.  
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Figure 5-16 BTV infection of marginal reticular cells and follicular dendritic cells 
Representative confocal photomicrographs of LN sections collected from BTV-8 infected sheep. (A) 
BTV NS2 (red) is expressed in MRC (desmin+, green). (B) Representative confocal images of LN 
sections from BTV-8 infected sheep showing infection of CD83
+
 follicular dendritic cells. Sections 
were stained for BTV NS2 (red), CD83 (green) and SMA (blue). (C) Higher magnification of a 
sheep FDC stained with CD83 (green) infected by BTV (red), DAPI (blue). (D) Tridimensional 
rendering of confocal stack images showing the infection of a FDC. False colour staining CD83 
(red) and BTV-NS2 (green), DAPI (blue). 
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5.2.2.4 T-lymphocytes and dendritic cells are not infected in sheep lymph 
nodes during BTV-8 infection 
Immunofluorescence and immunohistochemistry results showed that the 
localization of BTV infected cells was specific for clearly defined areas, 
suggesting a tropism of BTV for selected cells populations. Indeed, during our 
initial screening, BTV NS2 was rarely found in the paracortex of the lymph node, 
which is an area delimited by FRCs and mainly populated by T-lymphocytes and 
DCs. By using immunofluorescence double labelling, we never found BTV in 
association with CD3+ T-lymphocytes (Figure 5-17A) and only occasionally with 
dendritic cells, defined as CD208+/MHC-II+/Fascinhigh cells with dendritic 
morphology located in the paracortical area of the LN (Figure 5-17B).  
 
Figure 5-17 Cells in the paracortical area are rarely infected 
Representative confocal images of LN sections collected from BTV-8 infected sheep. (A) Sections 
were stained for BTV (green) and CD3 (red). CD3+ T-lymphocytes were not infected by BTV that 
rarely localise in the paracortical area. (B) Sections were stained for BTV (red) and fascin (green). 
Fascin
+
 dendritic cells (DCs) localise in the paracortical area of the LN, DCs are rarely infected by 
BTV. 
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5.2.3 Similar cell tropism of attenuated BTV8H and wild type BTV-
8 in sheep LNs. 
We next tested whether the difference in virulence between wild type and 
attenuated BTV strains can be linked to the tropism of these viruses for specific 
cell types in the LNs of infected animals. The results described in the previous 
chapter show that the attenuated BTV8H infects skin and draining LNs but was 
not detected in blood and peripheral tissues. 
By confocal microscopy, BTV8H was detected in the same LN cell populations as 
BTV-8, including sinus lining cells, sinus macrophages and FDC (Figure 5-18). 
However, in animals infected with BTV8H only minor areas of the draining LN 
were infected. Moreover, the attenuated virus appeared to be cleared from the 
infected LNs earlier than the wild type virus (BTV-8). At 72 hpi only few infected 
cells were detectable in sections of draining LNs collected from sheep infected 
with the attenuated BTV8H (data not shown), whereas BTV-8 was detectable until 
96 hpi. These data indicate that the tropism of the attenuated BTV8H does not 
differ from the virulent strain (BTV-8), at least for the cells targeted in the LN. 
Therefore the attenuated phenotype must be linked to other virus-related 
aspects, such as lower replication efficiency or impaired capacity to escape the 
host immune responses. 
 
 
Figure 5-18 BTV8H present a similar infection pattern in sheep lymph node 
Confocal microscopy (stitched image of confocal tiles) of a whole sheep draining lymph node (LN) 
section collected from a BTV8H infected sheep at 24 hours post-infection (hpi). BTV-infected cells 
are shown in yellow, follicular dendritic cells in green (CNA.42), and dividing cells in purple (Ki67), 
while nuclei are stained with DAPI (blue), Note the localization of the virus along the subcapsular 
area and in the follicles. 
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5.2.4 BTV infects dendritic cells in goats lymph nodes 
BTV infection in goats usually results in an asymptomatic or mild disease (Spreull 
1905; Erasmus 1975; Caporale et al. 2014). Indeed, in the in vivo studies 
associated with this thesis (see Chapter 4), goats experimentally infected with 
BTV-8 presented only a mild increase in body temperature. Observations made 
by IHC highlighted a different localization of BTV in goat compared to sheep LNs, 
with numerous infected cells present in the paracortical area. In infected sheep, 
BTV was localised mainly in the cortical area of the LNs. We used multicolour 
confocal microscopy to identify the infected cells in goat LNs. Interestingly we 
found a similar distribution of the virus in the sinus lining cells, follicular B-cells 
and sinus macrophages. However, numerous MHC-II+/fascin+ interdigitating DCs 
were infected by BTV in the paracortical area (Figure 5-19) of goat LNs. BTV-
infected DCs were initially observed at 48 hpi and were present until 96 hpi. 
These findings highlight a major difference in the LN infection between sheep 
and goat, since at the same time point sheep DC do not appear infected. 
Moreover, infected goat DCs maintained a high expression of MHC-II (Figure 
5-19), contrary to what has been hypothesized for sheep DCs (Hemati et al. 
2009). 
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Figure 5-19 BTV infection of dendritic cells in goat lymph nodes. 
First row. Representative confocal micrographs of lymph node (LN) sections collected from BTV-8 
infected goats at 48 hpi. Images show the infection of dendritic cells localised in the paracortical 
area of the LN and of macrophages along the trabecular sinus. Sections were stained for fascin 
(green) and BTV (red). Bottom row. Representative confocal micrographs of LN sections collected 
from BTV-8 infected goats at 48 hpi. Images show the infection of MHC-II
+
 cells localised in the 
paracortical area of the LN. Sections were stained for MHC-II (green) and BTV (red). 
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5.3  Discussion 
BTV is one of the major infectious diseases affecting ruminants; however little is 
known regarding the progression of infection, the different subsets of cells 
targeted by the virus in the LNs and their role in the distribution of BTV in the 
tissues of the infected animals. 
In this chapter we specifically focused on the LN, which is with the skin one of 
the early sites of virus replication in BTV infected animals. We described the 
early arrival of BTV in the LNs and we systematically and sequentially identified 
the cell populations infected by the virus. In this way we were able to show that 
after its arrival in the subcapsular and trabecular sinuses, BTV infects a variety 
of cells and makes his way into the parenchyma of the LN exploiting B-cells and 
stromal cells interactions.  
Before this study, the general understanding was that BTV replicates mainly in 
endothelial cells and mononuclear phagocytes in the infected host. Our data 
clearly indicates that other cells types, such as MRC and FDC (lymphoid stromal 
cells) are infected by BTV in the LN of experimentally infected sheep and goats.  
Upon arrival in the SCS, BTV infects the lymphatic endothelial cells lining the 
sinus walls, as shown by detection of NS2 in these cells during the initial 48-72 
hpi. At the same time we identified BTV infection in CD163+ and CD169+ 
phagocytes present along the trabecular sinuses of the LN. This finding suggests 
that invasion of the LN by BTV proceeds from the SCS over two parallel fronts: 
(i) by infecting B-cells in the lymphoid follicles and their stromal network where 
it persists up to 4 dpi, and (ii) reaching the trabecular sinuses where the virus 
infects sinus lining cells and macrophages and it is cleared in approximately 48 
hours. 
This work describes for the first time the arrival of an arbovirus in a LN in an 
experimental animal different from the mouse, therefore some anatomical 
differences should be taken into account. In mouse models, lymph borne viruses 
are uptaken by a layer of CD169+ macrophages localised along the SCS 
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(Iannacone et al. 2010; Gray & Cyster 2012; Junt et al. 2007), whereas in sheep 
we failed to identify an homologous population of phagocytes in the same area. 
CD169+ macrophages are populating sheep trabecular sinuses, which in ruminants 
are also more prominent than in mouse. Many key functions have been 
attributed to SCS macrophages, including filtration of lymph borne pathogens to 
prevent their systemic distribution (Iannacone et al. 2010; Winkelmann et al. 
2014) and capture and presentation of antigens for B-cells activation (Carrasco & 
Batista 2007; Phan et al. 2007; Junt et al. 2007). The disruption of SCS 
macrophages has been associated with immunosuppression following infection 
and inflammation (Gaya et al. 2015; Phan et al. 2009). However, although few 
CD163+ macrophages were detected inside the SCS, the different localization of 
CD169+ macrophages in sheep raises questions about their function in different 
animal species. In sheep, CD169+ macrophages are localised so far away from the 
follicles that their role for B-cell activation could be questioned.  
The SCS forms a barrier that prevents the unrestricted passage of lymph borne 
antigens across the cortical area. Hence, it is interesting to note how, after the 
infection of the SCS, BTV reaches the FDC that are safely located at the centre 
of the follicle, indeed FDC have the capacity to present unprocessed antigens on 
their surface, and this would make them an easy target for immune activated 
cells. Two mechanisms have been described until now that can account for 
antigen transport to FDC: (a) small antigens <70kDa (5nm) get free access to a 
system of conduits that open in the SCS and branches in both the T- and B-cell 
areas (Roozendaal et al. 2009; Gretz et al. 1996; Rantakari et al. 2015), while 
(b) larger antigens are sampled by follicular B-cells from the SCS and shuttled to 
FDC. Both systems rely on the presence of prior immunity, since only opsonised 
antigens can be effectively picked up by FDC (Junt et al. 2007; Aguzzi et al. 
2014). Our confocal imaging data show that BTV rapidly co-localises with B-cells 
and FDC in naïve animals, without requirement of pre-existent antibodies or 
cognate B-cells. Hence a different mechanism of interaction must be involved, 
such as the presence of pre-existing natural antibodies recognising the virus, a 
complement-related opsonisation, or a direct receptor-virus interaction. BTV 
infectious particles are too large (74 nm) (Prasad et al. 1992) to directly access 
the conduits. However we identified numerous infected cells (sinus lining and 
MRC) forming the walls of the conduits leading to the follicles. It is therefore 
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possible that the virus spreads also by contiguity along these cells until reaching 
the FDC. Alternatively, motile infected B-cells could contribute to the virus 
spread by carrying it towards the centre of the follicles during their migrations 
and scanning for antigens, as this is supported by the finding that BTV-8 infected 
B-cells were identified underneath the SCS before FDC infection occurred.  
This is the first report of BTV infection of B-cells since previously the virus was 
identified in vivo only in endothelial cells and mononuclear phagocytes; their 
contribution, emphasized by our results, could be key in favouring virus spread 
in the LN. Interestingly, infected B-cells were observed only during the initial 24 
hpi, suggesting that after this point they lose susceptibility to infection. Previous 
in vitro experiments failed to infect bovine B-cells with BTV (Barratt-Boyes et al. 
1992) but studies of ovine B-cells have not been carried out. It is possible that a 
particular activation stage could be implicated in B-cells susceptibility to 
infection observed in vivo, similarly to what has been described for T-
lymphocytes (Barratt-Boyes et al. 1992). The destruction of the FDC network, 
and the resulting shut down of the germinal centre, could be implicated in 
altering the B-cells phenotype and their maturation stage. Indeed we observed a 
visible decrease in the number of CD21 expressing cells (mature B-cells) in the 
marginal zone of the follicles in the infected lymph node at late time points (72-
120 hpi). It would be therefore interesting to explore further this aspect of 
infection and its possible implication in the pathogenesis of disease. 
Our data also indicate that BTV infects the stromal cells located in the B-cell 
area of the LN. These cells contribute to the formation of the germinal centres 
by providing a supporting scaffolding, driving B-cells homing (through production 
of CXCL13) and activation, by secreting factor such as BAFF (B-cells activating 
factor) and IL-6. MRC have been recently identified as precursors of LN FDC in 
mouse (Jarjour et al. 2014), hence it is possible that the damage produced by  
BTV (namely a cytopathic virus) to FDC and their precursor could negatively 
affect the germinal centres function, at least temporarily, inducing a certain 
degree of immunosuppression.  
Moreover, we labelled (i) sinus lining cells, (ii) MRC and (iii) FDC with the same 
marker (CD83), and all these populations are targeted by BTV infection, whereas 
stromal cells of the T-cell area that do not express CD83, or pericytes 
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surrounding the HEV did not show markers of BTV replication. Interestingly the 
expression of CD83 changed upon infection. CD83 accomplishes numerous 
regulatory functions in the immune system and is implicated in B- and T-cell 
maturation and activation (Breloer & Fleischer 2008). The down regulation of 
CD83 on DCs has been described during herpes virus infections such as the one 
caused by varicella zoster virus (Morrow et al. 2003), human cytomegalovirus 
(Senechal 2004) and herpes simplex virus type 1 (Kummer et al. 2007). This 
process resulted in inhibition of T-cell proliferation and thus in a reduced 
immune response of the host (Kruse et al. 2000). Whether CD83 down regulation 
in specific subset of infected cells could have a major impact in the 
pathogenesis of BT remains still to be determined. 
Migratory DCs, present in the lymph draining the BTV inoculation site, have been 
described to be infected in sheep (Hemati et al. 2009). However, in our 
experimental model, we were unable to detect infected DCs in sheep LN. On the 
contrary, confocal imaging data, indicated the presence of numerous DCs 
infected with BTV in goat LNs, demonstrating that the lack of detection was not 
due to a technical problem or marker downregulation. In goats, these cells did 
not localise in direct contact with the subcapsular or the follicular area, hence it 
is not clear how they get infected. In mouse, different types of DCs 
subpopulations have been described (Henri et al. 2001; Guilliams et al. 2010), 
but a similar detailed classification is not available for ruminants DCs. In the 
mouse LN, the paracortical area is populated by a resident population of DCs 
sampling antigens arriving inside the conduit system, as well as by various 
populations of migratory DCs that transport antigens collected from the 
peripheral tissues (such as the skin). Hence, there are at least two different 
ways in which DCs could have been infected by BTV in goats. A different effect 
of BTV on sheep and goat DCs could be responsible for different pattern of 
infection. For example, sheep migratory DCs could lose the ability to reach the 
paracortical area of the LN due to a down regulation of CCR7 receptor upon 
infection or due to a lack of homing signals produced in the LN. Alternatively, 
BTV could induce a more severe and rapid apoptosis of sheep DCs during their 
migration in the lymph, before when they reach the LN. 
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In addition to the data discussed above, in this chapter we have characterised 
previously unknown markers for the identification of different populations of 
sheep lymphoid stromal cells (FRC, MRC, dark zone reticular cells and sinus 
lining cells), and different subsets of macrophages and DCs. It was ot possible to 
use more conventional markers for sheep DCs in this work (such as CD1 and 
CD11c) as we could use, for practical reasons, only fixed tissues. However, the 
identification of new DCs and macrophage markers, capable to be employed on 
formalin fixed tissues, will be extremely useful in many diagnostic and research 
setting. The markers identified could open the door to new functional studies on 
APCs of ruminants and the host response to pathogens. 
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6 Characterisation of the humoral immune 
response against BTV  
6.1 Introduction 
The current knowledge of the host immune response following initial BTV 
infection is limited. As is the case with most viral infections, ruminants infected 
with BTV develop a variety of antiviral immune responses; these include innate 
and BTV-specific adaptive responses. Although both humoral and cell-mediated 
immunity contribute to control viral infections, passive transfer studies have 
demonstrated that antibodies, unlike cytotoxic T-cells (Jeggo, Wardley & 
Brownlie 1984), can confer full protection to BTV and prevent viremia in newly 
infected sheep (Jeggo, Wardley & Taylor 1984). BTV infection results in the 
prompt production of antibodies to both structural and non-structural viral 
proteins. BTV-specific neutralising antibodies can confer long-lasting resistance 
to reinfection with the homologous BTV serotype, which form the basis of 
vaccination strategies to prevent BT disease (MacLachlan et al. 2014). 
Neutralising epitopes for BTV are localised on the outer capsid proteins VP2 and 
possibly VP5, which are the main determinants of the BTV serotype (Mertens et 
al. 1989; DeMaula et al. 2000; Shaw et al. 2013; Roy et al. 1990). On the 
contrary, complement fixation function is generally attributed to the VP7 
protein, which is well conserved across different serotypes (Huismans & Erasmus 
1981), and is able to provide a partial cross-serotype protection (Wade-Evans et 
al. 1996; Stewart et al. 2012). 
During BTV experimental infections, we and others have observed that a rapid 
onset of the antibody response in the ruminant host generally correlates with a 
more favourable clinical outcome (Caporale et al. 2014; Pages et al. 2014; 
Ratinier et al. 2016). Similar observations have been made for other arboviral 
infections including those caused by West Nile virus (Diamond et al. 2003), 
Japanese encephalitis virus (Burke et al. 1985; Libraty et al. 2002) and Crimean-
Congo haemorrhagic fever virus (Shepherd et al. 1989), however the underlining 
mechanism accounting for the delayed onset of antibodies is still unknown. 
Hence, we hypothesize that the early events of arbovirus infection can influence 
the development of humoral immunity and play a key role in disease 
pathogenesis and its clinical outcome.   
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In the previous chapter, we have shown that in sheep and goats a large 
proportion of BTV infected cells is localised in the cortical area of the draining 
LNs, just few hours after experimental BTV inoculation into the skin. The 
cortical area of the LN is where most of the B-cells reside, organised in clusters 
denominated B-cells follicles. Our results indicate that BTV specifically infects 
FDC in the follicles until 96 hpi. Follicular dendritic cells are specialised stromal 
cells critical for the formation of the follicles, since they can attract B-cells and 
retain antigens in the form of immune complexes for long period of times for 
presentation to B-cells. Antigen presentation leads to the activation of B-cells 
and the initiation of the GC reaction (De Silva & Klein 2015). After contacting 
the antigen, B-cells undergo a proliferative burst in the dark zone of the GC. 
Proliferating B-cells, called centroblasts, mutate their B-cells receptors (BCR) to 
increase their affinity for the antigen through point mutations in the 
immunoglobulin V region gene; this process is called somatic hypermutation. GCs 
are also the site of class switch recombination, in which the immunoglobulin H 
constant region is replaced to generate a different antibody isotype. Then, 
through a stringent selective process, B-cells carrying advantageous mutations 
are selected to differentiate into antibody producing plasma cells or long-lived 
memory cells, both of which eventually leave the LN and accumulate in the bone 
marrow (Vinuesa et al. 2010). This process of affinity maturation drives the 
production of antibodies with increased affinity for a cognate antigen, 
ultimately improving the efficiency of the humoral immune response.  
In this chapter we aimed to investigate the consequences of BTV infection on 
lymphoid follicles structure, cellular composition and functions. We observed a 
rapid depletion of FDC associated with the loss of organization of the B-cell 
follicles and a simultaneous shut down of centroblast division. We hypothesised 
that this could interfere with the development of a successful antibody response 
therefore we characterised the antibody response to BTV using virulent and 
attenuated strains. Our data indicate that the magnitude of the cytopathic insult 
induced by BTV on the germinal centres (GCs) varies with the virulence of the 
strain employed and that this in turn impairs the humoral immune response 
against the virus. Furthermore, the damage produced by BTV to the GCs results 
in a compromised capacity of B-cells to respond to subsequent antigenic 
challenges during a defined period of time. 
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6.2 Results 
6.2.1 BTV disrupts the follicular dendritic cell network 
We have shown in the previous chapter that BTV-8 infects FDC ad MRC. Given 
the central role of FDC in the formation of the GC we investigated the 
consequences of the infection of these cells by BTV. By using different markers 
for FDC in sheep LN sections, we observed that the reticular network of cells 
present in the follicles of infected sheep assumed an increasingly time-
dependent disrupted appearance both in the light (Figure 6-1A) and in the dark 
zone (Figure 6-1B). By 72 hpi the presence of FDC was visibly reduced across the 
whole LN. As expected, FDC staining in mock-infected controls at the 
corresponding time-points showed FDC in most of their LN follicles (Figure 6-1A-
B). 
In order to assess if the lack of FDC could be attributed to the virus cytopathic 
effect, we assessed the presence of activated caspase 3 as a marker of 
apoptosis. The immunohistochemical staining of infected sheep LNs revealed the 
presence of numerous apoptotic cells localised in the subcapsular and trabecular 
sinuses and inside the follicles between 8 and 24 hpi (Figure 6-2). On the 
contrary, activated caspase 3 was only minimally expressed in LNs of sheep 
infected with UV inactivated BTV8 or in mock-infected controls (Figure 6-2). 
These data suggest that apoptosis in the LNs of BTV-8 infected sheep is the 
consequence of virus replication (Figure 6-2) and could contribute to the 
observed FDC depletion. 
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Figure 6-1 BTV induces the disruption of follicular dendritic cells in the light and in the dark 
zone of the follicles 
(A) Confocal images of LN sections from BTV-8 infected sheep, at the indicated time post-infection 
(h), showing the progressive disruption of the CD83
+
 reticular cell network normally present in 
uninfected follicles. Sections are stained for BTV NS2 (red) and CD83 (green). Dashed lines help 
to identify follicles. (*) Indicate the cortical area were HEVs contain autofluorescent red blood cells. 
Scale bars represent 300µm. (B) Confocal tile scan images of LN sections collected from BTV8 
infected sheep showing the presence of FDC in the cortical area at different time points after 
infection. Sections were stained for BTV NS2 (red), CNA.42 (FDC, green) and DAPI (blue). Arrows 
indicate recognisable follicles. Scale bars represent 1mm. 
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Figure 6-2 Induction of apoptosis in the cortical area of BTV8 infected lymph nodes.  
Representative micrographs of immunohistochemical detection of activated caspase-3 (brown) at 
24 hours post infection in lymph node sections from sheep infected with BTV-8, UV-inactivated 
BTV8 or mock-infected controls. Micrographs representative of different areas are shown. Scale 
bars represent 50 µm. 
 
6.2.2 BTV infection hampers centroblasts division 
These results indicate that FDC in the LNs of infected sheep are destroyed by 
BTV-8 rapidly after intradermal inoculation. Considering that FDC are necessary 
for the recruitment of B-cells into follicles and the development of GCs (Wang et 
al. 2011) we proceeded to investigate if the disruption of the FDCs was 
associated to detectable changes in the organization of the GCs (Victora & 
Nussenzweig 2012).  
Initially we assessed the localization of B-cells in the cortical area of the LN, 
where the follicles are located. Despite the relative lack of FDC in BTV-infected 
draining LNs, we were still able to identify B-cells clustering into follicular 
structures, throughout the duration of the experiment (4h to 7 dpi). However, 
follicles of BTV-8 infected animals presented a less compact structure, with 
numerous scattered B-cells, compared to mock-infected controls (Figure 6-3). 
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Figure 6-3 Follicular dendritic cells infection alters B-cell localization  
Representative immunohistochemistry micrographs of LN sections collected from uninfected 
controls and BTV-infected sheep at 1 and 3 dpi. Higher magnification micrographs of individual 
follicles are shown in the bottom row. B-cells are stained with BSAP (brown). Scale bars represent 
200 µm (top row) or 100 µm (bottom row).  
 
 
 
Figure 6-4 Shut down of centroblasts division is accompanied by rarefaction of B-cells 
Representative immunohistochemistry micrographs of LN sections collected from uninfected 
controls and BTV-infected sheep at 1 and 5 dpi. Sequential sections were stained BSAP (B-cell), 
CD21 (B-cells and FDC) and Ki67
+
 (dividing cells). Higher magnification micrographs of individual 
follicles are shown on the right column for each group. 
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Secondly, we determined the existence of active GCs by assessing the presence 
of centroblasts (active B-cell) in the dark zone of the follicles, identified by the 
expression of the proliferation marker Ki67+. It is important to consider that 
sheep included in these studies were sourced from local farms and were 
therefore exposed to natural environmental factors; hence we could detect the 
presence of numerous GCs in their LNs. 
Notably, we observed a shutdown of the division of B-cells in the follicles of 
draining LN collected from BTV-8 infected animals already at 4-8 hpi, the lack of 
Ki67+ follicles was accompanied by the rarefaction of B-cells and the down 
expression of the CD21 marker (Figure 6-4). This phenotype was maintained at 
later time points in infected sheep, while in mock infected animals it was 
possible to identify numerous GCs with dividing B-cells throughout the duration 
of the experiment (Figure 6-4). At 4 hpi in experimentally infected sheep, 
follicles localised near the SCS presented virus infected FDC and displayed few 
dividing B-cells (Figure 6-5A-i and ii). On the contrary, at the same time point, 
follicles localised deeper in the cortex and not in direct contact with the SCS, 
did not show positive staining for the virus and preserved a normal structure, 
with FDC in the light zone and centroblasts in division in the dark zone (Figure 
6-5A-iii).  
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Figure 6-5 BTV infection of the follicles halts centroblasts division  
(A) Representative confocal images of LN sections collected from BTV infected sheep at 4 hpi 
showing the progression of virus replication in the cortical area. BTV NS2 (red), CNA.42 (green) 
and Ki67 (purple) staining are shown. Nuclei are stained with DAPI (blue). Note the presence of (i) 
an infected follicle with few Ki67
+
 cells (inset and higher magnification), (ii) a partially infected 
follicle showing disruption of the FDC network and (iii) an uninfected follicle. Scale bars represent 
200µm. (B) Representative confocal micrographs of LN sections collected from BTV-infected sheep 
at different time points after infection showing the arrest of centroblast division in infected follicles 
up to 3 dpi. Sections were stained for BTV NS2 (white), CNA.42 (green) and Ki67 (red). Nuclei are 
stained with DAPI (blue). Scale bars represent 100µm.  
 
In order to determine whether there was a correlation between virus infection 
and block of B-cells division, we assessed the presence of Ki67+ B-cells in 
infected and uninfected follicles (Figure 6-5B). This was quantified using 
sequential sections of LNs taken from infected animals, considering that in the 
same LN section we observed both BTV infected and uninfected areas, due to 
the progression of the infection. The percentage of BTV-8 infected follicles 
containing clusters of dividing B-cells was 50% at 4 hpi, this percentage 
decreased rapidly to 12.5% at 8 hpi and settled to 4-8% between 1 and 3 dpi. On 
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the contrary, in follicles where BTV-8 was not detectable, we observed that on 
average 48.6% of follicles contained clusters of dividing B-cells up to 48 hpi that 
decreased to 41.9% at 72 hpi (Figure 6-6). At later time points, as the virus 
began to be cleared from the LN, very few follicles presented BTV infected cells 
and therefore we could not carry out an accurate comparison between infected 
and uninfected follicles.  
 
Figure 6-6 Shut down of germinal centres in sheep lymph node is associated with the 
presence of BTV 
Graph showing the percentage of BTV-infected follicles containing dividing B-cells (Ki67
+
) in 
comparison to uninfected follicles within the same section in sheep lymph node. Sequential LN 
sections were stained for B-cells, BTV NS2 and Ki67. The total number of follicles per section was 
quantified (range = 44 to 254 follicles/section) in a minimum of 3 draining LN per each time point. 
Histograms represent mean ±SD (** P<0.01, *** P<0.001, **** P<0.0001, Two-Way ANOVA). 
 
We then compared the pattern observed in sheep with the one displayed by 
goats draining LNs. Similarly the presence of detectable BTV in the follicles was 
accompanied by a decrease in B-cell division (Figure 6-7). However, the 
shutdown of centroblasts appeared delayed in goats compared to sheep. Indeed 
at 8 hpi the percentage of infected follicles was 54.3% (not far from the 
percentage detected in uninfected follicles, 60.25%) and then slightly decreased 
to an average of 34.8% at 24 hpi. At 48 hpi no infected follicles were observed 
(percentage equal to zero) and this level was maintained at least until 96 hpi 
(Figure 6-7). It is of note that in goat LNs, BTV was still detectable at significant 
levels at 96 hpi infecting FDC in the follicles, while at this stage most of the 
virus was cleared in sheep. Interestingly, the percentage of uninfected follicles 
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presenting centroblasts in goat also underwent a decline going from an average 
of 60.25% at 8 hpi to 33.2% at 72 hpi (Figure 6).  
 
 
Figure 6-7 BTV induces the shutdown of germinal centres in goat lymph nodes 
Graph showing the percentage of BTV-infected follicles containing dividing B-cells (Ki67
+
) in 
comparison to uninfected follicles within the same section in goat lymph nodes. Sequential LN 
sections were stained for B-cells, BTV NS2 and Ki67. The total number of follicles per section was 
quantified (range = 48 to 329 follicles/section) in a minimum of 3 draining LN per each time point. 
Histograms represent mean ±SD. (* P≤0.05, ** P<0.01, Two-Way ANOVA). 
  
 
6.2.3 Division of B-cells in germinal centres resumes more rapidly 
in sheep infected with an attenuated BTV-8 strain (BTV8H)  
The data presented above suggest that BTV-8 infection and disruption of FDC 
induce shutdown of B-cell division in pre-existing GCs both in sheep and in goats. 
Hence, we used an attenuated strain of BTV-8 (BTV8H) (Janowicz et al. 2015) in 
order to assess if virus-induced block of B-cell division was correlated to BTV 
virulence. As described in the previous chapters, BTV8H replicates in the skin and 
draining LNs (near the inoculation sites) of the infected sheep but does not 
induce viremia nor does disseminates to peripheral tissues. To assess the effect 
of attenuation on B-cell proliferation, we infected sheep with either BTV8H, 
BTV-8 or control tissue culture media and compared the proportion of 
proliferating GCs (identified by clusters of Ki67+ B-cells) relative to the number 
of primary follicles. Clusters of B-cells and Ki67+ cells were quantified by 
microscopy in sequential LN sections collected at different times post-infection 
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(Figure 6-8). In LN collected at 3 and 4 dpi between 10 and 24% of follicles (on 
average) contained clusters of Ki67+ B cells in sheep infected with either wild 
type or attenuated BTV8H. In LN from mock-infected sheep however, Ki67
+ GCs 
represented the 68% of the total number of follicles throughout the duration of 
the experiment (Figure 6-8B). Interestingly, at 7 dpi the proportion of GCs 
returned to the values of mock-infected controls in animals infected with BTV8H 
but not in those infected with wild type BTV-8 (Figure 6-8). Hence, the extent of 
the cellular damage induced by BTV8H is reduced compared to wild type BTV-8, 
apparently resulting in an earlier recovery of B cells division in animals infected 
with the attenuated virus. 
In addition, in order to identify a link between the recovery of the GCs structure 
and the severity of disease (similarly to what was observed in BTV8H infected 
sheep), we screened the presence of Ki67+ GCs in draining LNs in goats infected 
with the virulent BTV-8 and in sheep infected with the BTV8IT2008 strain (at 7 dpi 
only). No GCs recovery was detected in these animals, and only a low 
percentage of Ki67+ GCs was identified in the draining LNs of both groups up to 7 
dpi (the end of the experiment), similarly to what was observed in BTV-8 
infected sheep (Figure 6-8B). 
 
  
Chapter 6  172 
 
Figure 6-8 Sheep infected with BTV8H display early recovery of germinal centers (GCs) 
compared to sheep and goat infected with BTV8, and sheep infected with BTV8ita  
(A) Representative immunohistochemistry micrographs of lymph node sections taken from mock 
infected control sheep, sheep infected with BTV8 and sheep infected with the attenuated BTV8H at 
7 days post-infection. Sequential sections were stained for B-cells (BSAP) and Ki67. Few GCs are 
visible in draining LNs collected from sheep infected with BTV8. (B) Graph showing the percentage 
of follicles displaying clusters of Ki67
+
 cells in draining lymph nodes (LNs) of mock infected sheep, 
sheep infected with BTV8, sheep infected with BTV8H, and goats infected with BTV8 at 3, 4 and 7 
days post-infection (dpi). Sheep infected with BTV8ita were only tested at 7 dpi. The number of 
follicles and Ki67 clusters were quantified in sequential sections stained either for BSAP (B-cells) or 
Ki67 as in panel A. The total number of follicles per section was quantified (range = 44 to 254 
follicles/section) in a minimum of 3 draining LN per each time point. (* P≤0.05; ** P≤0.01; *** 
P≤0.001 by one-way ANOVA). Bars represent the average values. 
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6.2.4 Antibody response differs in sheep infected with wild type 
or attenuated BTV-8.  
Our data indicated that BTV led to the suppression of GCs, which are the site of 
affinity-based selection that generates high affinity antibodies and memory B-
cells (Victora & Nussenzweig 2012). Therefore, we hypothesized that BTV could 
also affect the initiation of the host humoral immune response. In order to 
address our hypothesis, we characterized the antibody responses over 21 days in 
sheep infected with either BTV-8 (n=3) or BTV8H (n=5) (Figure 6-9).  
BTV-8 infected sheep showed a raise in body temperature (40-41°C) between 5 
and 7 dpi (Figure 6-9A). Animals infected with BTV-8 developed a prolonged 
viremia and, as seen in previous experiments (Chapter 4), the viremia peaked 
between 5 and 8 dpi, reaching approximately levels of 106 virus-copies/μg RNA, 
and then settling at 105 copies throughout the course of the experiment, until 
day 28 (Figure 6-9B). Interestingly, one sheep included in this group did not show 
increase in body temperature (39.3°C), and was also the only animal that 
presented a delayed peak of viremia (at 7 dpi instead of 5 dpi). On the contrary, 
and as in previous experimental infections (Chapter 3) (Janowicz et al. 2015), 
BTV8H did not induce fever or viremia in any of the infected sheep (Figure 6-9A-
B).  
To evaluate the kinetic of the humoral immune response towards both wild-type 
and attenuated strains we assessed the BTV VP7 specific IgG and IgM as well as 
virus neutralising antibodies. VP7 is a major BTV core protein that is well 
conserved across different serotypes, and therefore widely used for diagnostic 
purposes. No significant differences were observed in the levels of IgM between 
the two groups of infected animals at any of the time point analysed (7, 14, 21 
and 28 dpi) (Figure 6-9C). However, at 7 dpi BTV8H infected sheep produced 
significantly higher titres of both anti-BTV VP7 IgG and virus neutralizing 
antibodies compared to BTV-8 infected sheep (P≤0.05 in both cases) (Figure 
6-9D-E). These differences were transitory since by 14 dpi the two groups of 
experimentally infected sheep showed similar levels of both anti-VP7 IgG and 
anti-BTV-8 neutralizing antibodies (Figure 6-9D-E). In both BTV-8 and BTV8H 
infected sheep, antibody (IgG) avidity increased over time. However, BTV8H 
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infected animals consistently showed IgG of higher avidity towards VP7 at 7, 14 
and 21 dpi (P≤0.05) compared to BTV-8 infected sheep (Figure 6-9F). 
 
 
Figure 6-9 Sheep infected with attenuated BTV8H present an earlier onset of BTV specific 
IgG, neutralising antibodies and higher IgG avidity. 
Sheep were infected with BTV8 (n=3) or attenuated BTV8H (n=5) and monitored for 28 days. (A) 
Graph showing rectal temperature (average ±SD) in sheep infected with either BTV8 or BTV8H. 
Note that sheep infected with BTV8H do not present an increase in body temperature (B) Graph 
showing BTV RNA (average ±SD) in blood samples of experimentally infected sheep. Viral RNA 
was detected by qRT-PCR, and values are expressed as Log10 copy number per g of total RNA. 
Note that sheep infected with BTV8H do not present viremia. (C) Graph showing BTV VP7 IgM titre 
in the serum of sheep infected with either BTV8 or BTV8H. Serum was collected and tested by 
ELISA as described in Materials and Methods (D) Graph showing BTV VP7 IgG titre assessed by 
ELISA in sheep infected with either BTV8 or BTV8H. Note that BTV8H infected sheep present 
higher levels of IgG at 7 dpi. (E) Graph showing BTV8 neutralization titres assessed by 
microneutralization assay in serum of sheep infected with either BTV8 or BTV8H. Values represent 
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average ±SD and are expressed as Log10 of the 50% protective dose (PD50). BTV8H infected 
sheep present higher neutralization titre at 7 dpi. (F) Graph showing BTV VP7 IgG avidity in sheep 
infected with either BTV8 or BTV8H. Results are expressed as avidity index (AI), average ±SD. 
Note that antibody in BTV8H infected animals present constantly a higher avidity.  (*) = P≤0.05 by 
Mann-Whitney U-test. 
 
6.2.5 Antibody response of sheep infected with an Italian strain of 
BTV-8 (BTV8IT2008) 
We then questioned if a similar difference in neutralization and antibody avidity 
could be detected using a BTV strain that generally induces a mild clinical 
presentation in naturally infected animals, as observed in Italy in 2008 (Caporale 
et al. 2014). Therefore we infected intradermally 3 sheep as previously 
described with 6x102 PFU of BTV8IT2008. The animals were monitored for 28 days, 
the body temperature recorded, and blood and serum samples collected daily 
until day 14 and subsequently at day 21 and 28. The body temperature of 
BTV8IT2008 infected sheep did not present major differences compared to those 
observed in BTV-8 infected animals, with an increase between 5 and 8 dpi 
(Figure 6-10A). In BTV8IT2008 infected sheep, viremia started to increase 
exponentially at 3 dpi, reached a peak at 7 dpi (106 copies/μg RNA) and then 
plateaued at 105 copies/μg RNA from 10 until 28 dpi, when the experiment was 
terminated (Figure 6-10B), following a trend similar to what we observed in 
sheep infected with virulent BTV-8. No significant differences were detected in 
the two groups of infected animals (BTV8IT2008 and BTV-8) regarding the titres of 
BTV specific IgM, IgG, neutralizing antibodies and avidity levels (Figure 6-10C-F). 
Overall these results did not highlight any major differences in the clinical 
presentation and in the humoral response generated by BTV-8 and BTV8IT2008 in 
experimentally infected sheep. 
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Figure 6-10 Sheep infected with attenuated BTV8ita and BTV8 present similar clinical 
presentation and antibody response in experimentally infected animals. 
Sheep were infected with BTV8ita (n=3), a low virulence strain isolated in Italy, and monitored for 28 
days. Results obtained in BTV8 infected sheep are reported for comparative purpose.  
(A) Graph showing rectal temperature (average ±SD) in sheep infected with either BTV8ita or BTV8. 
(B) Graph showing BTV RNA (average ±SD) in blood samples of experimentally infected sheep. 
(C) Graph showing BTV VP7 IgM titre in the serum of sheep infected with either BTV8ita or BTV8. 
Serum was collected and tested by ELISA as described in Material and Methods (D) Graph 
showing BTV VP7 IgG titre assessed by ELISA in sheep infected with either BTV8ita or BTV8. (E) 
Graph showing BTV8 neutralization titres assessed by microneutralization assay in serum of sheep 
infected with either BTV8ita or BTV8. Values represent average ±SD and are expressed as Log10 of 
the 50% protective dose (PD50). (F) Graph showing BTV VP7 IgG avidity in sheep infected with 
either BTV8ita or BTV8. Results are expressed as avidity index (AI), average ±SD. 
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6.2.6 Antibody response of sheep infected with blood from a BTV-
8 infected animal. 
In a previous study, it has been showed that inoculation of infectious blood can 
induce more severe clinical signs compared to infection with a purified virus 
isolate (Caporale et al. 2014). In order to understand if an alteration of the B-
cell responses and antibody production could be associated with the level of 
disease severity, we investigated the antibody response of 5 sheep 
experimentally infected with 5 ml of BTV-8 infectious blood (BTV8blood). Serum 
was available from a previous experiment in which BTV8blood infected animals 
presented a higher level of viremia, sustained high body temperature and a 
worse clinical symptoms compared to animal infected with the BTV-8 isolated 
from blood and minimally passaged in cell culture (Caporale et al. 2014). Data 
regarding viremia and body temperature of these animals has been described in 
a previous study (Caporale et al. 2014). Interestingly, in these animals, we could 
demonstrate a complete lack of VP7 IgM response until 7 dpi (Figure 6-11A), as 
well as a slight delay in the reaching of the IgM peak (10-14 dpi), which however 
was 7 times the titre obtained in sheep infected with cell culture isolated 
strain (1344.25 in blood infected animals compared to 182.94 IgM units in animal 
infected with isolated virus, P≤0.0001 at 10 and 12 dpi and P≤0.01 at 14 dpi) 
(Figure 6-11A). This delayed and more elevated peak of IgM was associated with 
a delay in production of IgG that were first detectable at 14 dpi (Figure 6-11B), 
instead of the usual 7 dpi. The onset of neutralising antibodies was also delayed 
in sheep infected with BTV8blood as they were first detected at 10 dpi and in 
some animals not before 14 dpi (Figure 6-11C, P≤0.01 at 8 dpi and P≤0.001 at 10 
dpi). Compared to animals infected with BTV-8, no significant differences were 
found in the IgG avidity index at day 14, once the IgG started to be produced 
(Figure 6-11D). 
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Figure 6-11 Sheep infected with BTV-8 infectious blood present a delayed onset of BTV 
specific immunoglobulin and neutralizing antibodies. 
Serum of sheep intradermally infected with BTV8 infectious blood (BTV8blood n=5) was sourced 
from a previous experiment. Sheep infected with BTV8blood presented a worse clinical presentation 
and higher viremia compared to sheep infected with cell culture isolated BTV-8 strains. Results 
obtained in BTV8 infected sheep are reported for comparative purpose. (A) Graph showing BTV 
VP7 IgM titre in the serum of sheep infected with either BTV8blood or BTV8. Serum was collected 
and tested by ELISA as described in Material and Methods. Note that BTV8blood infected animals 
present a delayed onset of IgM followed by an higher peak at 12 dpi. (B) Graph showing BTV VP7 
IgG titre assessed by ELISA in sheep infected with either BTV8blood or BTV8. Note the delay in IgG 
onset in BTV8blood infected animals. (C) Graph showing BTV8 neutralization titres assessed by 
microneutralization assay in serum of sheep infected with either BTV8ita or BTV8. Values represent 
average ±SD and are expressed as Log10 of the 50% protective dose (PD50). Note the delayed 
onset of neutralising antibodies in BTV8blood infected sheep. (D) Graph showing BTV VP7 IgG 
avidity in sheep infected with either BTV8ita or BTV8. Results are expressed as avidity index (AI), 
average ±SD. (*) = P≤0.05, (**) = P≤0.01, (***) = P≤0.001, (****) = P≤0.0001 by Mann-Whitney U-
test. 
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6.2.7 Antibody response of goat infected with BTV-8 
Next, we infected we infected 3 goats with BTV-8 (2x106 PFU) intradermally, in 
order to ascertain if any differences in the antibody response against BTV were 
present in a species that generally do not show severe clinical signs of 
bluetongue. Only one of 3 infected goats presented a mild increase in body 
temperature between 9 and 12 dpi (reaching 40°C at 10 and 11 dpi) (Figure 
6-12A). As in previous experiments (Chapter 4), the onset of viremia in goats was 
delayed compared to BTV-8 infected sheep (P≤0.001 at 4 and 5 dpi). BTV was 
firstly detected in the blood of infected goats at 5 dpi and peaked on average 
between 7-10 dpi, however the virus titre in goat blood remained at a 
significantly lower levels compared to sheep (104 in goats versus 106 copies/g 
RNA in sheep, P≤0.01 at 6 dpi) (Figure 6-12B). Interestingly, the goat with 
increased temperature also presented a delayed peak of viremia (at 12-13 dpi 
instead of 7-9 dpi). Serum IgM in infected goats started to appear at 3 dpi, 
peaked between 7 and 12 dpi and then gradually decreased (Figure 6-12C). IgG 
were detected at extremely low levels at 7 dpi and gradually increased in titre 
throughout the remaining course of the experiment although never reached the 
high titres detected in sheep infected with the same virus (Figure 6-12D, P≤0.01 
at 28 dpi). Moreover, the production of BTV neutralising antibodies in goats was 
also delayed compared to sheep infected with the same BTV-8 strain. Although 
non statistically significantly difference were present, it's worth noticing that In 
goats, neutralising antibodies were not present at 7 dpi; one of the three 
infected animals produced neutralising antibodies at 10 dpi (3 days after sheep) 
while in the other two goats we could only detect neutralising antibody 
production starting from 14 and 21 dpi, respectively (Figure 6-12E). Finally, in 
the BTV-8 infected goats IgG avidity did not differed substantially from sheep 
infected with the same virus (Figure 6-12F). Interestingly, the last goat to 
develop neutralising antibodies was the same animal that presented a delayed 
peak of viremia and fever. The delay in neutralising antibodies and IgG 
production observed in goats, do not seem to affect negatively the clinical 
outcome of disease as for sheep. This might indicate the presence of different 
protective mechanisms acting effectively in goat, such as type I IFN response or 
cell-mediated activity.  
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Figure 6-12 Goats infected with BTV8 present a lower viremia and a delayed onset of 
neutralising antibodies. 
Goats were infected with BTV8 (n=3) and monitored for 28 days. Results obtained in BTV8 infected 
sheep are reported for comparative purpose.  (A) Graph showing rectal temperature (average ±SD) 
in goat and sheep infected with BTV8. Goats display only a mild increase in body temperature (B) 
Graph showing BTV RNA (average ±SD) in blood samples of experimentally infected goats and 
sheep. Note that goats present a lower viremia compared to sheep. (C) Graph showing BTV VP7 
IgM titre in the serum of goat infected with BTV8. Serum was collected and tested by ELISA as 
described in Materials and Methods (D) Graph showing BTV VP7 IgG titre assessed by ELISA in 
goats infected with BTV8. (E) Graph showing BTV8 neutralization titres assessed by 
microneutralization assay in serum of goats and sheep infected with BTV8.. Values represent 
average ±SD and are expressed as Log10 of the 50% protective dose (PD50). Note that goats 
present a delayed onset of neutralising antibodies compared to sheep. (F) Graph showing BTV 
VP7 IgG avidity in sheep infected with either BTV8ita or BTV8. Results are expressed as avidity 
index (AI), average ±SD.   (*) = P≤0.05, (**) = P≤0.01, (***) = P≤0.001, (****) = P≤0.0001 by Mann-
Whitney U-test. 
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6.2.8 BTV infection induces a temporary immunosuppression  
In the previous chapters and paragraphs we have shown that BTV-8 infection of 
FDC induces a disruption of the follicle organisation.  As a consequence, the 
anatomical alteration of the cortical area hampers the capacity of B-cell to 
effectively respond to BTV infection. Indeed, we observed a delayed onset of 
neutralising antibodies and in the affinity maturation process when a virulent 
strain was used for infection. 
The presence of complicating and secondary bacterial infections has been 
commonly described during the course of BTV (Umeshappa, Singh, et al. 2010; 
Veronesi et al. 2010; Erasmus 1975) and they have been generally considered a 
consequence of the lymphopenia detected during the early phases of infection. 
We hypothesised that the follicle infection could also be partially responsible of 
the observed immunosuppression and that the impairment of the B-cell 
responses is not only specific for BTV but may have broader implications towards 
other antigens that reach the LN at a second time after infection. 
In order to test this hypothesis, we assessed the ability of BTV-8 infected sheep 
to elicit a humoral response to an exogenous antigen. Hence, we used OVA as a 
model T-dependent antigen to test the capacity of infected follicles to respond 
to immunisation, T-dependent antigens require T-cell help to initiate a germinal 
centre reaction and to produce a high affinity class-switched serological 
response (Grant et al. 2012). The following experiments were planned at the 
CVR, in Glasgow, but were carried out by Dr Noemi Sevilla at the Instituto 
Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) in Madrid, 
Spain. 
A control group of sheep (n=5) was immunised with OVA as described in material 
and methods, without prior BTV infection (Figure 6 13A) and served to monitor a 
normal humoral response in healthy animals. Two additional groups of sheep 
were instead infected with BTV-8 and successively immunised with OVA at either 
24 (n=5) or 72 hpi (n=5). These times of immunisation were chosen to allow BTV 
to reach the draining LNs and induce the disruption of the existing GCs, since we 
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detected the most severe shutdown of Ki67+ B-cells between 24 and 96h hpi. To 
avoid confounding effects that might originate from BTV infection of the skin, 
OVA was inoculated subcutaneously, few centimetres a part from BTV 
inoculation sites, in areas drained by the inguinal or prescapular LNs.. 
Blood and serum were collected at predetermined time points (7, 14 and 21 days 
post-immunisation, dpim), the PBMC was isolated for detection of OVA-specific 
ASC by ELISPOT and OVA-specific antibodies evaluated by ELISAs.  
In control sheep we detected a peak of OVA-specific IgM at 7 dpim (mean 200 
Elisa units, EU) that decreased progressively at 14 and 21 dpim to reach a mean 
of 50 EU. Sheep immunised with OVA at 24h after BTV inoculation demonstrated 
a significant reduction in circulating OVA-specific IgM compared to controls at 7 
dpim (mean 32.4 EU, P<0.01), 14 dpim (mean 23.36 EU, P<0.01) and 21 dpim 
(mean 14.48 EU, P<0.01). 
The OVA-specific IgG response in healthy animals reached a mean of 84.76 EU at 
7 dpim and increased to 101.35 EU at 14 dpim, and 110.86 EU at 21 dpim. The 
corresponding IgG titre in animals immunised 24h after BTV infection was 
significantly lower both at 7 dpim (mean 40.6 EU, P<0.01) and 14 dpi (mean 74 
EU, P<0.05) compared to uninfected controls (FIGURE). 
The quantity of OVA-specific antibody produced was supported by the presence 
of circulating OVA specific ASC, which in control animals presented a peak at 7 
dpim (946.4 ASC/106 PBMC) and progressively decreased at 14 and 21dpim 
(114.2 and 103.8 ASC/106 PBMC respectively).  Strikingly, the formation of OVA-
specific ASC was almost completely ablated in BTV-8 infected animals both at 7 
(2.44 ASC/106 PBMC, P<0.01) and 14 dpim (10.2 ASC/106 PBMC, P<0.01). 
These data indicate that the formation of plasmacells able to produce OVA-
specific IgM and IgG is impaired during the early phases of BTV infection, 
suggesting that the capacity of germinal centres to respond to a second antigen 
has been compromised. 
On the other hand, animals immunized with OVA 72h after BTV infection 
exhibited a less substantial decrease in the levels of OVA-specific antibodies and 
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ASC compared to uninfected controls (Figure 6 13B). The variable results 
obtained at this time point might indicate a certain degree of inter-animal 
variability in the time required to recover GC functionality, with some of the 
sheep able to respond to immunization, and other sheep still non responsive. 
These data demonstrate that the inability of BTV infected sheep to elicit an 
OVA-specific antibody response is temporary. 
In order to further assess the GC functionality we assessed the process of 
somatic hypermutation taking place in the GCs by measuring the degree of 
affinity maturation of OVA-specific antibodies. Specifically, we compared the 
avidity index (AI) of OVA-specific IgG in BTV-infected and control sheep. No 
differences were detected at 7 dpim. However, both groups of sheep immunised 
with OVA after BTV infection (24 and 72 hpi) presented reduced antibody avidity 
at 14 dpim (AI=1.2, P≤0.05 for animal immunised 24 hpi and AI=1.18, P≤0.01 for 
animal immunised 72 hpi) compared to controls (AI=1.84), indicating an 
impairment in the process of affinity maturation in infected LNs that become 
evident as time passes. This difference was maintained also at 21 dpim in animal 
immunised 24 hpi (AI=0.84 P≤0.05, compared to controls AI=1.48). 
Overall these data indicate that BTV infection is not only able to produce a delay 
in virus-specific immune responses, but also capable to affect temporarily the 
ability of B-cells to respond to other incoming antigens. Thus, BTV induces an 
acute immune suppression that can favour the secondary infections described as 
complicating factors for the outcome of bluetongue. 
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Figure 6-13  BTV infection induces a transient immunosuppression 
(A) Experimental design.  Sheep were divided into three groups (n=5 per group). All groups were 
immunized with ovalbumin (OVA). Two of the three groups were previously infected with BTV 
either 24h or 72h before OVA immunization. (B) Graphs showing OVA-specific IgM and IgG titres 
assessed by ELISA, OVA-specific antibody secreting cells (ASC) assessed by ELISPOT and IgG 
avidity assessed by ELISA as described in Material and Methods. Serum was collected at 7, 14 
and 21 dpi. Each dot represents values for an individual sheep and bars represent the average 
values (* P≤0.05 and ** P≤0.01 by Mann-Whitney U-test). Note that sheep immunised with OVA 
24h after BTV infection presented lower IgM and IgG titres and a marked delay in ASC production. 
Both groups of BTV infected animals presented a lower OVA-IgG avidity compared to uninfected 
controls. 
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6.3 Discussion 
In this chapter we have shown that BTV8 rapidly infects and disrupt the FDC 
network present in lymphoid follicles. Our data indicate that this process 
induces an architectural and functional alteration of the GCs present in LNs 
draining the site of infection. Consequently, the early humoral immune response 
against BTV is impaired by the lack of FDC, as assessed by the delayed 
production of high affinity and neutralising antibodies which correlates with the 
severity of disease and the viral strain used. Furthermore, we showed that the 
capacity of B-cells to respond to a different antigenic stimulus is temporary 
hampered during BTV infection. 
To our knowledge this is the first report of FDC depletion directly caused by a 
virus. Pathogen-related depletion of FDC has been previously described during 
chronic infection with HIV and Leishmania (Smelt et al. 1997; Heesters et al. 
2015) as a result of CD8 T-cell mediated cytotoxic activity. Our data, on the 
contrary, are consistent with a direct CPE of the virus, given the rapidity of the 
cellular depletion (4-24 hpi), the abundant presence of BTV antigens in FDC and 
the increase in the number of apoptotic cells in the follicles.  
The capacity of the host to respond promptly to infection, by mounting an 
adequate humoral response is of paramount importance for pathogen control 
and clearance. The data presented in this chapter demonstrate that the 
disruption of FDC correlates with a sudden shutdown of centroblasts replication, 
blocking somatic hypermutation in the dark zone of the follicles that leads to 
the production of high affinity antibodies.  
The extent of the damage induced to the lymphoid follicles appears to be 
directly correlated to the virulence of the virus strain. We tested virulent and 
attenuated strains of BTV and we noticed that sheep infected with the 
attenuated BTV8H, that did not induce fever and viremia, presented an earlier 
recovery of GCs, higher neutralization titres and BTV specific antibodies with 
increased avidity.  BTV8H possesses attenuating mutations in several viral 
proteins hampering optimal replication both in vitro in primary cells, and in vivo 
in sheep and IFNAR-/- mice (Janowicz et al. 2015), hence it is probably 
outcompeted by the immune responses of the host. 
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To contrast a rapidly multiplying virus any delay in the development of an 
appropriate antibody response could favour virus dissemination in peripheral 
tissues. Indeed, passive serum transfer studies demonstrated that antibodies can 
confer full protection in newly infected sheep (Jeggo, Wardley & Taylor 1984). 
However, in natural occurring BTV infections, infectious viral particles can 
persist in blood for up to 2 months despite the presence of circulating 
neutralising antibodies (Bonneau et al. 2002; Koumbati et al. 1999; Singer et al. 
2001). These observations may suggest that once BTV has reached the blood, the 
neutralising antibodies have a limited capability to target and eliminate the 
virus, possibly due to the capacity of BTV to be sequestered in invaginations of 
the RBCs membrane where it cannot be reached by antibodies (Brewer & 
MacLachlan 1992). Hence, it is likely that even a slight delay in the production of 
neutralising antibodies and in the process of antibodies affinity maturation could 
confer an advantage to the systemic distribution of non-attenuated strains of 
BTV and might explain the differences observed with regards to the variability of 
clinical disease.  
In this chapter we characterised the humoral immune response elicited in sheep 
by different strains of BTV-8. We could not detect any major differences related 
to the presence of GCs, neutralising antibodies, onset and levels of IgM/IgG and 
IgG avidity in sheep infected by the Netherlands (BTV-8) and Italian (BTV8IT2008) 
strains of BTV. The latter was reported to be attenuated in both field and 
experimental infections (Caporale et al. 2014). However the discrepancies that 
we observed could reflect the small number of animals tested in this particular 
experiment (3 per group) that does not allow discerning subtle differences that 
might be visible on a larger population scale. We found instead tangible 
differences in the type of humoral immune response elicited in sheep inoculated 
with blood collected from a BTV-8 infected animal (BTV8blood). In this case, we 
noticed a significant delay of both IgM and IgG production that were associated 
with a more severe clinical presentation of disease and a higher viremia. It is 
interesting to note that these animals presented a delayed peak (but with 
relatively higher levels) of IgM compared to sheep infected with wild-type or 
attenuated BTV-8. It might be noteworthy to investigate if this was caused by an 
even more severe insult to the GCs, which could affect for a longer period of 
time the capacity of B-cells to undergo class switch recombination. A similar 
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process is described in the human hyper IgM syndromes (HIGM), where 
individuals affected present a group of primary immune deficiency disorders 
characterized by defective CD40 signalling by B-cells (Etzioni & Ochs 2004; 
Renshaw et al. 1994) which results in an altered class switch recombination and 
somatic hypermutation. Individuals with HIGM present decreased concentrations 
of serum IgG and IgA and normal or elevated IgM, leading to increased 
susceptibility to infections.  
Interestingly, sheep infected with infectious blood (BTV8blood) did not develop 
neutralising antibodies until 14 dpi, much later than sheep inoculated with tissue 
culture isolated BTV strains. Considering the worse disease presented by 
BTV8blood infected sheep, the complete lack of neutralising antibodies seems to 
have a negative impact on the clinical presentation and on the level of viremia 
presented by sheep.  Caporale et al. have recently shown that virus passaging in 
tissue culture can lead to adaptive changes in the viral genotype, in particular a 
genetic bottleneck was observed after viral passaging in mammalian BHK21 cells 
which lower the degree of the population variability compared to the viral 
quasispecies represented in blood (Caporale et al. 2014). Hence, this and other 
factors could contribute to the higher virulence displayed by a non-tissue culture 
passaged virus and could contribute to a more severe effect of BTV on the GCs. 
Curiously, while the lack of early neutralising antibodies seems to correlate with 
disease severity in sheep, this has not been observed in goats. Data presented 
show that unapparent or mild disease in goat is not accompanied by the 
presence of early neutralising antibodies, which tend to appear only 2 weeks 
after infection. Although different explanations could exist, it is possible that 
goats, unlike sheep, benefit of a T-helper1 (TH1) polarised immune response that 
is more efficient in counteracting BTV infection, while sheep may lean towards a 
T-helper2 (TH2) response that favours antibody production. However, further 
studies would be necessary to identify the determinants of species specificity of 
the immune responses and the role of T-cells in BTV infection. 
It is worth noting that in essentially all the experimentally infected sheep and 
goats used in this study, independently from the BTV strain used for infection, 
we observed the appearance of IgG in concomitance with the detection of 
neutralising antibodies. This observation suggests that BTV specific IgM do not 
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possess neutralising capacity. Hence, the processes of class switching and IgG 
affinity maturation are critical for the selection of B-cell clones targeting BTV 
neutralising epitopes.  
Our results demonstrated a rapid disappearance of the FDC network as a result 
of BTV infection. The maintenance of FDC in the follicles requires a continual 
interaction with B-cells expressing lymphotoxin alpha/beta (LTα/β); indeed, it 
has been demonstrated that FDC can rapidly collapse from their mature state 
and lose their capacity of retaining immune complexes within 24 h when 
deprived of LTα/β (Mackay & Browning 1998). 
Studies of the function of FDC have been performed in mouse models where 
their ablation was achieved trough an interference with tumour necrosis factor-
alpha (TNF-α) and LTα/β signalling (Mackay & Browning 1998), or by depletion of 
the genes that encode for these cytokines (Alimzhanov et al. 1997; Koni et al. 
1997; Matsumoto et al. 1997). These mice show an abnormal formation of the 
GCs and the production of low affinity antibodies (Koni & Flavell 1999). 
However, inference made about FDC in these studies are confounded by the fact 
that the lack of LTα or β induces a variety of alterations that are not only 
affecting FDC but many other cells and the development of the lymphoid tissues 
in general. For example, mice with a disrupted LTα or LTβ gene also lack LNs 
and Peyer’s patches (PP), and show profound defects of the splenic architecture. 
We have shown that BTV specifically targets and eliminates FDC in sheep and 
goats, making this experimental platform a useful model for the study of the 
depletion of FDC and the derived consequences. The phenotype that we describe 
in sheep, following FDC depletion, is similar to the one previously described in 
mouse, in regards of the impairment of GC functionality and antibody response. 
Cyster and colleagues described that upon FDC ablation, B-cells form 
disorganized bands of cells around T zones (Wang et al. 2011), in our 
observations, the B-cell scattering was limited, and follicular structures were 
still somewhat recognisable throughout the course of the experiment in the 
cortical area of infected LNs.  
GCs are generally described as dynamic anatomical structures that can be re-
utilised during immune responses to unrelated antigens (Schwickert et al. 2009), 
meaning that they are not supposed to undergo a regressive process upon a 
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subsequent immunisation.  Hence, it was surprisingly to observe the shut down 
and dispersal of B-cells during the early phases of BTV infection, since a similar 
effect has not been previously described in any other infection. The possibility 
that a pathogen could turn off these structures, manipulating host responses for 
its own advantage, is a novel finding and can open the door for the 
interpretation of similar observations made in unrelated pathological conditions. 
Our data show that BTV infection and disruption of FDC impairs the capacity of 
B-cells to respond to a subsequent antigenic stimulus by producing high affinity 
antibodies. In essence, BTV induces a transitory immunosuppression. Indeed, we 
found the titre and avidity of serum IgG and the number of ASC towards a second 
antigen (OVA) to be significantly lower in the presence of BTV. Interestingly, the 
lack of FDC induced also a delay in the IgM response against OVA, indicating that 
FDC can influence B-cell responses at various levels of maturation as suggested 
by previous in vitro studies (Aydar et al. 2005). The subversion of the host 
humoral immune response during BTV infection is however transient. Infected 
animals become responsive to newly administered exogenous antigen after a 
short time frame (3 days) although they still present a delay in the affinity 
maturation process, which is therefore the last function of the GCs to recover 
after FDC insult.  Although transient, this immunosuppression occurs at a key 
stage of infection, during which delayed antibody production is likely to affect 
the systemic spread of the virus and the clinical course of the disease. 
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7 Conclusions 
Globalization, ecological and climate changes and an increase in international 
travel have all favoured the geographic expansion of numerous arboviruses 
(arthropod-borne viruses) that now pose a considerable global burden to both 
human and animal health (Weaver & Reisen 2010). Similarly to other infectious 
agents, arboviruses induce a wide spectrum of clinical signs in the infected hosts 
and the clinical outcome of these infections is influenced by host- and pathogen-
related factors. Consequently, the characterization of the complex interactions 
between virus and host are critical for better understanding the pathogenesis of 
arbovirus infections.  
Arboviruses cause acute diseases making the study of the early stages of 
infection (i.e. before the onset of clinical signs) and the corresponding host 
responses in humans extremely difficult. Mouse models are widely used but they 
often fail to fully replicate the intricate interplay between host and pathogen, 
which is shaped by co-evolutionary adaptations. However, arboviruses naturally 
infect a variety of mammalian species providing opportunities to study viral 
infection in the natural host. In this study we used BTV, since observations made 
in the naturally occurring infection can be effectively reproduced in a 
convenient experimental setting using the same target animal species (Caporale 
et al. 2014). Studies on bluetongue in ruminants offer the unique perspectives of 
understanding arbovirus pathogenesis in the natural host. 
After gaining entry into the mammalian host, an arbovirus needs to overcome 
host antiviral responses in order to replicate abundantly in susceptible cells and 
produce sufficiently high titres in the bloodstream to be infectious for 
competent biting insects. In this study, we tracked the distribution of BTV in the 
infected animals after intradermal inoculation and we noticed that during the 
initial 48 h, BTV resides solely in the skin (at the inoculation site) and the 
corresponding draining LN. Therefore, we reasoned that the early events of viral 
replication taking place at these sites are key in establishing a successful 
infection in the host and may be critical in determining the clinical outcome of 
bluetongue.  
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One of the key discoveries made during this project was that BTV infects and 
disrupts FDC in the peripheral LNs. In turn, the lack of FDC impairs B-cell 
activation and division, and leads to disorganization of the GCs. This process 
induces an acute immunosuppression, characterised by the temporary inability 
of the B-cells to respond to antigenic stimuli. Hence, we describe for the first 
time a new strategy used by an arbovirus to modulate host immunity and we 
demonstrate how the early stages of infection can influence the severity of 
disease.    
The experimental infection of the natural host has the advantage to recapitulate 
the immunopathological events leading to disease in their entirety. Moreover, 
the sheep included in our experiments have been naturally exposed to 
environmental pathogens and commensals, which also contribute to shape the 
host immune system. Indeed, in the LNs of these sheep we found the presence of 
numerous GCs preceding infection with BTV. GCs are generally missing in 
laboratory mice kept in clean animal facilities. Therefore, the virus-induced 
lesions that we described in this study would have been difficult to observe in 
conventional murine models.  
It is becoming increasingly evident that viral infections can target the stromal 
network of cells that compose the lymphoid organs, inducing the disruption of 
the anatomic integrity and loss of immunocompetence. For example, 
lymphocytic choriomeningitis virus (LCMV) directly infects FRC in mouse spleen 
and LNs. This infection results in a T-cytotoxic mediated destruction of FRC and 
an altered functionality of the LN conduit network that contributes to viral 
persistence (Mueller et al. 2007; Scandella et al. 2008). Similarly, during highly 
pathogenic infections of non-human primates such as Ebola virus, Marburg virus 
and Lassa virus it is possible to observe a severe damage to secondary lymphoid 
organs attributed to the infection of FRC and endothelial cells, which is 
accompanied by a considerable level of cell death (Davis & Anderson 1997; 
Steele et al. 2009; Geisbert et al. 2003). It is interesting to note that in humans, 
fatal cases of Ebola are characterised by impaired humoral responses, with 
barely detectable levels of specific IgM and no IgG. In contrast, Ebola survivors 
present, from the early stages of infection, increasing levels of IgG directed 
against viral protein, followed by clearance of circulating viral antigen and 
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activation of cytotoxic T cells (Baize et al. 1999; Rowe et al. 1999). A defect in 
adaptive immunity if often associated with the severe outcome of viral 
haemorrhagic fevers, such as bluetongue, and our data indicate that this is at 
least in part due to the virulence of the viral strain and the extent of damage 
that it induces to the germinal centres. 
An impairment of the humoral immune response has also been observed during 
other arboviral infections, including those caused by West Nile virus (Diamond et 
al. 2003), Japanese encephalitis virus (Burke et al. 1985; Libraty et al. 2002) and 
Crimean-Congo haemorrhagic fever virus (Shepherd et al. 1989). However, virus 
infection of the lymphoid stromal cells was not linked to immunosuppression in 
any of the above mentioned cases.  
Current observations indicate that at least four factors can impair an early 
neutralizing-antibody response. These include (i) a low frequency of germline-
encoded immunoglobulin V-regions encoding neutralizing antibodies, (ii) active 
modification of the B-cell repertoire by depletion of certain B-cell subsets, (iii) 
induction of abnormal TH-cell function resulting in polyclonal B-cell activation, 
and (iv) immunopathological changes in secondary lymphoid organs (Hangartner 
et al. 2006). Our findings fall into the latter category, however we cannot 
completely exclude the possibility that any of the other factors could also 
contribute to the immune dysregulation that we observed in BTV infected sheep. 
In particular, BTV has been described to infect DCs in the lymph draining the 
infected skin (Hemati et al. 2009). Antigen presentation from DCs to TH cells in 
the LN is required to initiate the GC reaction and antibody production. Thus, an 
alteration of DCs, behaviour or density, consequent to virus infection could 
impact the activation of TH-cells and the resulting antibody response. Although 
in extremely rare cases, we found BTV-infected DCs in sheep LNs and our data 
highlighted a difference in the degree of DCs infection between sheep and goats. 
In light of these findings, it would be of interest to characterise the outcome of 
DCs infection in different animal species, to evaluate how this aspect can 
differentially influence the host immune responses. 
As observed in other studies (Ratinier et al. 2016; Caporale et al. 2014; Pages et 
al. 2014) we confirmed that the onset of neutralising antibodies is delayed in 
sheep infected with virulent strains of BTV (BTV-8 or BTV8blood) compared to 
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sheep inoculated with the attenuated BTV8H. Furthermore, we clearly show that 
the process of antibody affinity maturation is delayed in sheep infected with 
virulent strains. Therefore we provide a link between the immunopathology 
described in the infected LNs, the humoral response (neutralising antibody and 
affinity maturation) and the outcome of infection.  
In general, it is worth noting that presence of neutralising antibodies in vitro 
does not necessarily correlate with in vivo protection. Indeed, it has been 
demonstrated that in vivo protection is influenced by both the concentration of 
neutralising antibodies and by their avidity. Antibodies below a certain threshold 
of avidity fail to confer protection even when administered at elevated 
concentrations (Bachmann 1997). Hence, it is reasonable to assume that animals 
infected with attenuated BTV strains would acquire an earlier protection in 
comparison to the ones infected with virulent strains and that this would 
contribute to slowing or halting viral systemic spread. Furthermore, the 
induction of a non-protective low avidity antibody response, under some 
conditions can results in enhanced disease upon reinfection, as demonstrated by 
vaccination against respiratory syncytial virus (Delgado et al. 2009) and measles 
virus (Polack et al. 2003; Polack et al. 1999) where the presence of low-avidity 
antibodies contributed to disease severity through the formation of immune 
complexes and their deposition in various tissues. Curiously, the clinical 
presentation of the vaccine-induced atypical measles resembles many aspects of 
bluetongue, being characterised by high fever, vesicular or petechial rash, 
severe pneumonitis accompanied by pleural effusions, hilar adenopathy, 
peripheral oedema, and finally shock. 
The pathogenic effects of the lack of affinity maturation of BTV specific humoral 
responses would require further assessment (such as the evaluation of 
circulating immune complexes and its correlation to disease severity), in order 
to evaluate if an enhancement of disease could be ascribed to a deleterious 
effect of the impaired antibody responses. Evidence of a secondary reaction to 
BTV-specific antibodies, and a pathogenic process involving type I 
hypersensitivity have been identified in cattle but never characterised into 
details (Odeón et al. 1999; Anderson et al. 1987; Stott et al. 1982). 
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Our results show that BTV, by affecting the structural integrity of GCs, induces 
an acute immunosuppression in BTV infected animals, characterised by a 
dysregulation of B-cell responses. Sheep immunised with a different antigen 
(OVA) during the early phases of infection, failed to respond to immunisation 
and produce antibodies. This transitory immunosuppression could have serious 
repercussion in inducing disease complications and favouring the secondary 
microbial infections sometimes reported during bluetongue (Umeshappa, Singh, 
et al. 2010; Veronesi et al. 2010; Erasmus 1975). When planning vaccination 
campaigns, it will be important to consider that this immunosuppressive phase 
happens during the unapparent initial stages of BTV infection. Therefore, it is 
likely that in this condition, healthy looking animals subjected to routine herd 
vaccinations may return a poor immune response and results unprotected, 
determining vaccine failure. 
It is also interesting to note that the onset and type of antibody response during 
BTV infection varies significantly depending on the kind of inoculum used (blood 
or virus isolate), the species involved (sheep or goats) and the viral strain (BTV-
8, BTV8IT2008, BTV8H).  Notwithstanding small fluctuations, that could be likely 
ascribed to individual susceptibility, group of animals of the same species, when 
infected with the same inoculum tended to present a similar humoral immune 
response, in term of IgM onset and peak, IgG onset and titres, production of 
neutralising antibodies and serum avidity. These findings highlight the presence 
of species-specific factors able to influence the outcome of BTV infection. 
It is also important to highlight that in this study, in order to characterise the 
tropism of BTV, we overcame the lack of reagents available to identify sheep 
cell markers by screening a panel of over 60 antibodies. This allowed the novel 
identification of different populations of sheep antigen presenting cells and 
lymphoid stromal cells residing in the LN. These markers will be useful for other 
studies in ruminants, since we believe that an increased awareness of the 
diversity of the antiviral responses in different animal species would be of 
benefit to the fields of viral pathogenesis and immunity which have relied almost 
exclusively on mouse models. The use of a large animal model allowed us to 
dissect experimentally an arbovirus infection at the whole organism, tissue and 
cellular level in the natural target host. This was key in discovering the novel 
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effects reported in this study. Mouse models of arbovirus infection are limited by 
the fact that they generally lack a fully competent immune system in order to 
permit virus replication. Indeed, our histological analysis of infected mouse LNs 
after BTV infection revealed a different localization of BTV infected cells 
compared to sheep LN. 
In conclusion, this is the first study demonstrating induction of a transient 
immunosuppression by an arbovirus, and this is also the first report linking 
immunosuppression with virus infection and destruction of FDC. Our study has 
therefore shown how virus infection of FDC can subvert the host humoral 
responses and this can inform our understanding of the pathogenesis of many 
other human and animal arbovirus infections. The identification of this 
pathogenic process opens a way to explore previously uncharacterized 
mechanisms of arbovirus-host interactions and pathogenesis. Virus infection of 
FDC can also offers new avenues in understanding the origin of these cells and 
the key role they play in the biology of GCs and initiation of immune response 
(Figure 7-1) 
 
Figure 7-1 Graphic summary 
Normal germinal centres (GCs) (left) present follicular dendritic cells (FDC) in the light zone and 
reticular cells in the dark zone. In the dark zone, dividing B-cells, called centroblasts, undergo 
somatic hypermutation and clones with high affinity for the antigen are selected to differentiate into 
plasmacells and produce antibodies. Bluetongue virus (BTV) infects and destroys follicular 
dendritic cells and reticular cells in the germinal centres of infected animals. As a consequence we 
observe GCs disorganization, characterised by a shut down of centroblasts division and B-cell 
dispersion. Infected GCs are not able to respond to the virus or other antigens, such as ovalbumin 
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(OVA), in a timely manner. A delay in high affinity and neutralising antibodies can likely favour BTV 
dissemination in the animal tissues. 
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